CN1993342A - Intermediates for the preparation of halichondrin b - Google Patents
Intermediates for the preparation of halichondrin b Download PDFInfo
- Publication number
- CN1993342A CN1993342A CN 200580026228 CN200580026228A CN1993342A CN 1993342 A CN1993342 A CN 1993342A CN 200580026228 CN200580026228 CN 200580026228 CN 200580026228 A CN200580026228 A CN 200580026228A CN 1993342 A CN1993342 A CN 1993342A
- Authority
- CN
- China
- Prior art keywords
- vol
- added
- solution
- reaction
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
相关申请的交叉参考Cross References to Related Applications
本申请要求2004年6月3日提交的美国临时专利申请60/576,642、2004年11月10日提交的60/626,769和2005年3月18日提交的60/663,300的优先权,将上述各申请全部内容引入本文作为参考。This application claims priority to U.S. Provisional Patent Applications 60/576,642, filed June 3, 2004, 60/626,769, filed November 10, 2004, and 60/663,300, filed March 18, 2005, by The entire contents are incorporated herein by reference.
技术领域Technical field
本发明涉及在合成药用活性大环内酯化合物中,用作中间体的化合物。The present invention relates to compounds used as intermediates in the synthesis of pharmaceutically active macrolide compounds.
发明背景Background of the Invention
本发明涉及药用活性大环内酯,其合成以及其合成所用的中间体。软海绵素B(Halichondrin B)是一种有效的抗癌剂,最初从海洋海绵黑色软海绵(Halichondria okadai))中分离出来,随后在小轴海绵属(Axinella sp.)、Phakellia carteri和扁矛海绵属(Lissonderndryx sp.)中发现。1992年公布了软海绵素B的全合成(Aicher,T.D.等,J.Am.Chem.Soc.114:3162-3164)。已证明软海绵素B在体外抑制微管蛋白聚合、微管装配、βs-微管蛋白交联、GTP及长春花碱与微管蛋白结合以及依赖于微管蛋白的GTP水解,其在体外及体内均已显示出抗癌特性。因此,需要对制备用作抗癌剂的软海绵素B类似物的合成方法进行开发。The present invention relates to pharmaceutically active macrocyclic lactone, its synthesis and the intermediate used in its synthesis. Halichondrin B, a potent anticancer agent, was originally isolated from the marine sponge Halichondria okadai and subsequently found in Axinella sp. Found in the sponge genus (Lissonderndryx sp.). The total synthesis of halichondrin B was published in 1992 (Aicher, TD et al., J. Am. Chem. Soc. 114:3162-3164). Halichondrin B has been shown to inhibit tubulin polymerization, microtubule assembly, β s -tubulin cross-linking, GTP and vinblastine binding to tubulin and tubulin-dependent GTP hydrolysis in vitro. and have shown anticancer properties in vivo. Therefore, there is a need for the development of synthetic methods for the preparation of halichondrin B analogs useful as anticancer agents.
发明概述Invention Overview
如本文所述,本发明提供制备具有如抗癌活性或抗有丝分裂(阻断有丝分裂)活性等药用活性的软海绵素B类似物的方法。这些化合物包括式B-1939的化合物:As described herein, the present invention provides methods for preparing halichondrin B analogs having pharmaceutically useful activities such as anticancer activity or antimitotic (blocking mitosis) activity. These compounds include compounds of formula B-1939:
这些化合物用于治疗癌症和其它增生性疾病,包括但不限于黑素瘤、纤维肉瘤、白血病、结肠癌、卵巢癌、乳腺癌、骨肉瘤、前列腺癌、肺癌和ras转化的成纤维细胞。本发明还提供用于制备所述软海绵素B类似物的合成中间体。These compounds are useful in the treatment of cancer and other proliferative diseases including, but not limited to, melanoma, fibrosarcoma, leukemia, colon cancer, ovarian cancer, breast cancer, osteosarcoma, prostate cancer, lung cancer, and ras-transformed fibroblasts. The present invention also provides synthetic intermediates for preparing the halichondrin B analogs.
本发明某些实施方式的详述A detailed description of certain embodiments of the present invention
本发明的方法和中间体用于制备在诸如美国专利6,365,759和美国专利6,469,182(引入本文作为参考)中所描述的各种软海绵素B类似物。如以下方案I所示,总体上通过对三个片段F-1、F-2和F-3的组装来制备软海绵素B类似物。The methods and intermediates of the present invention are useful in the preparation of various halichondrin B analogs as described in, for example, US Patent 6,365,759 and US Patent 6,469,182 (incorporated herein by reference). As shown in Scheme I below, halichondrin B analogs were generally prepared by the assembly of three fragments F-1, F-2 and F-3.
方案IOption I
1、片段F-11. Fragment F-1
根据一种实施方式,本发明提供化合物F-1:According to one embodiment, the present invention provides compound F-1:
其中:PG1和PG2各自独立为氢或合适的羟基保护基;Wherein: PG 1 and PG 2 are each independently hydrogen or a suitable hydroxyl protecting group;
R1为R或OR;R 1 is R or OR;
R2为CHO或-CH=CH2;以及R 2 is CHO or -CH=CH 2 ; and
每个R独立为氢、C1-4卤代脂族基、苄基或C1-4脂族基,条件是当R1为OMe时,PG1和PG2不形成丙酮化合物基团。Each R is independently hydrogen, C 1-4 haloaliphatic, benzyl, or C 1-4 aliphatic, with the proviso that when R 1 is OMe, PG 1 and PG 2 do not form an acetonide group.
某些实施方式中,R1为OR。其它实施方式中,R1为OR,其中R为氢、甲基或苄基。In certain embodiments, R 1 is OR. In other embodiments, R 1 is OR, wherein R is hydrogen, methyl or benzyl.
某些实施方式中,PG1和PG2为氢。其它实施方式中,PG1和PG2中的一个为氢。In certain embodiments, PG 1 and PG 2 are hydrogen. In other embodiments, one of PG 1 and PG 2 is hydrogen.
合适的羟基保护基为本领域所熟知,包括在“有机合成中的保护基团(protecting Groups in organic synthesis)”(T.W.Greene和P.G.M.Wuts,第3版,John Wiley & Sons,1999,其全文引入本文作为参考)中详述的那些基团。某些实施方式中,PG1和PG2各自连同与之结合的氧原子一起独立选自酯、醚、甲硅烷基醚、烷基醚、芳基烷基醚和烷氧基烷基醚。这种酯的例子包括甲酸脂、乙酸酯、碳酸酯和磺酸酯。具体的例子包括甲酸酯、苯甲酰甲酸酯、氯乙酸酯、三氟乙酸酯、甲氧基乙酸酯、三苯基甲氧基乙酸酯、对氯苯氧基乙酸酯、3-苯基丙酸酯、4-氧代戊酸酯、4,4-(亚乙基二硫代)戊酸酯、新戊酸酯(三甲基乙酰基)、巴豆酸酯、4-甲氧基巴豆酸酯、苯甲酸酯、对苄基苯甲酸酯、2,4,6-三甲基苯甲酸酯;或者碳酸酯,例如甲基、9-芴基甲基、乙基、2,2,2-三氯乙基、2-(三甲基甲硅烷基)乙基、2-(苯磺酰)乙基、乙烯基、烯丙基和对硝基苄基碳酸酯。这种甲硅烷基醚的例子包括三甲基甲硅烷基醚、三乙基甲硅烷基醚、叔丁基二甲基甲硅烷基醚、叔丁基二苯基甲硅烷基醚、三异丙基甲硅烷基醚及其它的三烷基甲硅烷基醚。烷基醚包括甲基醚、苄基醚、对甲氧基苄基醚、3,4-二甲氧基苄基醚、三苯甲基醚、叔丁基醚、烯丙基醚以及烯丙氧羰基醚或衍生物。烷氧基烷基醚包括缩醛,例如甲氧基甲基醚、甲硫基甲基醚、(2-甲氧基乙氧基)甲基醚、苄氧基甲基醚、β-(三甲基甲硅烷基)乙氧基甲基醚和四氢吡喃基醚。芳基烷基醚的例子包括苄基醚、对甲氧基苄基醚(MPM)、3,4-二甲氧基苄基醚、O-硝基苄基醚、对硝基苄基醚、对卤代苄基醚、2,6-二氯苄基醚、对氰基苄基醚、2-和4-吡啶甲基醚。Suitable hydroxyl protecting groups are well known in the art and include "Protecting Groups in Organic Synthesis" (TW Greene and PGM Wuts, 3rd Edition, John Wiley & Sons, 1999, which is incorporated herein in its entirety as those groups detailed in reference). In certain embodiments, PG 1 and PG 2 are each independently selected from esters, ethers, silyl ethers, alkyl ethers, aryl alkyl ethers, and alkoxyalkyl ethers, together with the oxygen atoms bound thereto. Examples of such esters include formates, acetates, carbonates and sulfonates. Specific examples include formate, benzoylformate, chloroacetate, trifluoroacetate, methoxyacetate, triphenylmethoxyacetate, p-chlorophenoxyacetate ester, 3-phenylpropionate, 4-oxopentanoate, 4,4-(ethylenedithio)valerate, pivalate (trimethylacetyl), crotonate, 4-Methoxycrotonate, benzoate, p-benzylbenzoate, 2,4,6-trimethylbenzoate; or carbonates such as methyl, 9-fluorenylmethyl , ethyl, 2,2,2-trichloroethyl, 2-(trimethylsilyl)ethyl, 2-(benzenesulfonyl)ethyl, vinyl, allyl and p-nitrobenzyl Carbonate. Examples of such silyl ethers include trimethylsilyl ether, triethylsilyl ether, tert-butyldimethylsilyl ether, tert-butyldiphenylsilyl ether, triisopropyl Alkyl silyl ethers and other trialkyl silyl ethers. Alkyl ethers include methyl ether, benzyl ether, p-methoxybenzyl ether, 3,4-dimethoxybenzyl ether, trityl ether, t-butyl ether, allyl ether, and allyl ether Oxycarbonyl ethers or derivatives. Alkoxyalkyl ethers include acetals such as methoxymethyl ether, methylthiomethyl ether, (2-methoxyethoxy)methyl ether, benzyloxymethyl ether, β-(tri Methylsilyl)ethoxymethyl ether and tetrahydropyranyl ether. Examples of aryl alkyl ethers include benzyl ether, p-methoxybenzyl ether (MPM), 3,4-dimethoxybenzyl ether, O-nitrobenzyl ether, p-nitrobenzyl ether, p-halogenated benzyl ether, 2,6-dichlorobenzyl ether, p-cyanobenzyl ether, 2- and 4-picolyl ether.
某些实施方式中,F-1的PG1和PG2部分中的一个或两个为甲硅烷基醚或芳基烷基醚。其它的实施方式中,F-1的PG1和PG2部分中的一个或两个为叔丁基二甲基甲硅烷基(t-butyldimethylsilyl)或苯甲酰基。另外的实施方式中,F-1的PG1和PG2部分均为叔丁基二甲基甲硅烷基。In certain embodiments, one or both of the PG 1 and PG 2 moieties of F-1 are silyl ethers or aryl alkyl ethers. In other embodiments, one or both of the PG 1 and PG 2 moieties of F-1 is t-butyldimethylsilyl or benzoyl. In another embodiment, the PG 1 and PG 2 moieties of F-1 are both tert-butyldimethylsilyl.
根据另一种实施方式,PG1和PG2连同与它们结合的氧原子一起形成二醇保护基,例如环缩醛或缩酮,此类基团包括亚甲基、亚乙基、亚苄基、异亚丙基、亚环己基和亚环戊基;亚甲硅基衍生物,例如二叔丁基亚甲硅基和1,1,3,3-四异丙基二亚硅氧烷基衍生物;环碳酸酯及环硼酸酯。加入和脱除此类羟基保护基及其它保护基的方法为本领域所熟知,且可得自诸如“保护基(protecting Groups)”(P.J.Kocienski,Thieme,1994)和“有机合成中的保护基团(protective Groups in organicsynthesis)”(T.W.Greene和P.G.M.Wuts,第3版,John Wiley & Sons,1999)。根据另一种实施方式,PG1和PG2共同形成丙酮化合物基。According to another embodiment, PG 1 and PG 2 together with the oxygen atoms bound to them form a diol protecting group such as a cyclic acetal or ketal, such groups include methylene, ethylene, benzylidene , isopropylidene, cyclohexylene and cyclopentylene; silylene derivatives such as di-tert-butylsilylene and 1,1,3,3-tetraisopropyldisiloxane Derivatives; cyclic carbonates and cyclic boronic esters. Methods for the addition and removal of such hydroxyl protecting groups and others are well known in the art and can be obtained from examples such as "Protecting Groups (protecting Groups)" (PJ Kocienski, Thieme, 1994) and "Protecting Groups in Organic Synthesis". (protective Groups in organicsynthesis)" (TW Greene and PGM Wuts, 3rd ed., John Wiley & Sons, 1999). According to another embodiment, PG 1 and PG 2 together form an acetonide group.
根据一种实施方式,R2为CHO。According to one embodiment, R 2 is CHO.
根据另一种实施方式,R2为-CH=CH2。According to another embodiment, R 2 is -CH═CH 2 .
某些实施方式中,本发明提供式F-1的化合物,具有化合物F-1’所示的立体化学:In certain embodiments, the present invention provides compounds of formula F-1, having the stereochemistry shown in compound F-1':
其中每个变量同上文定义以及上文及此处的分类及亚类描述。Each of these variables is as defined above and described in categories and subcategories above and here.
某些实施方式中,提供以下化合物F-1a和F-1b:In certain embodiments, the following compounds F-1a and F-1b are provided:
其中,“TBS”指叔丁基二甲基甲硅烷基。Here, "TBS" means tert-butyldimethylsilyl.
F-1a和F-1b的详细合成在下面的实施例中进行阐述。The detailed synthesis of F-1a and F-1b is illustrated in the Examples below.
2、片段F-22. Fragment F-2
根据另一种实施方式,本发明提供化合物F-2:According to another embodiment, the present invention provides compound F-2:
其中:每个 独立为单键或双键,条件是两个 基不同时为双键;Of which: each independently as a single or double bond, provided that two The base is not a double bond at the same time;
LG1为合适的离去基团;LG 1 is a suitable leaving group;
X为卤素或-OSO2(Ry);X is halogen or -OSO 2 (R y );
Ry为C1-6脂族基或者饱和的、部分不饱和的或完全不饱和的5-7元环,其中Ry任选地被至多3个选自卤素、R、NO2、CN、OR、SR或N(R)2的基团取代;R y is a C 1-6 aliphatic group or a saturated, partially unsaturated or fully unsaturated 5-7 membered ring, wherein R y is optionally replaced by up to 3 members selected from halogen, R, NO 2 , CN, OR, SR or N(R) group substitution;
每个R独立为氢、C1-6卤代脂族基或C1-4脂族基;以及each R is independently hydrogen, C 1-6 haloaliphatic, or C 1-4 aliphatic; and
PG3为合适的羟基保护基。PG 3 is a suitable hydroxyl protecting group.
本文所用的合适的离去基团是容易被需要引入的化学基团取代的化学基团。合适的离去基团为本领域所熟知,例如参见“高等有机化学(Advanced Organic Chemistry)(Jerry March,第4版,pp.351-357,John Wiley and Sons,N.Y.(1992))。此类离去基团包括但不限于卤素、烷氧基、磺酰氧基、任选取代的烷基磺酰氧基、任选取代的烯基磺酰氧基、任选取代的芳基磺酰氧基和重氮基。合适的离去基团的例子包括氯、碘、溴、氟、甲磺酰基、甲苯磺酰基(mesyl)、三氟甲磺酸根(triflate)、硝基苯磺酰基(nosyl)和溴苯磺酰基(brosyl)。某些实施方式中,F-2的LG1部分(moiety)为磺酰氧基、任选取代的烷基磺酰氧基、任选取代的烯基磺酰氧基或任选取代的芳基磺酰氧基。另外的实施方式中,F-2的LG1部分为任选取代的烷基磺酰氧基。其它的实施方式中,F-2的LG1部分为甲磺酰基或甲苯磺酰基。A suitable leaving group as used herein is a chemical group that is readily substituted by the chemical group to be introduced. Suitable leaving groups are well known in the art, see for example "Advanced Organic Chemistry" (Jerry March, 4th edition, pp. 351-357, John Wiley and Sons, NY (1992)). Such Leaving groups include, but are not limited to, halogen, alkoxy, sulfonyloxy, optionally substituted alkylsulfonyloxy, optionally substituted alkenylsulfonyloxy, optionally substituted arylsulfonyloxy and diazo groups. Examples of suitable leaving groups include chlorine, iodine, bromine, fluorine, methanesulfonyl, tosyl (mesyl), triflate (triflate), nitrobenzenesulfonyl (nosyl ) and bromobenzenesulfonyl (brosyl). In certain embodiments, the LG 1 moiety of F-2 is sulfonyloxy, optionally substituted alkylsulfonyloxy, optionally substituted alkenylsulfonyl Acyloxy or optionally substituted arylsulfonyloxy. In another embodiment, the LG1 moiety of F-2 is an optionally substituted alkylsulfonyloxy group. In other embodiments, F-2's The LG 1 moiety is methylsulfonyl or tosyl.
某些实施方式中,F-2的X部分为卤素。另外的实施方式中,F-2的X部分为磺酰氧基、任选取代的烷基磺酰基、任选取代的烯基磺酰基或任选取代的芳基磺酰基。其它实施方式中,F-2的X部分为三氟甲磺酸根。In certain embodiments, the X moiety of F-2 is halogen. In other embodiments, the moiety X of F-2 is sulfonyloxy, optionally substituted alkylsulfonyl, optionally substituted alkenylsulfonyl, or optionally substituted arylsulfonyl. In other embodiments, the moiety X of F-2 is triflate.
某些实施方式中,F-2的PG3部分连同与之结合的氧原子一起为甲硅烷基醚。其它实施方式中,F-2的PG3部分连同与之结合的氧原子一起为酯基。根据本发明的一个方面,F-2的PG3部分连同与之结合的氧原子一起为叔丁基二甲基甲硅烷基。根据本发明的另一个方面,F-2的PG3部分连同与之结合的氧原子一起为新戊酰基或苯甲酰基。In certain embodiments, the PG3 moiety of F-2, together with the oxygen atom bound thereto, is a silyl ether. In other embodiments, the PG3 moiety of F-2, together with the oxygen atom bound thereto, is an ester group. According to one aspect of the invention, the PG3 moiety of F-2 together with the oxygen atom bound thereto is tert-butyldimethylsilyl. According to another aspect of the invention, the PG3 moiety of F-2 together with the oxygen atom bound thereto is pivaloyl or benzoyl.
某些实施方式中,本发明提供式F-2的化合物,具有化合物F-2’所示的立体化学:In certain embodiments, the present invention provides compounds of formula F-2, having the stereochemistry shown in compound F-2':
其中每个变量同上文定义以及上文及此处的分类及亚类描述。Each of these variables is as defined above and described in categories and subcategories above and here.
某些实施方式中,提供化合物F-2a或F-2b:In certain embodiments, compound F-2a or F-2b is provided:
其中“MsO”指甲磺酸根,“TfO”指三氟磺酸根,“Opv”指新戊酸根(pivaloate),“OBz”指苯甲酸根以及“TsO”指甲苯磺酸根。Wherein "MsO" refers to methanesulfonate, "TfO" refers to trifluorosulfonate, "Opv" refers to pivaloate, "OBz" refers to benzoate and "TsO" refers to toluenesulfonate.
另外的实施方式中,本发明提供式F-2b的化合物,其中所述化合物为结晶。根据另一种实施方式,提供式F-2b的化合物,其中所述化合物从链烷溶剂中结晶。某些实施方式中,提供F-2b结晶,其中所述化合物从戊烷或庚烷中结晶。其它实施方式中,提供F-2b结晶,其中所述化合物在约0℃结晶。In another embodiment, the present invention provides a compound of formula F-2b, wherein said compound is crystalline. According to another embodiment, there is provided a compound of formula F-2b, wherein said compound is crystallized from an alkane solvent. In certain embodiments, there is provided crystalline F-2b, wherein said compound is crystallized from pentane or heptane. In other embodiments, there is provided crystalline F-2b, wherein said compound crystallizes at about 0°C.
如以下方案A所示,式F-2的化合物一般由中间体F-2d和F-2e制备。Compounds of formula F-2 are generally prepared from intermediates F-2d and F-2e as shown in Scheme A below.
方案AOption A
因此,本发明的另一个方面是提供式F-2d的化合物:Therefore, another aspect of the present invention provides compounds of formula F-2d:
其中:R’为-CH=CH2或-C(O)H;Wherein: R' is -CH=CH 2 or -C(O)H;
AlK为直链或支链的C1-4脂族基;以及AlK is a linear or branched C 1-4 aliphatic group; and
PG5为合适的羟基保护基。PG 5 is a suitable hydroxyl protecting group.
合适的羟基保护基PG5同上文对化合物F-2的PG3部分的描述和定义。某些实施方式中,PG5连同与之结合的氧原子一起为甲硅烷基醚。另外的实施方式中,PG5为叔丁基二甲基甲硅烷基。Suitable hydroxy protecting groups PG5 are as described and defined above for the PG3 moiety of compound F-2. In certain embodiments, PG 5 together with the oxygen atom bound thereto is a silyl ether. In another embodiment, PG5 is tert-butyldimethylsilyl.
根据一种实施方式,化合物F-2d的AlK部分为甲基。According to one embodiment, the AlK moiety of compound F-2d is methyl.
某些实施方式中,提供式F-2d’的化合物:In certain embodiments, compounds of formula F-2d' are provided:
本发明的另一个方面提供式F-2e的化合物:Another aspect of the invention provides compounds of formula F-2e:
其中:R”为OH、OPG3或LG4;Where: R" is OH, OPG 3 or LG 4 ;
LG4为合适的离去基团;以及LG 4 is a suitable leaving group; and
每个PG3独立为合适的羟基保护基,条件是,当PG3为叔丁基二苯基甲硅烷基时,R”不是OMs。Each PG 3 is independently a suitable hydroxyl protecting group with the proviso that when PG 3 is tert-butyldiphenylsilyl, R" is not OMs.
本领域的普通技术人员能认识到化合物F-2e的R”部分可由OH变换成保护的羟基、OPG3或直接变换成LG4。这种变换为本领域熟练人员所知,尤其包括这里描述的那些。某些实施方式中R”为OH或LG4。式F-2e的离去基团LG4同上文对化合物F-2的LG1部分的描述和定义。某些实施方式中,LG4为甲苯磺酰基或甲磺酰基。One of ordinary skill in the art will recognize that the R" moiety of compound F-2e can be transformed from OH to a protected hydroxyl group, OPG 3 or directly to LG 4. Such transformations are known to those skilled in the art and include, inter alia, those described herein Those. In certain embodiments R" is OH or LG4 . The leaving group LG 4 of formula F-2e is as described and defined above for the LG 1 moiety of compound F-2. In certain embodiments, LG 4 is tosyl or methylsulfonyl.
化合物F-2e的PG3部分同上文对化合物F-2的PG3部分的定义和描述。某些实施方式中,PG3连同与之结合的氧原子一起构成甲硅烷基醚。另外的实施方式中,PG3为叔丁基二苯基甲硅烷基。The PG 3 moiety of compound F-2e is as defined and described above for the PG 3 moiety of compound F-2. In certain embodiments, PG 3 together with the oxygen atom bound thereto constitutes a silyl ether. In another embodiment, PG3 is t-butyldiphenylsilyl.
本发明的又一个方面提供式F-2f的化合物:Yet another aspect of the present invention provides compounds of formula F-2f:
其中AlK、PG3和PG5同一般性定义以及上文和此处的分类及亚类描述。通过本文所述的方法及本领域已知的那些方法,用式F-2f的化合物制备式F-2的化合物。Wherein AlK, PG 3 and PG 5 are the same as the general definition and the classification and subclass descriptions above and here. Compounds of formula F-2 are prepared from compounds of formula F-2f by methods described herein and those known in the art.
F-2a的详细合成在下面的实施例中进行阐述。The detailed synthesis of F-2a is illustrated in the Examples below.
或者,如以下方案II所示,由D-奎尼酸制备式F-2的化合物。式F-2的化合物的详细制备在下面的实施例中进行阐述。Alternatively, compounds of formula F-2 are prepared from D-quinic acid as shown in Scheme II below. The detailed preparation of compounds of formula F-2 is illustrated in the Examples below.
方案IIScheme II
从D-奎尼酸制备式F-2的化合物的另一种方法提供了由中间体12转换成中间体17的另一条路线(如以下方案III所示)。An alternative method for the preparation of compounds of formula F-2 from D-quinic acid provides an alternative route from intermediate 12 to intermediate 17 (shown in Scheme III below).
方案IIIScheme III
以上方案III表示通过Eschenmoser-Tanabe碎裂反应由中间体12制备中间体17的另一种方法,其中每个Rx独立为OPGx或CN,其中PGx为本文所述的合适的羟基保护基。然后根据以上方案II,用中间体17制备式F-2的化合物。Scheme III above shows an alternative method for preparing intermediate 17 from intermediate 12 via Eschenmoser-Tanabe fragmentation, wherein each Rx is independently OPGx or CN, where PGx is a suitable hydroxy protecting group as described herein. Intermediate 17 is then used to prepare compounds of formula F-2 according to Scheme II above.
从D-奎尼酸制备式F-2的化合物的又一种方法提供了由中间体9转换成中间体17的又一条路线(如以下方案IV所示)。Yet another method for the preparation of compounds of formula F-2 from D-quinic acid provides yet another route from intermediate 9 to intermediate 17 (shown in Scheme IV below).
方案IVPlan IV
其中PGy为本文所述的合适的羧基保护基,每个PGx独立为本文所述的合适的羟基保护基。wherein PGy is a suitable carboxy protecting group as described herein, and each PGx is independently a suitable hydroxy protecting group as described herein.
方案V表示用于由D-奎尼酸制备式F-2的化合物的中间体的再一种制备方法。Scheme V represents yet another preparation of intermediates useful in the preparation of compounds of formula F-2 from D-quinic acid.
方案VPlan V
在以上方案V中,中间体7(得自方案II),其中R为甲酯用于制备结晶中间体ER-817664。如以上方案V所述,PG5和PG6各自独立为合适的羟基保护基。某些实施方式中,PG5和PG6共同形成环二醇保护基。其它实施方式中,PG5和PG6共同形成亚环己基保护基。如以上方案V所述,LG5为合适的离去基团。这种合适的离去基团为本领域所熟知,包括本文所述的那些基团。某些实施方式中,LG5为甲磺酰基或甲苯磺酰基。In Scheme V above, Intermediate 7 (from Scheme II), wherein R is the methyl ester, was used to prepare crystalline intermediate ER-817664. As described in Scheme V above, PG5 and PG6 are each independently suitable hydroxyl protecting groups. In certain embodiments, PG 5 and PG 6 together form a cyclic diol protecting group. In other embodiments, PG 5 and PG 6 together form a cyclohexylene protecting group. As described in Scheme V above, LG 5 is a suitable leaving group. Such suitable leaving groups are well known in the art and include those described herein. In certain embodiments, LG 5 is methylsulfonyl or tosyl.
根据另一种实施方式,本发明提供式A的化合物:According to another embodiment, the present invention provides compounds of formula A:
其中: 表示单键或双键;in: Indicates a single or double bond;
n为1、2或3;n is 1, 2 or 3;
PG5和PG6各自独立为合适的羟基保护基;PG 5 and PG 6 are each independently a suitable hydroxyl protecting group;
W为CH-A或C(O);W is CH-A or C(O);
A为氧代或C1-6脂族基,其中A任选地被一个或更多个Q1基团取代;A is oxo or C 1-6 aliphatic, wherein A is optionally substituted by one or more Q groups;
每个Q1独立选自氰基、卤素、叠氮基、氧代、OR、SR、SO2R、OSO2R、N(R)2、NR(CO)R、NR(CO)(CO)R、NR(CO)N(R)2、NR(CO)OR、(CO)OR、O(CO)R、(CO)N(R)2、O(CO)N(R)2或OPG1,其中PG1为合适的羟基保护基,其中:Each Q 1 is independently selected from cyano, halogen, azido, oxo, OR, SR, SO 2 R, OSO 2 R, N(R) 2 , NR(CO)R, NR(CO)(CO) R, NR(CO)N(R) 2 , NR(CO)OR, (CO)OR, O(CO)R, (CO)N(R) 2 , O(CO)N(R) 2 , or OPG 1 , where PG 1 is a suitable hydroxyl protecting group, wherein:
A上的两个Q1任选地结合在一起以形成具有0-4个独立选自氮、氧或硫的杂原子的3-8元的饱和环、部分不饱和环或芳香环;以及 Two Q on A are optionally joined together to form a 3-8 membered saturated, partially unsaturated or aromatic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen or sulfur; and
每个R独立选自氢或任选取代的选自C1-6脂族基;5-10元的饱和碳环、部分不饱和碳环或芳香碳环;或者具有0-4个独立选自氮、氧或硫的杂原子的4-10元的饱和环、部分不饱或环或芳香环的基团,其中:Each R is independently selected from hydrogen or optionally substituted from C 1-6 aliphatic group; 5-10 membered saturated carbocycle, partially unsaturated carbocycle or aromatic carbocycle; or has 0-4 independently selected from 4-10 membered saturated, partially unsaturated or cyclic or aromatic ring groups of nitrogen, oxygen or sulfur heteroatoms, wherein:
同一氮原子上的两个R基任选地与所述氮原子结合在一起,以形成具有1-4个独立选自氮、氧或硫的杂原子的3-8元的饱和环、部分不饱和环或芳香环。Two R groups on the same nitrogen atom are optionally combined with the nitrogen atom to form a 3-8 membered saturated ring with 1-4 heteroatoms independently selected from nitrogen, oxygen or sulfur, partially inert Saturated or aromatic rings.
某些实施方式中,本发明提供式A的化合物,具有式A’所示的立体化学:In certain embodiments, the present invention provides a compound of formula A, having the stereochemistry shown in formula A':
其中每个变量同上文定义以及上文及此处的分类及亚类描述。Each of these variables is as defined above and described in categories and subcategories above and here.
某些实施方式中,本发明提供式A’的化合物,其中A为C(O)且所述化合物具有A’-1结构式:In certain embodiments, the present invention provides compounds of formula A', wherein A is C(O) and said compounds have the formula A'-1:
其中每个变量同上文定义以及上文及此处的分类及亚类描述。Each of these variables is as defined above and described in categories and subcategories above and here.
如上文所一般性定义的,式A和A’的A基为C1-6脂族基,其中A任选地被Q1取代。某些实施方式中,式A和A’的A基为C2-5脂族基,其中A被一个或更多个Q1基团取代。As generally defined above, the A group of formulas A and A' is a C 1-6 aliphatic group, wherein A is optionally substituted by Q 1 . In certain embodiments, the group A of formulas A and A' is a C 2-5 aliphatic group, wherein A is substituted with one or more Q 1 groups.
如上文所一般性定义的,式A和A’的每个Q1基独立选自氰基、卤素、叠氮基、氧代、OR、SR、SO2R、OSO2R、N(R)2、NR(CO)R、NR(CO)(CO)R、NR(CO)N(R)2、NR(CO)OR、(CO)OR、O(CO)R、(CO)N(R)2、O(CO)N(R)2或OPG1,其中PG1为合适的羟基保护基。某些实施方式中,式A和A’的每个Q1基独立选自氰基、卤素、叠氮基、氧代、N(R)2、OR、SR、SO2R或OSO2R。另外的实施方式中,式A和A’的每个Q1基独立选自氰基、卤素、叠氮基、氧代、OR、SR、SO2R、OSO2R、N(R)2、NR(CO)OR、NR(CO)R和O(CO)N(R)2。其它的实施方式中,示例性Q1基包括NH(CO)(CO)-(杂环基或杂芳基)、OSO2-(芳基或取代芳基)、O(CO)NH-(芳基或取代芳基)、氨基烷基、羟基烷基、NH(CO)(CO)-(芳基或取代芳基)、NH(CO)-(烷基)(杂芳基或杂环基)、O(取代的或未取代的烷基)(取代的或未取代的芳基)以及NH(CO)(烷基)(芳基或取代芳基)。As generally defined above, each Q1 group of formulas A and A' is independently selected from cyano, halo, azido, oxo, OR, SR, SO2R , OSO2R , N(R) 2. NR(CO)R, NR(CO)(CO)R, NR(CO)N(R) 2. NR(CO)OR, (CO)OR, O(CO)R, (CO)N(R) ) 2 , O(CO)N(R) 2 or OPG 1 , wherein PG 1 is a suitable hydroxyl protecting group. In certain embodiments, each Q 1 group of formulas A and A' is independently selected from cyano, halo, azido, oxo, N(R) 2 , OR, SR, SO 2 R or OSO 2 R. In another embodiment, each Q 1 group of formulas A and A' is independently selected from cyano, halogen, azido, oxo, OR, SR, SO 2 R, OSO 2 R, N(R) 2 , NR(CO)OR, NR(CO)R, and O(CO)N(R) 2 . In other embodiments, exemplary Q 1 groups include NH(CO)(CO)-(heterocyclyl or heteroaryl), OSO 2 -(aryl or substituted aryl), O(CO)NH-(aryl or substituted aryl), aminoalkyl, hydroxyalkyl, NH(CO)(CO)-(aryl or substituted aryl), NH(CO)-(alkyl)(heteroaryl or heterocyclyl) , O(substituted or unsubstituted alkyl)(substituted or unsubstituted aryl), and NH(CO)(alkyl)(aryl or substituted aryl).
某些实施方式中,式A和A’的A基具有以下特征之一:In some embodiments, the A group of formulas A and A' has one of the following characteristics:
(1)A具有至少一个选自羟基、氨基、叠氮基、卤素和氧代的取代基;(1) A has at least one substituent selected from hydroxyl, amino, azido, halogen and oxo;
(2)A为C1-6烷基,具有至少一个选自羟基、氨基和叠氮基的取代基;(2) A is a C 1-6 alkyl group with at least one substituent selected from hydroxyl, amino and azido;
(3)A具有至少两个独立选自羟基、氨基和叠氮基的取代基;(3) A has at least two substituents independently selected from hydroxyl, amino and azido;
(4)A具有至少两个独立选自羟基和氨基的取代基;(4) A has at least two substituents independently selected from hydroxyl and amino;
(5)A具有至少一个羟基取代基和至少一个氨基取代基;(5) A has at least one hydroxy substituent and at least one amino substituent;
(6)A具有至少两个羟基取代基;(6) A has at least two hydroxyl substituents;
(7)A为取代的C2-4脂族基;(7) A is a substituted C2-4 aliphatic group;
(8)A为取代的C3脂族基;(8) A is a substituted C aliphatic group;
(9)A具有在相对于将A连接至含G环的碳原子的α位上的(S)-羟基或(R)-羟基;以及(9) A has an (S)-hydroxyl or (R)-hydroxyl group at the alpha position relative to the carbon atom attaching A to the G-containing ring; and
(10)A为C1-6饱和脂族基,具有至少一个选自羟基和氰基的取代基。(10) A is a C 1-6 saturated aliphatic group having at least one substituent selected from hydroxyl and cyano.
术语“(S)-羟基”指具有羟基的碳原子的构型为(S)。本发明的实施方式还包括化合物,其中A在相对于与A相连的碳原子的(1)α和γ、(2)β和γ或(3)α和β位的各个碳原子上至少被取代一次。每个α、β和γ碳原子独立具有(R)或(S)构型。某些实施方式中,本发明提供所述化合物,其中A在相对于与A相连的碳原子的α和β位的各个碳原子上至少被取代一次。The term "(S)-hydroxyl" refers to the configuration of the carbon atom having the hydroxyl group as (S). Embodiments of the invention also include compounds wherein A is at least substituted on each carbon atom at the (1) alpha and gamma, (2) beta and gamma, or (3) alpha and beta positions relative to the carbon atom to which A is attached once. Each alpha, beta and gamma carbon atom independently has the (R) or (S) configuration. In certain embodiments, the present invention provides such compounds, wherein A is substituted at least once on each of the carbon atoms alpha and beta relative to the carbon atom to which A is attached.
式A及A’的示例性A基包括2,3-二羟丙基、2-羟乙基、3-羟基-4-全氟丁基、2,4,5-三羟戊基、3-氨基-2-羟丙基、1,2-二羟乙基、2,3-二羟基-4-全氟丁基、3-氰基-2-羟丙基、2-氨基-1-羟乙基、3-叠氮基-2-羟丙基、3,3-二氟-2,4-二羟丁基、2,4-二羟丁基、2-羟基-2-对氟苯基-乙基、-CH2(CO)(取代的或未取代的芳基)、-CH2(CO)(烷基或取代烷基,如卤代烷基或羟烷基)和3,3-二氟-2-羟基戊-4-烯基。Exemplary A groups of formulas A and A' include 2,3-dihydroxypropyl, 2-hydroxyethyl, 3-hydroxy-4-perfluorobutyl, 2,4,5-trihydroxypentyl, 3- Amino-2-hydroxypropyl, 1,2-dihydroxyethyl, 2,3-dihydroxy-4-perfluorobutyl, 3-cyano-2-hydroxypropyl, 2-amino-1-hydroxyethyl Base, 3-azido-2-hydroxypropyl, 3,3-difluoro-2,4-dihydroxybutyl, 2,4-dihydroxybutyl, 2-hydroxy-2-p-fluorophenyl- Ethyl, -CH 2 (CO) (substituted or unsubstituted aryl), -CH 2 (CO) (alkyl or substituted alkyl, such as haloalkyl or hydroxyalkyl) and 3,3-difluoro- 2-Hydroxypent-4-enyl.
某些实施方式中,A和A’之一的A基为3-氨基-2-羟丙基。In certain embodiments, the A group of one of A and A' is 3-amino-2-hydroxypropyl.
根据一个方面,本发明提供一种式A和A’之一的化合物,其中Q1为OPG1,其中PG1为合适的羟基保护基。合适的羟基保护基为本领域所熟知,包括在“有机合成中的保护基团”(T.W.Greene和P.G.M.Wuts,第3版,John Wiley & Sons,1999,将其全文引入本文作为参考)中详述的那些基团。某些实施方式中,式A和A’之一的PG1部分连同与之结合的氧原子一起选自酯、醚、甲硅烷基醚、烷基醚、芳基烷基醚和烷氧基烷基醚。这种酯的例子包括甲酸酯、乙酸酯、碳酸酯和磺酸酯。具体的例子包括甲酸酯、苯甲酰甲酸酯、氯乙酸酯、三氟乙酸酯、甲氧基乙酸酯、三苯基甲氧基乙酸酯、对氯苯氧基乙酸酯、3-苯基丙酸酯、4-氧代戊酸酯、4,4-(亚乙基二硫代)戊酸酯、新戊酸酯(三甲基乙酰基)、巴豆酸酯、4-甲氧基巴豆酸酯、苯甲酸酯、对苄基苯甲酸酯、2,4,6-三甲基苯甲酸酯,或者碳酸酯,例如甲基、9-芴基甲基、乙基、2,2,2-三氯乙基、2-(三甲基甲硅烷基)乙基、2-(苯磺酰)乙基、乙烯基、烯丙基和对硝基苄基碳酸酯。这种甲硅烷基醚的例子包括三甲基甲硅烷基醚、三乙基甲硅烷基醚、叔丁基二甲基甲硅烷基醚、叔丁基二苯基甲硅烷基醚、三异丙基甲硅烷基醚及其它的三烷基甲硅烷基醚。烷基醚包括甲基醚、苄基醚、对甲氧基苄基醚、3,4-二甲氧基苄基醚、三苯甲基醚、叔丁基醚、烯丙基醚以及烯丙氧羰基醚或衍生物。烷氧基烷基醚包括缩醛,例如甲氧基甲基醚、甲硫基甲基醚、(2-甲氧基乙氧基)甲基醚、苄氧基甲基醚、β-(三甲基甲硅烷基)乙氧基甲基醚和四氢吡喃基醚。芳基烷基醚的例子包括苄基醚、对甲氧基苄基醚(MPM)、3,4-二甲氧基苄基醚、O-硝基苄基醚、对硝基苄基醚、对卤代苄基醚、2,6-二氯苄基醚、对氰基苄基醚、2-和4-吡啶甲基醚。According to one aspect, the present invention provides a compound of one of formulas A and A', wherein Q 1 is OPG 1 , wherein PG 1 is a suitable hydroxyl protecting group. Suitable hydroxyl protecting groups are well known in the art and include those detailed in "Protecting Groups in Organic Synthesis" (TW Greene and PGM Wuts, 3rd Ed., John Wiley & Sons, 1999, which is incorporated herein by reference in its entirety). those groups. In certain embodiments, the PG moiety of one of formulas A and A', together with the oxygen atom bound thereto, is selected from esters, ethers, silyl ethers, alkyl ethers, aryl alkyl ethers, and alkoxyalkanes base ether. Examples of such esters include formates, acetates, carbonates and sulfonates. Specific examples include formate, benzoylformate, chloroacetate, trifluoroacetate, methoxyacetate, triphenylmethoxyacetate, p-chlorophenoxyacetate ester, 3-phenylpropionate, 4-oxopentanoate, 4,4-(ethylenedithio)valerate, pivalate (trimethylacetyl), crotonate, 4-Methoxycrotonate, benzoate, p-benzylbenzoate, 2,4,6-trimethylbenzoate, or carbonates such as methyl, 9-fluorenylmethyl , ethyl, 2,2,2-trichloroethyl, 2-(trimethylsilyl)ethyl, 2-(benzenesulfonyl)ethyl, vinyl, allyl and p-nitrobenzyl Carbonate. Examples of such silyl ethers include trimethylsilyl ether, triethylsilyl ether, tert-butyldimethylsilyl ether, tert-butyldiphenylsilyl ether, triisopropyl Alkyl silyl ethers and other trialkyl silyl ethers. Alkyl ethers include methyl ether, benzyl ether, p-methoxybenzyl ether, 3,4-dimethoxybenzyl ether, trityl ether, t-butyl ether, allyl ether, and allyl ether Oxycarbonyl ethers or derivatives. Alkoxyalkyl ethers include acetals such as methoxymethyl ether, methylthiomethyl ether, (2-methoxyethoxy)methyl ether, benzyloxymethyl ether, β-(tri Methylsilyl)ethoxymethyl ether and tetrahydropyranyl ether. Examples of aryl alkyl ethers include benzyl ether, p-methoxybenzyl ether (MPM), 3,4-dimethoxybenzyl ether, O-nitrobenzyl ether, p-nitrobenzyl ether, p-halogenated benzyl ether, 2,6-dichlorobenzyl ether, p-cyanobenzyl ether, 2- and 4-picolyl ether.
某些实施方式中,式A和A’之一的PG1部分连同与之结合的氧原子为甲硅烷基醚或芳基烷基醚。其它的实施方式中,式A和A’之一的PG1部分为叔丁基二甲基硅烷基或苯甲酰基。另外的实施方式中,式A和A’之一的PG1部分为叔丁基二甲基甲硅烷基(“TBS”)。In certain embodiments, the PG1 moiety of one of formulas A and A', together with the oxygen atom bound thereto, is a silyl ether or an arylalkyl ether. In other embodiments, the PG1 moiety of one of formulas A and A' is t-butyldimethylsilyl or benzoyl. In another embodiment, the PG1 moiety of one of Formulas A and A' is tert-butyldimethylsilyl ("TBS").
如上文所一般性定义的,A上的两个Q1任选地结合在一起以形成具有0-4个独立选自氮、氧或硫的杂原子的3-8元的饱和环、部分不饱和环或芳香环。某些实施方式中,A上的两个Q1共同形成环氧化环。As generally defined above, two Q 's on A are optionally joined together to form a 3-8 membered saturated ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, partially not Saturated or aromatic rings. In certain embodiments, two Q 's on A together form an epoxidized ring.
某些实施方式中,式A和A’的PG5和PG6基团独立选自上文对式A和A’的PG1基团所描述的那些合适的保护基。其它实施方式中,式A和A’的PG5和PG6基团结合在一起以形成环二醇保护基。这类二醇保护基为本领域所熟知,包括 Greene所描述的那些基团,且包括亚环己基和亚苄基二醇保护基。In certain embodiments, the PG5 and PG6 groups of formulas A and A' are independently selected from those suitable protecting groups described above for the PG1 groups of formulas A and A'. In other embodiments, the PG5 and PG6 groups of formulas A and A' are combined to form a cyclic diol protecting group. Such diol protecting groups are well known in the art and include those described by Greene , and include cyclohexylene and benzylidene diol protecting groups.
某些实施方式中,本发明根据以下方案V-a、V-b和V-c,提供一种制备式F-2的化合物的方法。In certain embodiments, the present invention provides a method of preparing a compound of formula F-2 according to the following schemes V-a, V-b and V-c.
方案V-aScheme V-a
其它实施方式中,本发明提供ER-817664结晶。In other embodiments, the present invention provides crystalline ER-817664.
方案V-bScheme V-b
方案V-cScheme V-c
以ER-817664作为结晶中间体,方案VI-a表示用该化合物制备用于制备式F-2的化合物的中间体的一种通用方法。Using ER-817664 as a crystallization intermediate, Scheme VI-a shows a general procedure for using this compound to prepare intermediates useful in the preparation of compounds of formula F-2.
方案VI-aScheme VI-a
如以下方案VI-b所示,在另一种制备用于制备式F-2的化合物的中间体的方法中,使用以上方案VI-a所述的三醇中间体。In another method for the preparation of intermediates useful in the preparation of compounds of formula F-2, as shown in Scheme VI-b below, the triol intermediate described in Scheme VI-a above is used.
方案VI-bScheme VI-b
在如上所示的方案VI-b中,用高碘酸盐处理三醇中间体以生成醛。使该化合物与甲基维悌希试剂同系化(homologated),将所得的烯烃还原成酯类化合物。用N-碘代丁二酰亚胺处理剩余的游离羟基以生成碘代中间体,用硼氢化钠还原酯以生成上述羟基化合物。本领域普通技术人员将认识到所得的碘代化合物与以上方案II所述的化合物21相符,其中化合物21在羟基位置上具有保护基。最后经过锌处理得到上述内酯。本领域普通技术人员将认识到所得的内酯化合物与以上方案II所述的化合物22相符,其中化合物22在羟基位置上具有保护基。In Scheme VI-b shown above, the triol intermediate is treated with periodate to generate the aldehyde. This compound is homologated with methyl-Wittig reagent and the resulting olefin is reduced to an ester compound. Treatment of the remaining free hydroxyl with N-iodosuccinimide yields the iodo intermediate and reduction of the ester with sodium borohydride yields the above hydroxyl compound. One of ordinary skill in the art will recognize that the resulting iodo compound corresponds to compound 21 described above in Scheme II, wherein compound 21 has a protecting group at the hydroxyl position. Finally, the above-mentioned lactone is obtained through zinc treatment. One of ordinary skill in the art will recognize that the resulting lactone compound corresponds to compound 22 described above in Scheme II, wherein compound 22 has a protecting group at the hydroxyl position.
如以下方案VII所示,在用于从D-奎尼酸制备式F-2的化合物的中间体的另一种制备方法中,提供了起始于方案II所述的中间体2的又一条路线。In another preparation of intermediates for the preparation of compounds of formula F-2 from D-quinic acid as shown in Scheme VII below, a further route starting from intermediate 2 described in Scheme II is provided route.
方案VIIScheme VII
在以上方案VII中,用中间体2(得自方案II)制备立体选择形式的ER-812829。优选地,其它保护基团可用于保护二醇ER-812829。这类基团为本领域普通技术人员所已知,包括亚环己基和亚苄基二醇保护基。首先,步骤(a)中,用2-溴氯乙酸处理ER-811510的羟基以生成ER-812771。用与Murphy等描述的方法(Tettrahedron Letters,40,(1991)3455-3456)基本相似的方法,以三苯膦处理该溴代中间体以就地(in situ)生成维悌希试剂。然后该维悌希试剂形成内酯ER-812772。步骤(b)中,对双键进行立体选择加氢得到ER-812829。In Scheme VII above, intermediate 2 (from Scheme II) was used to prepare a stereoselective form of ER-812829. Preferably, other protecting groups can be used to protect the diol ER-812829. Such groups are known to those of ordinary skill in the art and include cyclohexylene and benzylidene diol protecting groups. First, in step (a), the hydroxyl group of ER-811510 is treated with 2-bromochloroacetic acid to generate ER-812771. The brominated intermediate was treated with triphenylphosphine to generate the Wittig reagent in situ in a manner substantially similar to that described by Murphy et al. (Tettrahedron Letters, 40, (1991) 3455-3456). The Wittig reagent then forms the lactone ER-812772. In step (b), the double bond is subjected to stereoselective hydrogenation to obtain ER-812829.
如以下方案VII-a所示,本发明还提供一种用于从D-奎尼酸制备式F-2的化合物的中间体的制备方法,该方法起始于以上方案VII所示的中间体ER-812829。As shown in Scheme VII-a below, the present invention also provides a process for the preparation of intermediates for the preparation of compounds of formula F-2 from D-quinic acid, starting from the intermediates shown in Scheme VII above ER-812829.
方案VII-aScheme VII-a
3、片段F-33. Fragment F-3
根据另一种实施方式,本发明提供化合物F-3:According to another embodiment, the present invention provides compound F-3:
其中,每个PG4独立选自合适的羟基保护基;Wherein, each PG 4 is independently selected from a suitable hydroxyl protecting group;
R3为CHO或C(O)OR4;R 3 is CHO or C(O)OR 4 ;
R4为合适的羧基保护基;以及 R is a suitable carboxy protecting group; and
LG2为合适的离去基团。LG 2 is a suitable leaving group.
合适的羧酸酯保护基为本领域所熟知,在“有机合成中的保护基团”(T.W.Greene和P.G.M.Wuts,第3版,John Wiley & Sons,1999)中得到详细描述。某些实施方式中,F-3的R4基为任选取代的C1-6脂族基或任选取代的芳基。合适的R4基的例子包括甲基、乙基、丙基、异丙基、丁基、异丁基、苄基和苯基,其中每个基团任选被取代。Suitable carboxylate protecting groups are well known in the art and are described in detail in "Protecting Groups in Organic Synthesis" (TW Greene and PGM Wuts, 3rd edition, John Wiley & Sons, 1999). In certain embodiments, the R group of F-3 is an optionally substituted C 1-6 aliphatic group or an optionally substituted aryl group. Examples of suitable R groups include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, benzyl and phenyl, each of which is optionally substituted.
如上文所述,合适的离去基团为本领域所熟知,例如参见“高等有机化学(Advanced organic Chemistry)(Jerry March,第4版,pp.351-357,John Wiley and Sons,N.Y.(1992))。此类离去基团包括但不限于卤素、烷氧基、磺酰氧基、任选取代的烷基磺酰氧基、任选取代的烯基磺酰氧基、任选取代的芳基磺酰氧基、甲硅烷基和重氮基(diazonium moieties)。合适的离去基团的例子包括氯、碘、溴、氟、甲磺酰基(mesyl)、甲苯磺酰基、三氟甲磺酸根(triflate)、硝基苯磺酰基(nosyl)和溴苯磺酰基(brosyl)。某些实施方式中,F-3的LG2部分为碘。As noted above, suitable leaving groups are well known in the art, see, for example, "Advanced Organic Chemistry" (Jerry March, 4th Edition, pp. 351-357, John Wiley and Sons, NY (1992 )). Such leaving groups include, but are not limited to, halogen, alkoxy, sulfonyloxy, optionally substituted alkylsulfonyloxy, optionally substituted alkenylsulfonyloxy, optionally substituted Arylsulfonyloxy, silyl and diazonium moieties. Examples of suitable leaving groups include chlorine, iodine, bromine, fluorine, mesyl, tosyl, trifluoromethane Triflate, nosyl, and brosyl. In certain embodiments, the LG 2 moiety of F-3 is iodine.
根据另一种实施方式,合适的离去基团可在反应介质中就地生成。例如,式F-3的化合物中的LG2可由该式F-3的化合物的前体就地生成,其中所述前体含有容易被LG2就地取代的基团。这种取代的一个具体例子中,所述式F-3的化合物的前体含有被例如碘等LG2就地取代的基团(例如,三甲基甲硅烷基)。碘的来源可以为诸如N-碘代丁二酰亚胺等。合适离去基团的这类就地生成已为本领域所熟知,例如参见Id。According to another embodiment, a suitable leaving group can be generated in situ in the reaction medium. For example, LG 2 in a compound of formula F-3 can be generated in situ from a precursor of the compound of formula F-3, wherein the precursor contains a group readily substituted in situ by LG 2 . In a specific example of such substitution, the precursor of the compound of formula F-3 contains a group (eg trimethylsilyl) substituted in situ with LG 2 such as iodine. The source of iodine can be such as N-iodosuccinimide and the like. Such in situ generation of suitable leaving groups is well known in the art, see for example Id.
如上文所述,合适的羟基保护基为本领域所熟知,包括在“有机合成中的保护基团”(T.W.Greene和P.G.M.Wuts,第3版,John Wiley& Sons,1999,将其全文引入本文作为参考)中详述的那些基团。某些实施方式中,每个PG4连同与之结合的氧原子独立选自酯、醚、甲硅烷基醚、烷基醚、芳基烷基醚和烷氧基烷基醚。这类酯的例子包括甲酸酯、乙酸酯、碳酸酯和磺酸酯。具体的例子包括甲酸酯、苯甲酰甲酸酯、氯乙酸酯、三氟乙酸酯、甲氧基乙酸酯、三苯基甲氧基乙酸酯、对氯苯氧乙酸酯、3-苯基丙酸酯、4-氧代戊酸酯、4,4-(亚乙基二硫代)戊酸酯、新戊酸酯(三甲基乙酰基)、巴豆酸酯、4-甲氧基巴豆酸酯、苯甲酸酯、对苄基苯甲酸酯、2,4,6-三甲基苯甲酸酯,或者碳酸酯,例如甲基、9-芴基甲基、乙基、2,2,2-三氯乙基、2-(三甲基甲硅烷基)乙基、2-(苯磺酰)乙基、乙烯基、烯丙基和对硝基苄基碳酸酯。此类甲硅烷基醚包括三甲基甲硅烷基醚、三乙基甲硅烷基醚、叔丁基二甲基甲硅烷基醚、叔丁基二苯基甲硅烷基醚、三异丙基甲硅烷基醚及其它的三烷基甲硅烷基醚。烷基醚包括甲基醚、苄基醚、对甲氧基苄基醚、3,4-二甲氧基苄基醚、三苯甲基醚、叔丁基醚、烯丙基醚以及烯丙氧羰基醚或衍生物。烷氧基烷基醚包括缩醛,例如甲氧基甲基醚、甲硫基甲基醚、(2-甲氧基乙氧基)甲基醚、苄氧基甲基醚、β-(三甲基甲硅烷基)乙氧基甲基醚和四氢吡喃基醚。芳基烷基醚的例子包括苄基醚、对甲氧基苄基醚(MPM)、3,4-二甲氧基苄基醚、O-硝基苄基醚、对硝基苄基醚、对卤代苄基醚、2,6-二氯苄基醚、对氰基苄基醚、2-和4-吡啶甲基醚。As noted above, suitable hydroxyl protecting groups are well known in the art, including in "Protecting Groups in Organic Synthesis" (TW Greene and PGM Wuts, 3rd ed., John Wiley & Sons, 1999, which is incorporated herein by reference in its entirety) those groups detailed in . In certain embodiments, each PG 4 together with the oxygen atom bound thereto is independently selected from esters, ethers, silyl ethers, alkyl ethers, arylalkyl ethers and alkoxyalkyl ethers. Examples of such esters include formates, acetates, carbonates and sulfonates. Specific examples include formate, benzoylformate, chloroacetate, trifluoroacetate, methoxyacetate, triphenylmethoxyacetate, p-chlorophenoxyacetate , 3-phenylpropionate, 4-oxopentanoate, 4,4-(ethylenedithio)pentanoate, pivalate (trimethylacetyl), crotonate, 4 - Methoxycrotonate, benzoate, p-benzylbenzoate, 2,4,6-trimethylbenzoate, or carbonates such as methyl, 9-fluorenylmethyl, Ethyl, 2,2,2-trichloroethyl, 2-(trimethylsilyl)ethyl, 2-(phenylsulfonyl)ethyl, vinyl, allyl and p-nitrobenzyl carbonate ester. Such silyl ethers include trimethylsilyl ether, triethylsilyl ether, tert-butyldimethylsilyl ether, tert-butyldiphenylsilyl ether, triisopropylmethylsilyl ether, Silyl ethers and other trialkylsilyl ethers. Alkyl ethers include methyl ether, benzyl ether, p-methoxybenzyl ether, 3,4-dimethoxybenzyl ether, trityl ether, t-butyl ether, allyl ether, and allyl ether Oxycarbonyl ethers or derivatives. Alkoxyalkyl ethers include acetals such as methoxymethyl ether, methylthiomethyl ether, (2-methoxyethoxy)methyl ether, benzyloxymethyl ether, β-(tri Methylsilyl)ethoxymethyl ether and tetrahydropyranyl ether. Examples of aryl alkyl ethers include benzyl ether, p-methoxybenzyl ether (MPM), 3,4-dimethoxybenzyl ether, O-nitrobenzyl ether, p-nitrobenzyl ether, p-halogenated benzyl ether, 2,6-dichlorobenzyl ether, p-cyanobenzyl ether, 2- and 4-picolyl ether.
某些实施方式中,F-3的PG4部分中的一个、两个或三个连同与它们结合的氧原子一起为甲硅烷基醚或芳基烷基醚。其它实施方式中,F-3的PG4部分中的一个、两个或三个为叔丁基二甲基甲硅烷基或苄基。另外的实施方式中,F-3中的所有三个PG4部分均为叔丁基二甲基甲硅烷基。In certain embodiments, one, two or three of the PG4 moieties of F-3, together with the oxygen atom to which they are bound, are silyl ethers or arylalkyl ethers. In other embodiments, one, two or three of the PG 4 moieties of F-3 are t-butyldimethylsilyl or benzyl. In other embodiments, all three PG 4 moieties in F-3 are tert-butyldimethylsilyl.
根据另一种实施方式,提供式F-3的化合物,其中所述化合物具有式F-3’所示的立体化学:According to another embodiment, a compound of formula F-3 is provided, wherein said compound has the stereochemistry shown in formula F-3':
其中每个变量同上文定义以及上文及此处的分类及亚类描述。Each of these variables is as defined above and described in categories and subcategories above and here.
某些实施方式中,提供化合物F-3a:In certain embodiments, compound F-3a is provided:
其中“TBS”指叔丁基二甲基甲硅烷基。Where "TBS" refers to tert-butyldimethylsilyl.
F-3a的详细合成在下面的实施例中进行阐述。The detailed synthesis of F-3a is illustrated in the Examples below.
4、对F-1、F-2和F-3进行组装以制备化合物I4. Assemble F-1, F-2 and F-3 to prepare compound I
总体上,如以下方案VIII所示,对片段F-1和F-2进行偶合。方案VIIIIn general, fragments F-1 and F-2 were coupled as shown in Scheme VIII below. Scheme VIII
以上方案VIII表示一种由片段F-1和F-2制备中间体F-5a的通用方法。首先,用与Kishi等描述的方法(Org Lett,4:25,p 4431(2002))基本相似的方法,对片段F-1和F-2进行偶合以得到中间体F-4。该偶合在手性唑(ER-807363)存在下进行,抑或在不存在ER-807363条件下进行。但是,ER-807363存在下所进行的F-1与F-2的偶合反应具有更高的选择性。用六甲基二硅基胺基钾(potassiumhexamethyldisilazide)处理F-4,形成F-4的分子内威廉逊醚(williamsonether),然后提供立体异构体混合物形式的四氢吡喃F-5。然后对该立体异构体进行分离,得到F-5a。这三个步骤的详细内容在下面的实施例中进行描述。Scheme VIII above shows a general procedure for the preparation of intermediate F-5a from fragments F-1 and F-2. First, fragments F-1 and F-2 were coupled to obtain intermediate F-4 by a method substantially similar to that described by Kishi et al. (Org Lett, 4:25, p 4431 (2002)). The coupling is carried out in the presence of chiral oxazole (ER-807363) or in the absence of ER-807363. However, the coupling reaction of F-1 and F-2 in the presence of ER-807363 was more selective. Treatment of F-4 with potassium hexamethyldisilazide forms the intramolecular williams onether of F-4, which then provides tetrahydropyran F-5 as a mixture of stereoisomers. The stereoisomers are then separated to afford F-5a. The details of these three steps are described in the Examples below.
根据另一种实施方式,本发明提供化合物F-4:According to another embodiment, the present invention provides compound F-4:
其中PG1、PG2、PG3、LG1和R1同一般性定义以及上文和此处的亚类定义。wherein PG 1 , PG 2 , PG 3 , LG 1 and R 1 are as defined in general and as subclasses above and here.
某些实施方式中,本发明提供式F-4的化合物,其中所述化合物具有式F-4’所示的立体化学:In certain embodiments, the present invention provides a compound of formula F-4, wherein said compound has the stereochemistry shown in formula F-4':
其中PG1、PG2、PG3、LG1和R1同一般性定义以及上文和此处的亚类定义。wherein PG 1 , PG 2 , PG 3 , LG 1 and R 1 are as defined in general and as subclasses above and here.
本发明还提供化合物F-4a:The present invention also provides compound F-4a:
其中“MsO”指甲磺酸根,“TBS”指叔丁基二甲基甲硅烷基,“OPv”指新戊酸根。Where "MsO" refers to methanesulfonate, "TBS" refers to tert-butyldimethylsilyl, and "OPv" refers to pivalate.
F-4a的详细合成在下面的实施例中进行描述。The detailed synthesis of F-4a is described in the Examples below.
根据又一种实施方式,本发明提供化合物F-5。According to yet another embodiment, the present invention provides compound F-5.
其中各PG1、PG2、PG3、LG1和R1同一般性定义以及上文和此处的亚类定义。wherein each of PG 1 , PG 2 , PG 3 , LG 1 and R 1 is as defined generally and as defined above and here for subclasses.
某些实施方式中,本发明提供式F-5的化合物,具有式F-5’或F-5a所示的立体化学。In certain embodiments, the present invention provides compounds of formula F-5 having the stereochemistry of formula F-5' or F-5a.
其中各PG1、PG2、PG3、LG1和R1同一般性定义以及上文和此处的亚类定义。wherein each of PG 1 , PG 2 , PG 3 , LG 1 and R 1 is as defined generally and as defined above and here for subclasses.
如以下方案IX所示,脱除中间体F-5a的PG3基团,然后将所得羟基化合物F-6与化合物F-3a(其中R3为CHO)偶合,以生成F-7。As shown in Scheme IX below, the PG3 group of intermediate F-5a is removed, and the resulting hydroxyl compound F-6 is then coupled with compound F-3a (wherein R3 is CHO) to generate F-7.
方案IXPlan IX
以上方案IX表示由F-3a和F-6制备中间体F-9的一种通用方法。先用正丁基锂和然后用醛F-3a处理砜中间体F-6。然后用Dess-Martin试剂氧化所得的二醇中间体F-7以生成酮-醛中间体F-8,然后用SmI2处理F-8,得到中间体F-9。这些步骤的详细内容在下面的实施例中进行描述。Scheme IX above shows a general procedure for the preparation of intermediate F-9 from F-3a and F-6. The sulfone intermediate F-6 is treated first with n-butyllithium and then with aldehyde F-3a. The resulting diol intermediate F-7 is then oxidized with Dess-Martin reagent to give the keto-aldehyde intermediate F-8, which is then treated with SmI to give intermediate F-9. Details of these steps are described in the Examples below.
方案XProgram X
以上方案X描述一种由F-9a(LG2为碘)制备本发明软海绵素B类似物的通用方法。首先,在与以上方案V所述的那些条件基本相似的条件下,进行分子内偶合以生成羟基化合物F-10。另一种方法中,在本文所述的手性唑配体的存在下进行分子内偶合。加入手性唑配体提高反应产率,增大反应效率。该反应的详细内容在下面的实施例中进行描述。然后将化合物F-10氧化成F-11。用适当的方法脱除F-11的羟基保护基得到F-12。本领域普通技术人员将认识到脱除化合物F-11的保护基的适当方法取决于实际使用的保护基,包括 Greene所述的那些基团。例如,当F-11的各个羟基保护基均为TBS基时,可通过任选缓冲的四丁基氟化铵处理来实现这种脱除。这些步骤的详细内容在下面的实施例中进行描述。Scheme X above describes a general method for the preparation of halichondrin B analogs of the invention from F-9a (LG 2 is iodine). First, under conditions substantially similar to those described in Scheme V above, an intramolecular coupling is performed to generate the hydroxyl compound F-10. In another approach, the intramolecular coupling is performed in the presence of the chiral oxazole ligands described herein. The chiral oxazole ligand is added to increase the reaction yield and increase the reaction efficiency. The details of this reaction are described in the Examples below. Compound F-10 is then oxidized to F-11. The hydroxy protecting group of F-11 is removed by an appropriate method to obtain F-12. One of ordinary skill in the art will recognize that the appropriate method for deprotecting compound F-11 depends on the actual protecting group used, including those described by Greene . For example, when each hydroxy protecting group of F-11 is a TBS group, this removal can be achieved by optionally buffered tetrabutylammonium fluoride treatment. Details of these steps are described in the Examples below.
中间体F-12用于制备诸如美国专利6,365,759和美国专利6,469,182(通过引用将其全文结合到本文中)所述的各种软海绵素B类似物。Intermediate F-12 was used in the preparation of various halichondrin B analogs such as those described in US Patent 6,365,759 and US Patent 6,469,182, which are hereby incorporated by reference in their entirety.
实施例Example
以软海绵素B类似物B-1939的制备为例,以下实施例描述了用本发明方法和化合物合成软海绵素B类似物。Taking the preparation of halichondrin B analogue B-1939 as an example, the following examples describe the synthesis of halichondrin B analogues using the methods and compounds of the present invention.
本领域的普通技术人员将认识到,通过本发明方法,由本发明化合物所制备的多种软海绵素B类似物包括但不限于美国专利6,214,865和6,365,759(将其全文引入作为参考)所述的那些软海绵素B类似物。因此,应理解的是,以下以实施例形式描述的合成方法并不限制所附权利要求定义的本发明范围。Those of ordinary skill in the art will recognize that the various halichondrin B analogs prepared from the compounds of the invention by the methods of the invention include, but are not limited to, those described in U.S. Pat. Halichondrin B analogue. Accordingly, it should be understood that the synthetic procedures described below in the form of examples do not limit the scope of the invention as defined by the appended claims.
实施例1Example 1
F-1a的制备:Preparation of F-1a:
在适当大小的容器中,使D-葡糖醛酸-6,3-内酯(1份重量,1当量)与乙腈(3份体积)及丙酮(9份体积)混合。加入浓硫酸催化剂,保持体系回流3小时。检查体系中D-葡糖醛酸-6,3-内酯的溶解情况。冷却反应液至25℃,搅拌15小时。加入固体碳酸氢钠(0.5份重量),另外搅拌反应液3小时。过滤去除固体,部分浓缩有机物,并与另外的乙腈(2份重量)共沸。ER-806045未经分离而用于下一步反应。In an appropriately sized vessel, D-glucurono-6,3-lactone (1 wt, 1 eq) was mixed with acetonitrile (3 vol) and acetone (9 vol). Concentrated sulfuric acid catalyst was added, and the system was kept under reflux for 3 hours. Check the dissolution of D-glucurono-6,3-lactone in the system. The reaction solution was cooled to 25°C and stirred for 15 hours. Solid sodium bicarbonate (0.5 wt) was added and the reaction was stirred for an additional 3 hours. The solids were removed by filtration and the organics were partially concentrated and azeotroped with additional acetonitrile (2 wt). ER-806045 was used in the next reaction without isolation.
-20℃下,将粗品ER-806045(1份重量,1当量)溶解于乙腈(6.5份体积)中。保持内温低于5℃条件下,加入吡啶(1.5份体积,4.0当量)并缓慢加入SO2Cl2(0.38份体积,1.02当量)。保持内温低于10℃条件下,乙腈(0.5份体积)冲洗下将反应液反加到冷水(28份体积)中,进行猝灭。通过庚烷(2份体积)冲洗过滤及干燥分离得到白色固体状ER-806410(0.87份重量,79%理论值)。Crude ER-806045 (1 wt, 1 eq) was dissolved in acetonitrile (6.5 vol) at -20°C. Pyridine (1.5 vol, 4.0 eq) was added and SO2Cl2 (0.38 vol, 1.02 eq) was added slowly keeping the internal temperature below 5 °C. The reaction was quenched by adding back into cold water (28 vol) while flushing with acetonitrile (0.5 vol) while keeping the internal temperature below 10°C. ER-806410 (0.87 wt, 79% theory) was isolated as a white solid by filtration through heptane (2 vol) and drying.
在适当大小的容器中加入ER-806410(1份重量,1当量)和THF(10份体积),然后冷却至10℃。加入湿的钯碳(5%,0.5份重量),搅拌多相溶液10分钟。反应液经吡啶(0.44份重量,1.3当量)缓冲,在氢气氛下放置3小时。过滤反应液,用水(2份体积)和乙酸乙酯(10份体积)冲洗固体。所得溶液经1N盐酸(2.1份体积)酸化,充分混合,分离所得各层。依次用碳酸氢钠水溶液(5份体积)和水(5份体积)洗涤有机层。减压浓缩有机物,所得产物用IPA(3.4份体积)重结晶,15℃下加入庚烷(3.4份体积)进一步收获产物,分离得到白色固体状ER-806047(产率67%)。Charge ER-806410 (1 wt, 1 eq) and THF (10 vol) in an appropriately sized vessel and cool to 10°C. Wet palladium on carbon (5%, 0.5 wt) was added and the heterogeneous solution was stirred for 10 minutes. The reaction solution was buffered with pyridine (0.44 wt, 1.3 eq) and placed under a hydrogen atmosphere for 3 hours. The reaction was filtered and the solids were rinsed with water (2 vol) and ethyl acetate (10 vol). The resulting solution was acidified with 1N hydrochloric acid (2.1 vol), mixed well, and the resulting layers were separated. The organic layer was washed sequentially with aqueous sodium bicarbonate (5 vol) and water (5 vol). The organics were concentrated under reduced pressure and the resulting product was recrystallized from IPA (3.4 vol) and further harvested by addition of heptane (3.4 vol) at 15°C to isolate ER-806047 as a white solid (67% yield).
在适当大小的容器中加入ER-806047(1份重量,1当量)和甲苯(8份体积),然后冷却至-40℃。保持内温低于-35℃条件下,加入DIBAL的17重量%甲苯溶液(4.6份重量,1.1当量)。对反应液进行测定后,保持温度低于10℃条件下,加入丙酮(0.15份重量,0.5当量),使过量的试剂猝灭。低于10℃下,反应液用乙酸乙酯(7份体积)和15%柠檬酸水溶液(8份重量)稀释,在20℃下搅拌直至得到澄清溶液。分离各层,水层用乙酸乙酯(2×10份体积)反萃取两次。合并的有机物依次用碳酸氢钠水溶液(5份体积)和盐水(5份体积)洗涤后经硫酸镁(0.2份重量)干燥。过滤后,减压下部分浓缩有机层,并与甲苯(4份体积)形成共沸物。以THF溶液的形式保存产物,用于下一步反应。Charge ER-806047 (1 wt, 1 eq) and toluene (8 vol) in an appropriately sized vessel and cool to -40°C. A 17 wt% solution of DIBAL in toluene (4.6 wt, 1.1 eq) was added maintaining the internal temperature below -35°C. After the reaction solution was measured, acetone (0.15 wt, 0.5 eq) was added to quench the excess reagent while keeping the temperature below 10°C. Below 10°C, the reaction was diluted with ethyl acetate (7 vol) and 15% aqueous citric acid (8 wt) and stirred at 20°C until a clear solution was obtained. The layers were separated and the aqueous layer was back extracted twice with ethyl acetate (2 x 10 vol). The combined organics were washed successively with aqueous sodium bicarbonate (5 v) and brine (5 v) and dried over magnesium sulfate (0.2 wt). After filtration, the organic layer was partially concentrated under reduced pressure and formed an azeotrope with toluene (4 vol). The product was stored as a THF solution for the next reaction.
在适当大小的容器中加入TMSCH2MgCl的醚溶液(20重量%,2.04份重量,3.0当量),在5℃以下冷却。保持内温低于15℃条件下,向反应容器中加入ER-806048(1份重量,1当量)的THF(7份体积)溶液。使反应液升温至35℃,保持1.5小时。冷却反应液,低于20℃下用甲苯(7份体积)进行稀释,用乙酸(3份体积)进行猝灭。反应液进一步用10%氯化铵水溶液(6份重量)稀释,充分混合,分离各层。有机层依次用碳酸氢钠水溶液(5份体积)和盐水(5份体积)洗涤。经硫酸镁(0.2份重量)干燥,过滤,然后减压浓缩溶液,分离得到ER-807114的甲苯浓溶液(产率90%)。A solution of TMSCH2MgCl in ether (20 wt%, 2.04 wts, 3.0 equiv) was added to an appropriately sized vessel and cooled below 5°C. A solution of ER-806048 (1 wt, 1 eq) in THF (7 vol) was added to the reaction vessel keeping the internal temperature below 15°C. The temperature of the reaction solution was raised to 35° C. and maintained for 1.5 hours. The reaction was cooled, diluted below 20°C with toluene (7 vol), and quenched with acetic acid (3 vol). The reaction solution was further diluted with 10% aqueous ammonium chloride solution (6 wt), mixed well, and the layers were separated. The organic layer was washed sequentially with aqueous sodium bicarbonate (5 vol) and brine (5 vol). Drying over magnesium sulfate (0.2 wt), filtration, and concentration of the solution under reduced pressure isolated ER-807114 as a concentrated toluene solution (90% yield).
在适当大小的容器中依次加入ER-807114(1份重量,1当量)和THF(20份体积),将溶液冷却至5℃以下。加入KHMDS的15重量%甲苯溶液(9.16份重量,2.0当量)。用10%氯化铵水溶液(5份体积)猝灭反应。分离各层,有机层依次用氯化铵(5份体积)、2N盐酸(8.5份体积)、碳酸氢钠水溶液(5份体积)和水(5份体积)洗涤。用乙酸乙酯将有机物转移至浓缩器中,浓缩至粘性油(产率90%)。在35℃下,用甲苯(4份体积)和庚烷(4份体积)对该物质进行重结晶,在更低的温度下(15℃和10℃),用庚烷(2×4份体积)进一步收获产物(产率94%)。ER-807114 (1 wt, 1 eq) and THF (20 vol) were added sequentially in an appropriately sized vessel and the solution was cooled to below 5°C. A 15 wt% solution of KHMDS in toluene (9.16 wt, 2.0 equiv) was added. The reaction was quenched with 10% aqueous ammonium chloride (5 vol). The layers were separated and the organic layer was washed sequentially with ammonium chloride (5 vol), 2N hydrochloric acid (8.5 vol), aqueous sodium bicarbonate (5 vol), and water (5 vol). The organics were transferred to a concentrator with ethyl acetate and concentrated to a viscous oil (90% yield). The material was recrystallized from toluene (4 vol) and heptane (4 vol) at 35°C, and at lower temperatures (15°C and 10°C) from heptane (2 x 4 vol ) to further harvest the product (yield 94%).
在适当大小的容器中加入KOtBu(0.67份重量,1.2当量)和THF(7.7份体积),冷却至内温为-20℃。保持内温低于-7℃条件下,加入ER-806049(1份重量,1当量)的THF(2.3份体积)溶液。最高温度保持在-7℃的条件下,加入纯BnBr。-20℃下搅拌反应液2小时,10℃下搅拌10小时。反应液用10%氯化铵水溶液(4份体积)猝灭,用甲苯(4份体积)稀释,充分混合。分离各层,有机层用10%盐水(4份体积)洗涤,经硫酸镁(0.15份重量)干燥。减压浓缩后分离得到ER-806050的tBuOH溶液(2.5份体积)(产率95%)。KOtBu (0.67 wt, 1.2 eq) and THF (7.7 vol) were added to an appropriately sized vessel and cooled to an internal temperature of -20°C. A solution of ER-806049 (1 wt, 1 eq) in THF (2.3 vol) was added keeping the internal temperature below -7°C. Pure BnBr was added while the maximum temperature was maintained at -7°C. The reaction solution was stirred at -20°C for 2 hours and at 10°C for 10 hours. The reaction was quenched with 10% aqueous ammonium chloride (4 vol), diluted with toluene (4 vol), and mixed well. The layers were separated and the organic layer was washed with 10% brine (4 v) and dried over magnesium sulfate (0.15 wt). After concentration under reduced pressure a solution of ER-806050 in tBuOH (2.5 vol) was isolated (95% yield).
在适当大小的容器中依次加入K3Fe(CN)6(3.5份重量,3.4当量)、K2CO3(1.5份重量,3.4当量)、(DHQ)2AQN(0.0134份重量,0.005当量)、水(18份体积)、tBuOH(13份体积)和ER-806050的tBuOH溶液(1份重量,1当量溶于5份体积中)。将多相混合物冷却至内温为0℃,加入K2OsO4·2H2O(0.0029份重量,0.22摩尔%)。36小时后,0℃下,用Na2S2O3(3.5当量,1.7份重量)猝灭反应,使烧瓶升温过夜至室温。15小时后,将混合物转移至后处理容器(workupvessel)中,用甲苯(15份体积)和水(4份体积)稀释。剧烈搅拌并分离两相混合物。有机层用盐水(10份体积)洗涤,经浓缩和溶剂交换得到二醇ER-806051和ER-806052粗混合物的10%甲苯溶液(产率92%)。In an appropriately sized vessel, add K3Fe (CN)6 (3.5 wt, 3.4 eq), K2CO3 (1.5 wt, 3.4 eq), ( DHQ) 2AQN (0.0134 wt, 0.005 eq) , water (18 vol), tBuOH (13 vol), and ER-806050 in tBuOH (1 wt, 1 eq in 5 vol). The heterogeneous mixture was cooled to an internal temperature of 0°C, and K 2 OsO 4 ·2H 2 O (0.0029 wt, 0.22 mol %) was added. After 36 hours, the reaction was quenched with Na2S2O3 (3.5 eq, 1.7 wt) at 0 °C and the flask was allowed to warm to room temperature overnight. After 15 hours, the mixture was transferred to a workup vessel and diluted with toluene (15 vol) and water (4 vol). Stir vigorously and separate the biphasic mixture. The organic layer was washed with brine (10 vol), concentrated and solvent exchanged to give a crude mixture of diols ER-806051 and ER-806052 in 10% toluene (92% yield).
用另外的甲苯(3份重量)对ER-806051/52(1份重量,1当量)的甲苯溶液(10.1重量%,9.9份重量)进行进一步稀释。在甲苯溶液中加入N-甲基吗啉(0.94份重量,3.0当量)和DMAP(0.075份重量,0.2当量),将所得混合物冷却至15℃以下。保持内温低于25℃条件下,加入苯甲酰氯。然后在75℃下搅拌反应液12小时。冷却反应液至15℃,保持温度低于25℃条件下,用1N盐酸(5份体积)进行猝灭。充分混合并分离各层。有机层依次用盐水(3份重量)、碳酸氢钠水溶液(3份重量)和盐水(3份重量)洗涤。干燥有机层(硫酸镁,0.25份重量),用活性碳(0.1份重量)处理,经甲苯(1份重量)过滤(Celite,0.3份重量)。减压下部分浓缩产物,与甲苯(3份重量)形成共沸物。分离得到双苯甲酸酯ER-806053/54的甲苯溶液(5份体积)(产率95%)。A solution of ER-806051/52 (1 wt, 1 eq) in toluene (10.1 wt%, 9.9 wts) was further diluted with additional toluene (3 wts). N-methylmorpholine (0.94 wt, 3.0 eq) and DMAP (0.075 wt, 0.2 eq) were added to the toluene solution, and the resulting mixture was cooled to below 15°C. While keeping the internal temperature below 25°C, add benzoyl chloride. The reaction was then stirred at 75°C for 12 hours. The reaction was cooled to 15°C and quenched with 1N hydrochloric acid (5 vol) keeping the temperature below 25°C. Mix well and separate layers. The organic layer was washed sequentially with brine (3 wts), aqueous sodium bicarbonate (3 wts) and brine (3 wts). The organic layer was dried (magnesium sulfate, 0.25 wt), treated with activated carbon (0.1 wt), and filtered (Celite(R), 0.3 wt) through toluene (1 wt). The product was partially concentrated under reduced pressure forming an azeotrope with toluene (3 wt). A toluene solution of the bisbenzoate ER-806053/54 (5 vol) was isolated (95% yield).
在惰性气氛下,将20重量%TiCl4(6.42份重量,3.6当量)的甲苯溶液冷却至15℃。保持内温低于30℃条件下,加入Ti(OiPr)4(0.64份重量,1.2当量),搅拌所得溶液15分钟。将烯丙基TMS(1.03份重量,4.8当量)与前一步骤得到的ER-806053/54(1份重量,1当量)的22重量%甲苯溶液(4.55份重量,1当量)预混合,加到新鲜生成的Ti(OiPr)Cl3中。在加样期间保持内温低于30℃。20-30℃下,搅拌反应液2小时。冷却反应液至-5℃,用1N盐酸(6份体积)进行猝灭,期间保持内温低于30℃。充分搅拌后,分离各层,有机层依次用1N盐酸(3份体积)和盐水(2×3份体积)洗涤。有机层与硫酸镁(0.3份重量)及活性碳(0.15份重量)一起搅拌,甲苯(1体积)冲洗下,过滤通过Celite塞(0.2份重量)。浓缩后分离得到C-34的3∶1混合物形式的产物,产率83%。经IPA/正庚烷重结晶,得到ER-806055(C-34>99.5%d.e.,产率71%)Under an inert atmosphere, a solution of 20 wt% TiCl4 (6.42 wt, 3.6 eq) in toluene was cooled to 15°C. While keeping the internal temperature below 30°C, Ti(OiPr) 4 (0.64 wt, 1.2 eq) was added, and the resulting solution was stirred for 15 minutes. Allyl TMS (1.03 wt, 4.8 eq) was premixed with 22 wt% toluene solution (4.55 wt, 1 eq) of ER-806053/54 (1 wt, 1 eq) obtained in the previous step, and into freshly generated Ti(OiPr)Cl 3 . Keep the internal temperature below 30 °C during the sample addition. The reaction solution was stirred for 2 hours at 20-30°C. The reaction was cooled to -5°C and quenched with 1N hydrochloric acid (6 vol) while keeping the internal temperature below 30°C. After thorough stirring, the layers were separated and the organic layer was washed sequentially with 1N hydrochloric acid (3 vol) and brine (2 x 3 vol). The organic layer was stirred with magnesium sulfate (0.3 wt) and activated carbon (0.15 wt), rinsed with toluene (1 vol), and filtered through a plug of Celite (R) (0.2 wt). The product was isolated after concentration as a 3:1 mixture of C-34 in 83% yield. Recrystallization from IPA/n-heptane afforded ER-806055 (C-34>99.5%de, yield 71%)
室温下,在适当大小的容器内加入醇ER-806055(1份重量,1当量)、甲苯(7份体积)、DMSO(0.31份重量,2.0当量)和三乙胺(0.78份重量,4.0当量)。将所得溶液冷却至-19℃。保持内温低于-10℃条件下,滴加TCAA(0.84份重量,1.4当量)。另外搅拌反应液10分钟。保持内温低于10℃条件下,反应液用IPA(0.5份体积)稀释,用1N盐酸(5份体积)猝灭。分离各层,依次用碳酸氢钠水溶液(5份重量)和水(3份体积)洗涤有机层。减压下部分浓缩有机层(粗产物产率100%),进一步与另外的甲苯(4份体积)形成共沸物。将所得的酮(ER-806058)溶解于最后4份体积的甲苯中,检测水份含量,用于下一步反应。Add alcohol ER-806055 (1 wt, 1 eq), toluene (7 vol), DMSO (0.31 wt, 2.0 eq) and triethylamine (0.78 wt, 4.0 eq) in an appropriately sized container at room temperature ). The resulting solution was cooled to -19°C. TCAA (0.84 wt, 1.4 equiv) was added dropwise keeping the internal temperature below -10°C. The reaction was stirred for an additional 10 minutes. The reaction was diluted with IPA (0.5 vol) and quenched with 1N HCl (5 vol) keeping the internal temperature below 10°C. The layers were separated and the organic layer was washed sequentially with aqueous sodium bicarbonate (5 wt) and water (3 v). The organic layer was partially concentrated under reduced pressure (crude yield 100%) and further azeotroped with additional toluene (4 vol.). The resulting ketone (ER-806058) was dissolved in the last 4 volumes of toluene, and the water content was checked for the next reaction.
将ER-107446(1份重量,1.5当量)的THF(2.7份体积)溶液冷却至10℃,保持内温低于15℃条件下,用25.2重量%LHMDS的THF溶液(5.2份重量,1.4当量)处理。在第二个容器中,将粗品ER-806058的甲苯溶液(21.9重量%,5.4份体积)冷却至10℃。保持内温低于20℃条件下,将第一个容器中的内容物转移至含有基质(substrate)的溶液中。搅拌反应液30分钟,然后加入1M盐酸(6.5份体积)进行猝灭,期间保持内温低于20℃。分离各层,有机层用1∶1的甲醇/水(4×5份体积)洗涤四次后用碳酸氢钠水溶液(5份体积)和盐水溶液(2×5份体积)洗涤。产物经硫酸镁(0.52份重量)干燥、过滤(用0.7份体积甲苯冲洗),减压浓缩至重油。A solution of ER-107446 (1 wt, 1.5 eq) in THF (2.7 vol) was cooled to 10°C, keeping the internal temperature below 15°C, and 25.2% by weight of LHMDS in THF (5.2 )deal with. In a second vessel, a solution of crude ER-806058 in toluene (21.9 wt%, 5.4 vol) was cooled to 10°C. While maintaining the internal temperature below 20°C, transfer the contents of the first container to the solution containing the substrate. The reaction was stirred for 30 minutes and then quenched by the addition of 1M hydrochloric acid (6.5 vol) while keeping the internal temperature below 20°C. The layers were separated and the organic layer was washed four times with 1:1 methanol/water (4 x 5 vol) followed by aqueous sodium bicarbonate (5 vol) and brine solution (2 x 5 vol). The product was dried over magnesium sulfate (0.52 wt), filtered (rinsing with 0.7 vol of toluene), and concentrated under reduced pressure to a heavy oil.
室温下,将ER-806059溶解于1∶1甲苯/乙腈(5份体积)中。保持起始温度低于40℃条件下,加入过滤TMSI(1.23份重量,4当量)。加热反应液至60℃,保持2小时。冷却反应液至-15℃,低于30℃下,用25%氢氧化铵水溶液进行猝灭。搅拌反应内容物过夜,分离各层。在有机层中另加入甲苯(5份体积)和水(2份体积)。充分混合并分离各层。然后依次用10%亚硫酸钠水溶液(5份体积)、1N盐酸(5份体积)、5%碳酸氢钠水溶液(5份体积)和盐水(5份体积)洗涤有机层。有机层经硫酸镁(0.2份重量)干燥、过滤、部分浓缩,得到50%甲苯溶液,用于下一步反应。ER-806059 was dissolved in 1:1 toluene/acetonitrile (5 vol) at room temperature. While maintaining the initial temperature below 40°C, filtered TMSI (1.23 wt, 4 eq) was added. The reaction solution was heated to 60 °C for 2 hours. The reaction solution was cooled to -15°C, and quenched with 25% aqueous ammonium hydroxide solution below 30°C. The reaction contents were stirred overnight and the layers were separated. Additional toluene (5 vol) and water (2 vol) were added to the organic layer. Mix well and separate layers. The organic layer was then washed successively with 10% aqueous sodium sulfite (5 vol), 1N hydrochloric acid (5 vol), 5% aqueous sodium bicarbonate (5 vol), and brine (5 vol). The organic layer was dried over magnesium sulfate (0.2 wt), filtered, and partially concentrated to obtain a 50% solution in toluene, which was used in the next reaction.
在适合大小的容器中,65℃下混合NaBH(OAc)3(1.19份重量,3.15当量)、Bu4NCl(1.04份重量,2.1当量)、DME(8.2份体积)和甲苯(4份体积),并室温下搅拌。将混合物加热至75℃,保持1小时。75℃下加入50重量%ER-806060(1份重量,1当量)的甲苯溶液,另用甲苯(0.3份体积)冲洗。反应温度升高至85℃,搅拌反应液2-4小时。冷却反应液至<10℃,保持内温低于20℃条件下,用水(3.2份体积)进行猝灭。充分混合并分离各层。有机层依次用碳酸氢钠水溶液(2×5份体积)和水(2×5份体积)洗涤。有机层经过浓缩和溶剂交换得到40重量%ER-806061的甲醇溶液。In an appropriately sized vessel, mix NaBH(OAc) 3 (1.19 wt, 3.15 eq), Bu4NCl (1.04 wt, 2.1 eq), DME (8.2 vol), and toluene (4 vol) at 65 °C , and stirred at room temperature. The mixture was heated to 75°C for 1 hour. A 50 wt% solution of ER-806060 (1 wt, 1 eq) in toluene was added at 75°C and rinsed with additional toluene (0.3 vol). The reaction temperature was raised to 85°C, and the reaction solution was stirred for 2-4 hours. The reaction was cooled to <10°C and quenched with water (3.2 vol) while keeping the internal temperature below 20°C. Mix well and separate layers. The organic layer was washed sequentially with aqueous sodium bicarbonate (2 x 5 vol) and water (2 x 5 vol). The organic layer was concentrated and solvent exchanged to obtain a 40% by weight solution of ER-806061 in methanol.
将ER-806061(1份重量,1.0当量)的甲醇溶液(40重量%)溶解于另外的甲醇(1.6份体积)中。加入碳酸钾(0.24份重量,1.0当量),反应温度升高至50℃,保持1小时。冷却反应液至15℃,内温低于30℃条件下,用1N盐酸(3.5份体积,2当量)进行猝灭。用水(3.9份体积)和甲苯(3份体积)稀释反应液。分离各层,水层用甲苯(1.5份体积)反萃取。水相中加入碳酸氢钠(0.3份重量)和氯化钠(0.6份重量),用nBuOH(3份体积)反萃取。合并该三份有机相,并浓缩至干,得到粗品三醇ER-806064和无机盐。80℃下,将产物溶解于7∶1甲苯/nBuOH中,经热过滤、冷却重结晶和搅拌过夜。经过滤和甲醇冲洗后分离得到ER-806064(F-1b)(五步总产率57%)。FAB(+)-MS M/z357(M+H)。熔点96.2℃。A solution of ER-806061 (1 wt, 1.0 eq) in methanol (40 wt%) was dissolved in additional methanol (1.6 vol). Potassium carbonate (0.24 wt, 1.0 eq) was added and the reaction temperature was raised to 50°C for 1 hour. The reaction was cooled to 15°C and quenched with 1N hydrochloric acid (3.5 vol, 2 eq) at an internal temperature below 30°C. The reaction was diluted with water (3.9 vol) and toluene (3 vol). The layers were separated and the aqueous layer was back extracted with toluene (1.5 vol). NaHCO3 (0.3 wt) and NaCl (0.6 wt) were added to the aqueous phase and back extracted with nBuOH (3 v). The three organic phases were combined and concentrated to dryness to give crude triol ER-806064 and inorganic salts. The product was dissolved in 7:1 toluene/nBuOH at 80°C, filtered hot, recrystallized by cooling and stirred overnight. ER-806064(F-1b) was isolated after filtration and methanol rinse (57% overall yield over five steps). FAB(+)-MS M/z 357(M+H). The melting point is 96.2°C.
25℃下,使纯化的三醇ER-806064(1份重量,1当量)分散于丙酮(2份体积)中,用2,2-二甲氧基丙烷(1份体积)稀释,用浓硫酸(0.0086份重量,0.03当量)处理。搅拌反应液直至均匀。反应液用甲苯(5份体积)稀释,加至5%碳酸钾(2份体积)中进行猝灭。充分混合并分离各层。有机层用10%盐水洗涤,经硫酸钠(0.5份重量)干燥。溶液经过滤(甲苯冲洗)和减压浓缩得到黄色油状的ER-806126。该物质用于下一步骤。At 25 °C, the purified triol ER-806064 (1 wt, 1 eq) was dispersed in acetone (2 v), diluted with 2,2-dimethoxypropane (1 v), washed with concentrated sulfuric acid (0.0086 wt, 0.03 eq) was treated. Stir the reaction until homogeneous. The reaction was diluted with toluene (5 vol) and quenched into 5% potassium carbonate (2 vol). Mix well and separate layers. The organic layer was washed with 10% brine, dried over sodium sulfate (0.5 wt). The solution was filtered (toluene rinse) and concentrated under reduced pressure to afford ER-806126 as a yellow oil. This material was used in the next step.
将固体NaOtBu(0.34份重量,1.4当量)溶解于THF(2.7份体积)和DMF(0.3份体积)后冷却至10℃以下。保持内温低于15℃条件下,THF(0.5份体积)冲洗下,将ER-806126(1份重量,1当量)的THF(2.5份体积)溶液加至NaOtBu溶液中。搅拌30分钟后,保持温度低于15℃条件下,加入甲基碘(0.204份体积,1.3当量)(放热)。使反应液升温至25℃,反应液用水(5份体积)猝灭,用甲苯(7份体积)稀释。充分混合并分离各层。有机层用盐水(2×5份体积)洗涤两次,经硫酸钠(0.5份重量)干燥、过滤和减压浓缩。Solid NaOtBu (0.34 wt, 1.4 eq) was dissolved in THF (2.7 vol) and DMF (0.3 vol) and cooled to below 10°C. A THF (2.5 vol) solution of ER-806126 (1 wt, 1 eq) was added to the NaOtBu solution under a THF (0.5 vol) rinse while keeping the internal temperature below 15°C. After stirring for 30 min, methyl iodide (0.204 vol, 1.3 eq) was added keeping the temperature below 15°C (exotherm). The reaction was allowed to warm to 25°C, quenched with water (5 vol) and diluted with toluene (7 vol). Mix well and separate layers. The organic layer was washed twice with brine (2 x 5 vol), dried over sodium sulfate (0.5 wt), filtered and concentrated under reduced pressure.
将ER-806068(1份重量,1当量)溶解于1份体积的甲醇中。加入水(1.5份体积)和2N盐酸(1.25份体积,1当量),并在25℃下搅拌反应液。10℃下,将反应液反加到2M NaOH(1.34份体积)中进行猝灭。反应液用乙酸异丙酯(5份体积)稀释。充分混合并分离各层。水层用5份体积的乙酸异丙酯反萃取,合并的有机层经硫酸镁(0.5份重量)干燥、过滤和减压浓缩得到粗品二醇ER-806063。ER-806068 (1 wt, 1 eq) was dissolved in 1 vol methanol. Water (1.5 vol) and 2N hydrochloric acid (1.25 vol, 1 eq) were added and the reaction was stirred at 25°C. The reaction was quenched back into 2M NaOH (1.34 vol) at 10 °C. The reaction was diluted with isopropyl acetate (5 vol). Mix well and separate layers. The aqueous layer was back extracted with 5 volumes of isopropyl acetate and the combined organic layers were dried over magnesium sulfate (0.5 wt), filtered and concentrated under reduced pressure to afford crude diol ER-806063.
向25℃的粗品ER-806063(1份重量,1.0当量)的DMF(4份体积)溶液中加入咪唑(0.62份重量,3.4当量),然后在低于30℃的内温下,加入TBSCl(1.02份重量,2.53当量)。25℃下搅拌反应液。反应液用MTBE(10份体积)稀释,用水(4份体积)洗涤。有机层依次用1M盐酸(3份体积)、水(3份体积)、碳酸氢钠水溶液(3份体积)和盐水(3份体积)洗涤。有机层经硫酸镁(0.5份重量)干燥、用1份体积的MTBE冲洗过滤,减压浓缩,用庚烷(4份体积)进行溶剂交换。To a solution of crude ER-806063 (1 wt, 1.0 eq) in DMF (4 v) at 25°C was added imidazole (0.62 wt, 3.4 eq) followed by addition of TBSCl ( 1.02 parts by weight, 2.53 equivalents). The reaction solution was stirred at 25°C. The reaction was diluted with MTBE (10 vol) and washed with water (4 vol). The organic layer was washed sequentially with 1M hydrochloric acid (3 vol), water (3 vol), aqueous sodium bicarbonate (3 vol), and brine (3 vol). The organic layer was dried over magnesium sulfate (0.5 wt), filtered rinsed with 1 vol of MTBE, concentrated under reduced pressure, and solvent exchanged with heptane (4 vol).
将ER-806065(1份重量,1当量)溶解于庚烷、异辛烷或IPA(10份体积)中。冷却溶液至-60℃(±10℃)以下。低温下,在溶液中鼓泡通过臭氧,直至该溶液保持蓝色。用氮气吹扫溶液15-30分钟,边继续用氮气吹洗,边使反应液升温至5℃。加入7-15重量%Lindlar催化剂(铅毒化的5%钯/碳酸钙,0.1份重量)。反应器头(reactor head)用氮气吹扫数次,抽空、置于一个氢气氛(g)下。然后使反应液升温至室温(20-25℃)。搅拌反应液2.5小时。所得的多相溶液过滤通过Celite(1.0份重量,以MTBE(2份体积)作为冲洗液)。浓缩溶液至干,分离得到1.0份重量的粗品ER-806067。粗分离物经庚烷或异辛烷重结晶,得到ER-806067(F-1a),为白色固体结晶(五步产率68%)。FAB(+)-MS M/z601(M+H)。熔点64.5℃。ER-806065 (1 wt, 1 eq) was dissolved in heptane, isooctane or IPA (10 vol). Cool the solution to below -60°C (±10°C). Ozone was bubbled through the solution at low temperature until the solution remained blue. The solution was purged with nitrogen for 15-30 minutes, and the temperature of the reaction solution was raised to 5° C. while continuing to purse with nitrogen. 7-15% by weight of Lindlar's catalyst (5% palladium/calcium carbonate poisoned with lead, 0.1 parts by weight) was added. The reactor head was purged several times with nitrogen, evacuated, and placed under a hydrogen atmosphere (g). The reaction was then allowed to warm to room temperature (20-25°C). The reaction was stirred for 2.5 hours. The resulting heterogeneous solution was filtered through Celite( R) (1.0 wt, with MTBE (2 vol) as rinse). The solution was concentrated to dryness and 1.0 parts by weight of crude ER-806067 was isolated. The crude isolate was recrystallized from heptane or isooctane to obtain ER-806067 (F-1a) as a white crystalline solid (68% yield over five steps). FAB(+)-MS M/z 601(M+H). The melting point is 64.5°C.
实施例2Example 2
F-2a的制备Preparation of F-2a
在反应器中加入预冲洗的Amberlyst15(0.05份重量)和水(4.63份体积),冷却至内温为0-5℃。保持内温为约5℃条件下,在反应器中加入2,3-二氢呋喃(1份重量,1当量),搅拌1.5小时。在第二个反应器中加入水(4.63份体积),加热至内温为35℃。在相同反应器中加入锡粉(2.2份重量,1.3当量),分别用2,3-二溴丙烯(3.71份重量,1.3当量)和48%氢溴酸(0.002份体积)稀释。观察到反应开始(以温度示踪值达到36-38℃指示)之后,保持内温低于45℃条件下,在第二个反应器中分批加入2,3-二溴丙烯(9×0.37份重量)。加样完毕后,在35℃内温下,另外搅拌第二个反应器的内容物60分钟。以使内温不超过45℃的速度,将第一个反应器的过滤内容物加到第二个反应器中。加样完毕后,撤除热源,在第二个反应器中加入Celite545(2.0份重量),搅拌所得混合物30分钟。多相混合物过滤通过Celite545垫(2.0份重量),另外用水(5份体积)洗涤滤饼。将所有的滤液合并入一个反应器中,加入浓盐酸(1.5份体积)直至云雾状溶液变澄清。剧烈搅拌下,在该反应器中加入氯化钠(3.6份重量),分层。分离并搁置有机层。用正丁醇(20份体积)萃取水层。排放水层,在反应器中加入第一次分离得到的有机物。有机物用浓碳酸氢钠(24份体积)洗涤,然后用正丁醇(20份体积)反萃取水层。合并所有的有机物,并进行真空浓缩。将浓缩物溶解于MTBE(10份体积)中,过滤,滤液浓缩至2份体积。搅拌下,使浓缩物冷却至内温为0℃,然后加入正庚烷(4份体积)。0℃内温下,搅拌多相混合物2小时,通过过滤分离得到目的产物,真空干燥得到白色粉末状的ER-806909(1.34份重量,0.45当量)。The reactor was charged with pre-rinsed Amberlyst 15 (0.05 wt) and water (4.63 vol) and cooled to an internal temperature of 0-5°C. While keeping the internal temperature at about 5°C, 2,3-dihydrofuran (1 wt, 1 eq) was added into the reactor and stirred for 1.5 hours. Water (4.63 vol) was added to the second reactor and heated to an internal temperature of 35°C. In the same reactor was charged tin powder (2.2 wt, 1.3 eq) and diluted with 2,3-dibromopropene (3.71 wt, 1.3 eq) and 48% hydrobromic acid (0.002 vol), respectively. After observing the onset of the reaction (indicated by the temperature trace reaching 36-38° C.), 2,3-dibromopropene (9×0.37 parts by weight). After the addition was complete, the contents of the second reactor were stirred for an additional 60 minutes at an internal temperature of 35°C. The filtered contents of the first reactor were added to the second reactor at such a rate that the internal temperature did not exceed 45°C. After the addition was complete, the heat source was removed, Celite (R) 545 (2.0 wt.) was added to the second reactor, and the resulting mixture was stirred for 30 minutes. The heterogeneous mixture was filtered through a pad of Celite (R) 545 (2.0 wt) and the filter cake was washed with additional water (5 vol). All filtrates were combined into one reactor and concentrated hydrochloric acid (1.5 vol) was added until the cloudy solution became clear. Under vigorous stirring, sodium chloride (3.6 wt) was added to the reactor, and the layers were separated. Separate and set aside the organic layer. The aqueous layer was extracted with n-butanol (20 vol). The aqueous layer was drained and the reactor was charged with the first isolated organics. The organics were washed with concentrated sodium bicarbonate (24 vol) and the aqueous layer was back extracted with n-butanol (20 vol). All organics were combined and concentrated in vacuo. The concentrate was dissolved in MTBE (10 vol), filtered and the filtrate concentrated to 2 vol. With stirring, the concentrate was allowed to cool to an internal temperature of 0°C, then n-heptane (4 vol.) was added. The heterogeneous mixture was stirred for 2 hours at an internal temperature of 0°C, and the target product was isolated by filtration and dried in vacuo to obtain ER-806909 (1.34 wt, 0.45 eq) as a white powder.
在反应器中加入咪唑(0.65份重量,2当量)、ER-806909(1份重量,1当量)和无水DMF(4.04份体积)。搅拌下,将反应器冷却至内温为0℃,然后以使内温不超过15℃的速度加入叔丁基二苯基氯硅烷(1.25份重量,0.95当量)。保持内温为<15℃条件下,另外搅拌反应液1小时。在反应器中加入水(3.2份体积)和正庚烷(6.4份体积)。搅拌混合物5-15分钟,分层。分离并搁置有机层。用正庚烷(3.2份体积)萃取水层。合并所有的有机物,用盐水(3.2份体积)洗涤,真空浓缩至恒重,得到黄色油状的ER-806545(2.13份重量,0.95当量)。该产物未经进一步纯化而用于下一步骤。The reactor was charged with imidazole (0.65 wt, 2 eq), ER-806909 (1 wt, 1 eq) and anhydrous DMF (4.04 vol). With stirring, the reactor was cooled to an internal temperature of 0°C, then tert-butyldiphenylchlorosilane (1.25 wt, 0.95 eq) was added at such a rate that the internal temperature did not exceed 15°C. Keeping the internal temperature at <15°C, the reaction solution was stirred for another 1 hour. Water (3.2 vol) and n-heptane (6.4 vol) were added to the reactor. The mixture was stirred for 5-15 minutes and the layers were separated. Separate and set aside the organic layer. The aqueous layer was extracted with n-heptane (3.2 vol). All organics were combined, washed with brine (3.2 vol), and concentrated in vacuo to constant weight to afford ER-806545 (2.13 wt, 0.95 eq) as a yellow oil. This product was used in the next step without further purification.
用模拟移动床(SMB)色谱分离对映异构体ER-806909,得到黄色油状的ER-808373(0.55份重量,0.55当量)和ER-806721(0.45份重量,0.45当量)。用于分离对映异构体ER-806909的SMB色谱规程如下:Enantiomers ER-806909 were separated by simulated moving bed (SMB) chromatography to give ER-808373 (0.55 wt, 0.55 eq) and ER-806721 (0.45 wt, 0.45 eq) as yellow oils. The SMB chromatography protocol used to separate enantiomers ER-806909 is as follows:
柱和介质: Chiracel OD柱20μm 30mm×Column and medium: Chiracel OD column 20μm 30mm×
150mm(12根柱)
溶剂体系: 96∶4(体积/体积)庚烷∶叔丁醇(流动相)Solvent system: 96:4 (v/v) heptane: tert-butanol (mobile phase)
模拟移动床色谱仪: Knauer SMB系统CSEP C912Simulated moving bed chromatograph: Knauer SMB system CSEP C912
等温线(朗格缪尔,由迎头分析确定)Isotherm (Langmuir, determined by head-on analysis)
非目标异构体: Qi*=2.8768×Ci/(1+0.02327*Ci)Non-target isomer: Qi * = 2.8768×Ci/(1+0.02327*Ci)
目标异构体: Qi=4.5320×Ci/(1+0.0034595*Ci)Target isomer: Qi=4.5320×Ci/(1+0.0034595*Ci)
*其中Qi=固相浓度(g/L),Ci=液相浓度(g/L) * Where Qi = solid phase concentration (g/L), Ci = liquid phase concentration (g/L)
柱孔隙率: 0.658Column porosity: 0.658
温度: 27℃Temperature: 27℃
用 EuroChrom 2000 for windows,SMB指南1.2版(Wissenschaftliche Geratebau Dr.-Ing.Herbert Knauer GmbH,D-14163柏林;作者H.Kniep和A.Seidel-Morgenstern)对流速等进行模拟计算:Use EuroChrom 2000 for windows, SMB guide version 1.2 (Wissenschaftliche Geratebau Dr.-Ing. Herbert Knauer GmbH, D-14163 Berlin; authors H. Kniep and A. Seidel-Morgenstern) to simulate the flow rate, etc.:
进样(feed)浓度: 36g/L(ER-806909)Injection (feed) concentration: 36g/L (ER-806909)
进样液流速(1号泵) 15mL/minInjection liquid flow rate (No. 1 pump) 15mL/min
洗脱液流速(2号泵) 76.4mL/minEluent flow rate (No. 2 pump) 76.4mL/min
IV区(3号泵)流速 107mL/minZone IV (pump No. 3) flow rate 107mL/min
II区(4号泵)流速 134.3mL/min(实际流速=Zone II (Pump No. 4) flow rate 134.3mL/min (actual flow rate =
143.5mL/min) 143.5mL/min)
I区流速 183.4mL/minFlow rate in Zone I 183.4mL/min
III区流速 149.3mL/minZone III flow rate 149.3mL/min
萃余液*流速 42.3mL/min*萃余液=弱结合异构Raffinate * Flow Rate 42.3mL/min * Raffinate = weakly bound isomer
体 body
萃取液流速 49.1mL/min*萃取液=强结合异构Extract flow rate 49.1mL/min * Extract = strongly bound isomer
体 body
间歇时间(tact time)Intermittent time (tact time)
(端口切换时间) 0.8864分钟(53.18秒,实际间歇时间(Port switching time) 0.8864 minutes (53.18 seconds, actual intermittent time
=54秒)= 54 seconds)
用以上规程,按下列方式分离对映异构体ER-806909。对于11小时运转,将10L流动相(含36g/L的ER-806909)泵(SilogmodelChemtech)送通过直径为142mm,孔径为0.45μm的尼龙滤器(Cole-Parmer # 2916-48),进入进样槽(feed tank)。洗脱液槽中注满36L流动相,该流动相已通过管线内的直径为45mm的1μm玻璃纤维滤器(Whatman GFC)过滤,在运转过程中另行加入的1份体积。SMB仪的内温调节至27℃。Using the above protocol, enantiomer ER-806909 was separated in the following manner. For an 11 hour run, pump 10 L of mobile phase (36 g/L of ER-806909) (Silogmodel Chemtech) through a 142 mm diameter, 0.45 μm pore nylon filter (Cole-Parmer # 2916-48) into the injection tank (feed tank). The eluent tank was filled with 36 L of mobile phase, which had been filtered through a 1 μm glass fiber filter (Whatman GFC) with a diameter of 45 mm in the pipeline, and an additional volume was added during operation. The internal temperature of the SMB instrument was adjusted to 27°C.
最初启动时,进样口和洗脱液进口均与洗脱液槽相连。用流动相溶剂对进样泵和洗脱液泵进行注液和清洗。启动SMB仪的柱切换,开启泵,逐渐提高流速至全速,同时保持各泵之间的绝对流速差。一旦达到全速,测量萃余液流速和萃取液流速,调节泵流速以对泵技术规格中的偏差进行校正。进样泵(1号泵)减速至0mL/min,进口重新与进样槽相连,给该泵注入进样溶液,然后逐步将流速回调到全速的运转速度。萃余液和萃取液出口连入分离槽中,每2小时得到各个样品。用下述HPLC方法,通过分析HPLC监测样品的手性纯度。调节2号、3号和4号泵的流速以及间歇时间,以得到所需要的出口纯度。During initial startup, both the sample inlet and the eluent inlet are connected to the eluent tank. Prime and rinse the injection and eluent pumps with mobile phase solvent. Start the column switching of the SMB instrument, turn on the pumps, and gradually increase the flow rate to full speed, while maintaining the absolute flow rate difference between the pumps. Once at full speed, measure the raffinate flow rate and extract flow rate and adjust the pump flow rate to correct for deviations in pump specifications. The injection pump (No. 1 pump) was decelerated to 0mL/min, the inlet was connected to the injection tank again, the injection solution was injected into the pump, and then the flow rate was gradually returned to the full speed. The outlets of raffinate and extract were connected to the separation tank, and each sample was obtained every 2 hours. The chiral purity of the samples was monitored by analytical HPLC using the HPLC method described below. Adjust the flow rate and intermittent time of No. 2, No. 3 and No. 4 pumps to obtain the required outlet purity.
运转结束时,再次将进样泵的流速降低至0,并使之与洗脱液槽相连。使进样泵恢复至全速,洗涤体系20分钟。在洗涤期间,萃余液和萃取液出口保持开启10分钟(10次间歇),洗涤后,出口连入分离槽中。逐步浓缩洗柱液,并在后续运转时加入样品中。At the end of the run, reduce the flow rate of the injection pump to 0 again and connect it to the eluent tank. Return the injection pump to full speed and wash the system for 20 minutes. During the washing period, the raffinate and extract outlets were kept open for 10 minutes (10 intervals). After washing, the outlets were connected to the separation tank. The column wash was gradually concentrated and added to the sample in subsequent runs.
将每次运转结束时所收集的萃取液(ER-806721)与从同一批起始物中收集的物质合并,用下表1所述的分析HPLC方法再次分析最后批合并物的手性纯度。对所收集的萃余液(ER-808373)进行同样的操作。The extracts (ER-806721) collected at the end of each run were combined with material collected from the same starting batch and the final batch pool was reanalyzed for chiral purity using the analytical HPLC method described in Table 1 below. The same operation was performed on the collected raffinate (ER-808373).
表1 ER-806721手性纯度的HPLC分析
检测:254nm处的紫外吸收值Detection: UV absorbance at 254nm
在反应器中加入三苯膦(0.7份重量,1.2当量)、对硝基苯甲酸(0.45份重量,1.2当量)、ER-808373(1份重量,1当量)和无水甲苯(8份体积)。冷却反应液至内温为0℃,以使内温不超过7℃的速度,缓慢加入DEAD(1.17份重量,1.2当量)。加入正庚烷(3.3份体积),将混合物冷却至内温为10℃,然后搅拌30-40分钟。过滤去除所得的沉淀物。分别用正庚烷(3.3份体积)、TBME(0.55份体积)、正庚烷(1.1份体积)和MTBE(0.55份体积)洗涤滤饼。合并所有的滤液并进行真空浓缩。将粗浓缩物溶解于THF(8份体积)中,然后加入水(0.8份体积)和二水氢氧化锂(0.18份重量,2当量)。室温下搅拌混合物后加入正庚烷(3.3份体积),搅拌5分钟。加入水(2.2份体积)和正庚烷(3.3份体积),搅拌两相混合物5分钟,使分层。分离水层,必要时用正庚烷进行反萃取。合并有机层并进行真空浓缩。粗产物经SiO2柱色谱纯化得到浅黄色油状的ER-806721(0.74-0.85份重量,0.74-0.85当量)。Triphenylphosphine (0.7 wt, 1.2 eq), p-nitrobenzoic acid (0.45 wt, 1.2 eq), ER-808373 (1 wt, 1 eq) and anhydrous toluene (8 vol ). The reaction solution was cooled to an internal temperature of 0°C, and DEAD (1.17 wt, 1.2 eq) was slowly added at such a rate that the internal temperature did not exceed 7°C. n-Heptane (3.3 vol) was added and the mixture was cooled to an internal temperature of 10°C, then stirred for 30-40 minutes. The resulting precipitate was removed by filtration. The filter cake was washed with n-heptane (3.3 vol), TBME (0.55 vol), n-heptane (1.1 vol) and MTBE (0.55 vol), respectively. All filtrates were combined and concentrated in vacuo. The crude concentrate was dissolved in THF (8 vol), then water (0.8 vol) and lithium hydroxide dihydrate (0.18 wt, 2 eq) were added. After the mixture was stirred at room temperature, n-heptane (3.3 vol.) was added and stirred for 5 minutes. Water (2.2 vol) and n-heptane (3.3 vol) were added and the biphasic mixture was stirred for 5 minutes to allow the layers to separate. The aqueous layer was separated and back-extracted with n-heptane if necessary. The organic layers were combined and concentrated in vacuo. The crude product was purified by SiO 2 column chromatography to afford ER-806721 (0.74-0.85 wt, 0.74-0.85 eq) as pale yellow oil.
在反应器中加入ER-806721(1份重量,1当量)和无水二氯甲烷(4.2份体积)。将反应液冷却至内温为0-5℃,然后加入三乙胺(0.34份重量,1.5当量)、对甲苯磺酰氯(0.51份重量,1.2当量)和4-(二甲氨基)吡啶(0.001份重量,0.25当量)。室温下搅拌所得的混合物48小时,然后加入水(1.8份体积)和二氯甲烷(1.8份体积)。充分搅拌后,分离有机物,并浓缩有机物。将浓缩物溶解于MTBE(1.8份体积)中,用盐水(1.8份体积)洗涤。分离并搁置有机层。水层用MTBE(1.8份体积)反萃取,然后合并所有的有机物并进行真空浓缩。MTBE(7份体积)洗脱下,粗品油过滤通过SiO2塞(70-230目,1份重量),真空浓缩滤液。将浓缩物溶解于IPA(5份体积)中,加入水(0.25份体积)。将所得混合物冷却至内温为15℃,然后加入ER-807204晶种。放入晶种后,将混合物冷却至内温为0℃,搅拌4-5小时。过滤悬浮液,用冷的IPA(1份体积)洗涤滤饼,真空干燥滤饼至恒重,得到白色粉末状的ER-807204(1.05份重量,0.78当量)。IR(薄膜,cm-1)λ2597,1633,1363,1177,907,729.LRMS m/z 602(M+H).The reactor was charged with ER-806721 (1 wt, 1 eq) and anhydrous dichloromethane (4.2 vol). The reaction solution was cooled to an internal temperature of 0-5°C, then triethylamine (0.34 parts by weight, 1.5 equivalents), p-toluenesulfonyl chloride (0.51 parts by weight, 1.2 equivalents) and 4-(dimethylamino)pyridine (0.001 parts by weight, 0.25 equivalents). The resulting mixture was stirred at room temperature for 48 hours, then water (1.8 vol) and dichloromethane (1.8 vol) were added. After stirring well, the organics were separated and concentrated. The concentrate was dissolved in MTBE (1.8 vol) and washed with brine (1.8 vol). Separate and set aside the organic layer. The aqueous layer was back extracted with MTBE (1.8 vol), then all organics were combined and concentrated in vacuo. Eluting with MTBE (7 vol), the crude oil was filtered through a plug of SiO2 (70-230 mesh, 1 wt), and the filtrate was concentrated in vacuo. The concentrate was dissolved in IPA (5 vol) and water (0.25 vol) was added. The resulting mixture was cooled to an internal temperature of 15°C, and then ER-807204 seed crystals were added. After seeding, the mixture was cooled to an internal temperature of 0° C. and stirred for 4-5 hours. The suspension was filtered, the filter cake was washed with cold IPA (1 v), and the filter cake was dried in vacuo to constant weight to afford ER-807204 (1.05 wt, 0.78 eq) as a white powder. IR (thin film, cm-1) λ2597, 1633, 1363, 1177, 907, 729. LRMS m/z 602 (M+H).
在反应器中加入21%乙醇钠的乙醇溶液(2.97份重量,0.9当量)。加热该溶液至内温为65℃,然后以使内温不超过70℃的速度加入丙二酸二乙酯(3.24份重量,2当量)。搅拌混合物30分钟,然后经3-5小时加入ER-806906(1份重量,1当量)。加样完毕后,搅拌反应液60分钟,然后冷却至内温为50℃。以使内温不超过65℃的速度加入浓盐酸(0.84重量,1.05当量)。蒸馏脱除DMF(3份体积)和乙醇后加入六水氯化镁(0.21份重量,0.1当量)的蒸馏水(0.25份体积,1.4当量)溶液。将所得混合物加热至内温为135℃,同时去除馏出液。回流加热混合物,然后冷却至室温,加入盐水(12份体积)和TBME(16份体积)。分离有机层,用水(1.3份体积)和盐水(1.2份体积)洗涤后真空浓缩。产物经蒸馏纯化得到ER-805552(0.95-1.09份重量,0.71当量)。A 21% solution of sodium ethoxide in ethanol (2.97 wts, 0.9 eq) was added to the reactor. The solution was heated to an internal temperature of 65°C, then diethyl malonate (3.24 wt, 2 eq) was added at such a rate that the internal temperature did not exceed 70°C. The mixture was stirred for 30 minutes, then ER-806906 (1 wt, 1 eq) was added over 3-5 hours. After adding the sample, the reaction solution was stirred for 60 minutes, and then cooled to an internal temperature of 50°C. Concentrated hydrochloric acid (0.84 wt, 1.05 equiv) was added at such a rate that the internal temperature did not exceed 65°C. After removal of DMF (3 vol) and ethanol by distillation, a solution of magnesium chloride hexahydrate (0.21 wt, 0.1 eq) in distilled water (0.25 vol, 1.4 eq) was added. The resulting mixture was heated to an internal temperature of 135°C while removing distillate. The mixture was heated at reflux, then cooled to room temperature, and brine (12 vol) and TBME (16 vol) were added. The organic layer was separated, washed with water (1.3 vol) and brine (1.2 vol) and concentrated in vacuo. The product was purified by distillation to give ER-805552 (0.95-1.09 wt, 0.71 equiv).
在反应器中加入1.0M LHMDS的甲苯溶液(6.61份重量,1.04当量),冷却至内温为-75℃。将ER-805552(1份重量,1当量)溶解于无水THF中,以使内温不超过-70℃的速度加到反应器中。加样完毕后,搅拌所得混合物30分钟,在第二个反应器中加入无水THF(2.5份体积)和甲基碘(1.27份重量,1.25当量),冷却至内温为-75℃。以使内温不超过-65℃的速度,向甲基碘溶液中加入ER-805552的THF溶液。加样完毕后,-78℃内温下搅拌反应液30分钟。剧烈搅拌下,将反应液逆猝灭(inverse quenched)至1N盐酸溶液(1 0份体积)和MTBE(8份体积)中。加样完毕后,分离并弃去水层。有机层用盐水溶液(3份体积)洗涤,进行真空浓缩。产物经蒸馏纯化得到ER-806724(0.75份重量)的约6/1非对映异构体混合物。A 1.0M solution of LHMDS in toluene (6.61 parts by weight, 1.04 equivalents) was added to the reactor, and cooled to an internal temperature of -75°C. ER-805552 (1 wt, 1 eq) dissolved in anhydrous THF was added to the reactor at such a rate that the internal temperature did not exceed -70°C. After the addition was complete, the resulting mixture was stirred for 30 minutes, anhydrous THF (2.5 vol) and methyl iodide (1.27 wt, 1.25 eq) were added to a second reactor and cooled to an internal temperature of -75°C. The THF solution of ER-805552 was added to the methyl iodide solution at such a rate that the internal temperature did not exceed -65°C. After adding the sample, the reaction solution was stirred for 30 minutes at an internal temperature of -78°C. The reaction was inverse quenched into 1 N hydrochloric acid solution (10 vol) and MTBE (8 vol) with vigorous stirring. After the addition was complete, the aqueous layer was separated and discarded. The organic layer was washed with brine solution (3 vol) and concentrated in vacuo. The product was purified by distillation to give ER-806724 (0.75 wt) as an approximately 6/1 diastereomeric mixture.
在反应器中加入盐酸N,O-二甲基羟胺(1.05份重量,1.5当量)和无水CH2Cl2(8.1份体积),冷却至内温为0℃。以使内温不超过5℃的速度加入2M三甲基铝的甲苯溶液(3.93份重量,1.5当量)。另外搅拌反应液10分钟,以使内温不超过5℃的速度加入ER-806724。反应液用CH2Cl2(15份体积)稀释,然后以使内温不超过10℃的速度加到内温为0℃的1.3M酒石酸钠(20份体积)中进行逆猝灭。加样完毕后,使分层,分离并搁置水层。有机物用水(1份体积)洗涤,经硫酸钠(1份重量)干燥、过滤,真空浓缩至除去极微量的二氯甲烷。在浓缩物中分别加入无水DMF(6.3份体积)、咪唑(0.64份重量,1.5当量)和叔丁基二甲基氯硅烷(0.94份重量,0.97当量)。加入水(5份体积)和MTBE(10份体积),搅拌所得混合物,使分层。分离并弃去水层。有机层用水(5份体积)洗涤,分离各层。加入1N氢氧化钠(2.5份体积)和甲醇(2.5份体积),搅拌所得混合物。分离水层,有机层用盐水(2.5份体积)洗涤后真空浓缩得到棕色油状的ER-806753(1.94份重量,0.91当量)。N,O-dimethylhydroxylamine hydrochloride (1.05 parts by weight, 1.5 equivalents) and anhydrous CH 2 Cl 2 (8.1 parts by volume) were added to the reactor, and cooled to an internal temperature of 0°C. A 2M solution of trimethylaluminum in toluene (3.93 wt, 1.5 eq) was added at such a rate that the internal temperature did not exceed 5°C. The reaction solution was stirred for another 10 minutes so that the internal temperature did not exceed 5°C and ER-806724 was added at a rate. The reaction solution was diluted with CH 2 Cl 2 (15 vol), and then back-quenched by adding to 1.3M sodium tartrate (20 vol) at 0°C at such a rate that the internal temperature did not exceed 10°C. After the addition was complete, the layers were allowed to separate and the aqueous layer was set aside. The organics were washed with water (1 v), dried over sodium sulfate (1 wt), filtered, and concentrated in vacuo to remove traces of dichloromethane. To the concentrate were added anhydrous DMF (6.3 vol), imidazole (0.64 wt, 1.5 eq) and tert-butyldimethylsilyl chloride (0.94 wt, 0.97 eq) respectively. Water (5 vol) and MTBE (10 vol) were added and the resulting mixture was stirred to allow the layers to separate. The aqueous layer was separated and discarded. The organic layer was washed with water (5 vol) and the layers were separated. 1N Sodium hydroxide (2.5 vol) and methanol (2.5 vol) were added and the resulting mixture was stirred. The aqueous layer was separated and the organic layer was washed with brine (2.5 vol) and concentrated in vacuo to afford ER-806753 (1.94 wt, 0.91 eq) as a brown oil.
在反应器中加入ER-806753(1份重量,1当量)、CH2Cl2(5份体积)和NMO的50%水溶液(0.8份重量,1.1当量)。将混合物冷却至内温为10℃后加入0.197M OsO4的甲苯(0.06份体积,0.004当量)溶液。加入亚硫酸钠(0.1份重量,0.25当量)和水(0.85份体积),搅拌反应液1小时。混合物用盐水(0.85份体积)稀释,真空浓缩有机物至约1/3体积。在第二个反应器中先后加入高碘酸盐钠(1.3份重量,2当量)和THF(2.5份体积)。混合物用pH=7的磷酸缓冲液(3.0份体积)稀释,冷却至内温为20℃。以使内温不超过30℃的速度加入浓二醇。加样完毕后,室温下搅拌所得混合物。加入水(1.25份体积)、MTBE(7份体积)和盐水溶液(1.25份体积),分离各层。有机物用盐水溶液(1份体积)和饱和碳酸氢钠(1份体积)的混合物二次洗涤。最后,有机物与盐水(1份体积)和10%(重量/体积)硫代硫酸钠溶液(1份体积)的混合物搅拌1小时,然后真空浓缩。粗物质经SiO2柱色谱纯化得到黄色油状的ER-806754(0.93份重量,0.93当量)IR(薄膜,cm-1)λ2953,2856,1725,1664,1463,1254,1092,833.LRMS m/z 332(M+H)。The reactor was charged with ER-806753 (1 wt, 1 eq), CH2Cl2 (5 vol) , and a 50% aqueous solution of NMO (0.8 wt, 1.1 eq). After the mixture was cooled to an internal temperature of 10°C, a 0.197M solution of OsO4 in toluene (0.06 vol, 0.004 eq) was added. Sodium sulfite (0.1 wt, 0.25 eq) and water (0.85 vol) were added and the reaction was stirred for 1 hour. The mixture was diluted with brine (0.85 vol), and the organics were concentrated in vacuo to about 1/3 volume. Sodium periodate (1.3 wt, 2 eq) was added to a second reactor followed by THF (2.5 vol). The mixture was diluted with pH=7 phosphate buffer (3.0 vol) and cooled to an internal temperature of 20°C. Concentrated diol was added at such a rate that the internal temperature did not exceed 30°C. After the addition was complete, the resulting mixture was stirred at room temperature. Water (1.25 vol), MTBE (7 vol) and brine solution (1.25 vol) were added and the layers were separated. The organics were washed twice with a mixture of brine solution (1 vol) and saturated sodium bicarbonate (1 vol). Finally, a mixture of organics with brine (1 vol) and 10% (w/v) sodium thiosulfate solution (1 vol) was stirred for 1 hour, then concentrated in vacuo. The crude material was purified by SiO column chromatography to give ER-806754 (0.93 wt, 0.93 equiv) IR (thin film, cm-1) λ 2953, 2856, 1725, 1664, 1463, 1254, 1092, 833.LRMS m/ z 332(M+H).
在反应器中加入ER-806629(1.53份重量,3.1当量)和THF(10.5份体积),喷射氮气60分钟,使溶液脱气。在第二个惰性反应器中加入ER-807204(1份重量,1.0当量)、ER-806754(0.66份重量,1.2当量)和THF(2.7份体积),喷射氩气45分钟,使该溶液脱气。在含有ER-806906的反应器中先后加入CrCl2(0.63份重量,3.1当量)和三乙胺(0.52份重量,3.1当量)。在30-35℃内温下,搅拌该深绿色悬浮液1小时,冷却至0-5℃,然后加入NiCl2(0.1当量)。经0.5小时向第一个反应器中缓慢加入第二个反应器的内容物,使反应液升温至室温。冷却反应液至内温为0℃,然后经30分钟加入乙二胺(1.0份重量,10当量),在25℃内温下,搅拌反应液至少30分钟。在反应液中加入水(4份体积)、TBME(10份体积)和正庚烷(1份体积),搅拌所得混合物15分钟,使各相分开(约30min)。分离水层,用TBME(约7.5份体积)反萃取。合并有机层,用水(5份体积)、盐水(3份体积)洗涤,真空浓缩至最小体积。在粗混合物中加入IPA(10份体积)和SiO2(1份重量),在25℃内温下,搅拌所得混合物至多4天。过滤悬浮液,滤饼用IPA(2×1份体积)洗涤。在滤液中加入正庚烷(6.6份体积),真空浓缩混合物直至形成悬浮液。过滤混合物,滤饼用正庚烷洗涤,然后真空浓缩混合物。粗产物经SiO2柱色谱纯化得到亮黄色(clear yellow)油状的ER-807524(0.54份重量,0.48当量)IR(薄膜,cm-1)λ2934,1668,1471,1108,833.LRMS m/z 704(M+Na)。The reactor was charged with ER-806629 (1.53 wt, 3.1 eq) and THF (10.5 vol), and the solution was degassed by sparging nitrogen for 60 minutes. In a second inert reactor, ER-807204 (1 wt, 1.0 eq), ER-806754 (0.66 wt, 1.2 eq) and THF (2.7 vol) were charged and the solution was degassed by sparging argon for 45 minutes. gas. The reactor containing ER-806906 was charged with CrCl2 (0.63 wt, 3.1 eq) followed by triethylamine (0.52 wt, 3.1 eq). The dark green suspension was stirred at an internal temperature of 30-35°C for 1 hour, cooled to 0-5°C, and then NiCl2 (0.1 eq.) was added. The contents of the second reactor were added slowly to the first reactor over 0.5 hours and the reaction was allowed to warm to room temperature. The reaction solution was cooled to an internal temperature of 0°C, then ethylenediamine (1.0 wt, 10 eq) was added over 30 minutes, and the reaction solution was stirred at an internal temperature of 25°C for at least 30 minutes. Water (4 vol), TBME (10 vol) and n-heptane (1 vol) were added to the reaction, the resulting mixture was stirred for 15 min and the phases were allowed to separate (approximately 30 min). The aqueous layer was separated and back extracted with TBME (ca. 7.5 vol). The organic layers were combined, washed with water (5 vol), brine (3 vol), and concentrated in vacuo to minimum volume. IPA (10 vol) and SiO2 (1 wt) were added to the crude mixture and the resulting mixture was stirred at an internal temperature of 25°C for up to 4 days. The suspension was filtered and the filter cake was washed with IPA (2 x 1 vol). To the filtrate was added n-heptane (6.6 vol) and the mixture was concentrated in vacuo until a suspension formed. The mixture was filtered, the filter cake was washed with n-heptane, and the mixture was concentrated in vacuo. The crude product was purified by SiO column chromatography to give ER-807524 (0.54 wt, 0.48 eq) IR (film, cm-1) λ 2934, 1668, 1471, 1108, 833.LRMS m/z as a clear yellow oil 704 (M+Na).
在反应器中加入ER-807524(1份重量,1当量)和无水THF(1.25份体积)。将混合物冷却至内温为-20℃,以使内温不超过0℃的速度加入3M甲基氯化镁(0.59份体积,1.2当量)。加样完毕后,经2小时使混合物升温至内温为0℃。将反应混合物加至半饱和的氯化铵(2.62份体积)中进行逆猝灭,剧烈混合下,用TBME(2份体积)稀释所得混合物。弃去水层,有机物用盐水(2份体积)洗涤后真空浓缩。粗产物经SiO2柱色谱纯化得到黄色油状的ER-807525(0.79-0.82份重量,0.85-0.88当量)。The reactor was charged with ER-807524 (1 wt, 1 eq) and anhydrous THF (1.25 vol). The mixture was cooled to an internal temperature of -20°C, and 3M methylmagnesium chloride (0.59 vol, 1.2 eq) was added at such a rate that the internal temperature did not exceed 0°C. After the addition was complete, the mixture was allowed to warm to an internal temperature of 0°C over 2 hours. The reaction mixture was backquenched by adding half saturated ammonium chloride (2.62 vol) and the resulting mixture was diluted with TBME (2 vol) with vigorous mixing. The aqueous layer was discarded and the organics were washed with brine (2 v) and concentrated in vacuo. The crude product was purified by SiO 2 column chromatography to afford ER-807525 (0.79-0.82 wt, 0.85-0.88 eq) as a yellow oil.
在反应器中加入ER-807525(1份重量,1当量)、N-苯基双三氟甲磺酰胺(0.59份重量,1.1当量)和无水THF(4.1份体积),将混合物冷却至内温为-75℃。以使内温不超过-60℃的速度加入0.5MKHMDS的甲苯溶液(2.75份重量,1当量),然后使反应液经2小时升温至-20℃。以使内温不超过0℃的速度用半饱和的氯化铵(2.4份体积)猝灭反应。使混合物升温至内温为20℃,加入正庚烷(2.4份体积)。搅拌混合物,分离并弃去水层。有机层用饱和碳酸氢钠(每次2.3份体积)洗涤三次,然后经真空浓缩得到ER-807526(1.2-1.4份重量,1.0-1.2当量)。该物质不经进一步纯化,用于下一步骤。ER-807525 (1 wt, 1 eq), N-phenylbistrifluoromethanesulfonamide (0.59 wt, 1.1 eq) and anhydrous THF (4.1 vol) were added to the reactor, and the mixture was cooled to The temperature is -75°C. A 0.5 M KHMDS solution in toluene (2.75 wt, 1 eq) was added at such a rate that the internal temperature did not exceed -60°C, and then the reaction solution was allowed to warm to -20°C over 2 hours. The reaction was quenched with half-saturated ammonium chloride (2.4 vol) at such a rate that the internal temperature did not exceed 0°C. The mixture was allowed to warm to an internal temperature of 20°C and n-heptane (2.4 vol.) was added. The mixture was stirred, and the aqueous layer was separated and discarded. The organic layer was washed three times with saturated sodium bicarbonate (2.3 vol each), then concentrated in vacuo to give ER-807526 (1.2-1.4 wt, 1.0-1.2 eq). This material was used in the next step without further purification.
20℃下,在反应器中加入ER-807526(1份重量,1当量)和无水甲醇(3份体积)。加入1.25M盐酸的IPA溶液(4份体积,5当量),搅拌混合物3小时。搅拌下分批加入固体碳酸氢钠(0.42份重量,5当量),直至反应混合物的pH达到6-7。甲醇(3×2份体积)洗涤下,过滤反应混合物。真空浓缩所有的滤液,然后经SiO2柱色谱纯化得到ER-807527(0.43份重量,0.79-0.85当量)。The reactor was charged with ER-807526 (1 wt, 1 eq) and anhydrous methanol (3 vol) at 20°C. 1.25M hydrochloric acid in IPA (4 vol, 5 eq) was added and the mixture was stirred for 3 hours. Solid sodium bicarbonate (0.42 wt, 5 eq) was added portionwise with stirring until the pH of the reaction mixture reached 6-7. The reaction mixture was filtered with methanol (3 x 2 vol.) washes. All filtrates were concentrated in vacuo and then purified by SiO2 column chromatography to give ER-807527 (0.43 wt, 0.79-0.85 eq).
用制备HPLC色谱对非对映异构体混合物ER-807527进行分离,浓缩目标级分(desired fraction),得到亮黄色油状的ER-806730(0.56份重量,0.56当量)。用于分离ER-806730的制备HPLC色谱规程如下:The diastereomeric mixture ER-807527 was separated by preparative HPLC chromatography and the desired fraction was concentrated to give ER-806730 (0.56 wt, 0.56 equiv) as a bright yellow oil. The preparative HPLC chromatographic protocol used to isolate ER-806730 was as follows:
柱和介质: Kromasil球形硅胶柱,60A,粒径10Column and medium: Kromasil spherical silica gel column, 60A, particle size 10
μml,在7.7cm×60cm的Varian μml, in a Varian of 7.7cm×60cm
Dynamax Rampak柱中填充至7.7cmDynamax Rampak column filled to 7.7cm
(直径)×30cm(长度)(diameter)×30cm (length)
HPLC填充站: Varian(Rainin)Dynamax RampakHPLC filling station: Varian(Rainin)Dynamax Rampak
41/77mm柱填充站
HPLC泵: Varian(Rainin)SD-1钛泵头HPLC pump: Varian (Rainin) SD-1 titanium pump head
主(primary)HPLC检测器: Waters R403折射率检测器Main (primary) HPLC detector: Waters R403 Refractive Index Detector
副(secondary)HPLC检测器:Varian(Rainin)UV-1检测器(带有Deputy (secondary) HPLC detector: Varian (Rainin) UV-1 detector (with
制备流动池)Prepare flow cell)
色谱控制和获得软件: Varian(Rainin)Dynamax DA 1.4.6版Chromatographic control and acquisition software: Varian (Rainin) Dynamax DA version 1.4.6
色谱数据处理软件: Varian(Rainin)Dynamax R4.3版Chromatographic data processing software: Varian (Rainin) Dynamax R4.3 version
流动相: 28.5∶63.7∶7.85(体积/体积)正庚烷∶甲Mobile phase: 28.5:63.7:7.85 (volume/volume) n-heptane:methane
基叔丁醚∶2-丙醇 tert-butyl ether: 2-propanol
流速: 140mL/minFlow rate: 140mL/min
柱温: 室温(25℃)Column temperature: room temperature (25°C)
检测: 折射率,阴极(在16X处衰减),215nmDetection: Refractive Index, Cathode (attenuated at 16X), 215nm
处紫外吸收值UV absorption value at
流动相梯度: 等度Mobile Phase Gradient: Isocratic
运转时间: 40分钟Running time: 40 minutes
进样量: 10ml,含0.8g/mL的ER-807527Injection volume: 10ml, containing 0.8g/mL of ER-807527
用以上规程,按下列方式对非对映异构体ER-807527进行分离。首先用流动相将各批ER-807527稀释至0.1g/ml,并在真空下过滤通过孔径为1μm的47mm玻璃纤维滤器(Whatman GFC)。然后用旋转蒸发仪真空浓缩滤液。开始在SD-1 HPLC泵A(用流动相注液和清洗)上流动,将流速逐渐提高到140mL/min。对体系进行洗涤直至UV和RI检测器达到基线稳定。用新鲜的流动相对RI检测器的参比流动池进行冲洗。Using the above protocol, the diastereomer ER-807527 was separated in the following manner. Batches of ER-807527 were first diluted to 0.1 g/ml with mobile phase and filtered through a 47 mm glass fiber filter (Whatman GFC) with a pore size of 1 μm under vacuum. The filtrate was then concentrated in vacuo using a rotary evaporator. Start flow on SD-1 HPLC pump A (prime and wash with mobile phase) and gradually increase the flow rate to 140 mL/min. The system was washed until the UV and RI detectors reached baseline stabilization. Rinse the reference flow cell of the RI detector with fresh flow phase.
用流动相将当批ER-807527稀释至0.8g/mL浓度,以获得8gER-807527注射样的色谱。注射10mL溶质的等分试样,对应ER-807527峰值(约在24分钟峰顶开始,持续至35分钟),收集洗脱液。继续随后的注样和级分收集,直至耗尽起始原料。The equivalent batch of ER-807527 was diluted to a concentration of 0.8 g/mL with mobile phase to obtain a chromatogram of an 8 g ER-807527 injection. A 10 mL aliquot of the solute was injected corresponding to the ER-807527 peak (starting at approximately 24 min peak and continuing to 35 min) and the eluate was collected. Subsequent injections and fraction collections were continued until the starting material was exhausted.
将对应ER-806730的级分合并,用旋转蒸发仪进行真空浓缩。用表2所述的HPLC分析方法评价非对映异构纯度和面积%纯度面积。Fractions corresponding to ER-806730 were combined and concentrated in vacuo using a rotary evaporator. The HPLC analysis described in Table 2 was used to evaluate the diastereomeric purity and area % purity area.
表2 ER-806730非对映异构纯度的HPLC分析
检测:205nm处紫外吸收值Detection: UV absorption value at 205nm
在反应器中加入ER-806730(1份重量,1当量)和无水二氯甲烷(4.8份体积),冷却至内温为0℃。加入2,4,6-三甲基吡啶(1.16份重量,4当量)和DMAP(0.03份重量,0.1当量),搅拌所得混合物15分钟,然后以使内温不超过10℃的速度加入三甲基乙酰氯(0.3份重量,1.05当量)。加入水(3份体积),搅拌混合物15分钟。加入TBME(10份体积),另外搅拌混合物10分钟。有机层用1N盐酸(10份体积)洗涤直至2,4,6-三甲基吡啶呈负电性,然后分别用水(5份体积)、饱和碳酸氢钠(5份体积)和饱和盐水(5份体积)洗涤。真空浓缩有机层,浓缩物经SiO2柱色谱纯化得到黄色油状的ER-806732(1.02份重量,0.85当量)。ER-806730 (1 wt, 1 eq) and anhydrous dichloromethane (4.8 vol) were added to the reactor and cooled to an internal temperature of 0°C. 2,4,6-Collidine (1.16 wt, 4 eq) and DMAP (0.03 wt, 0.1 eq) were added, the resulting mixture was stirred for 15 minutes, then trimethylpyridine was added at such a rate that the internal temperature did not exceed 10 °C acetyl chloride (0.3 wt, 1.05 eq). Water (3 vol.) was added and the mixture was stirred for 15 minutes. TBME (10 v) was added and the mixture was stirred for an additional 10 minutes. The organic layer was washed with 1N hydrochloric acid (10 vol.) until 2,4,6-collidine was negatively charged, then water (5 vol.), saturated sodium bicarbonate (5 vol.) and saturated brine (5 vol. volume) wash. The organic layer was concentrated in vacuo, and the concentrate was purified by SiO2 column chromatography to afford ER-806732 (1.02 wt, 0.85 eq) as a yellow oil.
在反应器中加入ER-806732(1份重量,1当量)和无水THF(2.35份体积),冷却至内温为0℃。以使内温不超过10℃的速度先后加入三乙胺(0.22份重量,1.1当量)和甲磺酰氯(0.24份重量,1.05当量)。在0℃内温下搅拌反应液,然后剧烈搅拌下加入正庚烷(3.4份体积),使分层。有机物用饱和盐水(3.4份体积)洗涤,经饱和硫酸钠(2份重量)干燥、过滤,滤饼用正庚烷洗涤直至ER-805973(F-2a)呈负电性。真空浓缩滤液,得到ER-805973(1.12份重量,0.97当量)。粗品ER-805973(F-2a)未经进一步纯化而用于下一步骤。IR(薄膜,cm-1)λ2961,1725,1413,1208,926.LRMS m/z 579(M+H)。The reactor was charged with ER-806732 (1 wt, 1 eq) and anhydrous THF (2.35 vol) and cooled to an internal temperature of 0°C. Triethylamine (0.22 wt, 1.1 eq) and methanesulfonyl chloride (0.24 wt, 1.05 eq) were added successively at such a rate that the internal temperature did not exceed 10°C. The reaction was stirred at 0°C internal temperature, then n-heptane (3.4 vol) was added with vigorous stirring and the layers were allowed to separate. The organics were washed with saturated brine (3.4 v), dried over saturated sodium sulfate (2 wt), filtered, and the filter cake was washed with n-heptane until ER-805973 (F-2a) was negatively charged. The filtrate was concentrated in vacuo to afford ER-805973 (1.12 wt, 0.97 equiv). Crude ER-805973 (F-2a) was used in the next step without further purification. IR (thin film, cm-1) λ 2961, 1725, 1413, 1208, 926. LRMS m/z 579 (M+H).
实施例3Example 3
ER-806730的另一种制法Another preparation method of ER-806730
在反应器中加入奎尼酸(1份重量)、环己酮(2.11当量,1.08重量)和浓硫酸(0.011当量,0.0056份重量)。加热反应混合物至160℃,通过共沸蒸馏脱除水分(在100℃开始共沸)。将反应液冷却至90℃-100℃,加入碳酸氢钠(0.0096份重量)和甲苯(3.6份重量)。使反应液经4-6小时冷却至室温,所得沉淀物经过滤、甲苯(2×0.9份重量)洗涤以及干燥得到白色粉末状的1(0.97份重量)。The reactor was charged with quinic acid (1 wt), cyclohexanone (2.11 eq, 1.08 wt) and concentrated sulfuric acid (0.011 eq, 0.0056 wt). The reaction mixture was heated to 160°C and water was removed by azeotropic distillation (azeotrope started at 100°C). The reaction solution was cooled to 90°C-100°C, and sodium bicarbonate (0.0096 parts by weight) and toluene (3.6 parts by weight) were added. The reaction was allowed to cool to room temperature over 4-6 hours, and the resulting precipitate was filtered, washed with toluene (2 x 0.9 wt) and dried to give 1 (0.97 wt) as a white powder.
混合化合物1(1当量,1份重量)和咪唑(2.5当量,0.80份重量),用氮气吹扫,使之悬浮于无水THF(10份体积)中。以使温度保持低于30℃的速度加入TMSCl(1.2当量,0.61份重量)。将反应液冷却至室温,加入庚烷(10份体积),对所得的悬浮液进行过滤。滤饼用1∶1庚烷/THF(10份体积)洗涤,通过常压蒸馏,用甲苯交换滤液溶剂,得到2a(1.34份重量,计算值)的甲苯(约5份重量)溶液。Compound 1 (1 eq, 1 wt) and imidazole (2.5 eq, 0.80 wt) were mixed, purged with nitrogen, and suspended in anhydrous THF (10 v). TMSCl (1.2 equiv, 0.61 wt) was added at such a rate that the temperature was kept below 30°C. The reaction was cooled to room temperature, heptane (10 vol) was added and the resulting suspension was filtered. The filter cake was washed with 1:1 heptane/THF (10 v) and the filtrate solvent exchanged with toluene by atmospheric distillation to give a solution of 2a (1.34 wt, calculated) in toluene (ca. 5 wt).
冷却2a溶液至-78℃,以使温度保持低于-65℃的速度加入DIBAL-H(1.5M甲苯溶液,1.2当量,2.1份重量)。用甲醇(0.3当量,0.034份重量)猝灭过量的DIBAL-H,使溶液升温至0℃。以使温度保持低于25℃的速度,将溶液转移至30重量%罗谢尔盐(RochelleSalt)水溶液(10份重量)和碳酸氢钠(1份重量)的溶液中。剧烈搅拌混合物,得到两相溶液。分离各层,用MTBE(5份体积)萃取水层。合并的有机层先后用水(2.5份重量)和饱和盐水(2.5份重量)洗涤。浓缩有机物,与TFH进行溶剂交换以得到2b(0.98份重量,计算值)的TFH(5份体积)溶液。Cool the 2a solution to -78°C and add DIBAL-H (1.5M in toluene, 1.2 equiv, 2.1 wts) at such a rate that the temperature remains below -65°C. Excess DIBAL-H was quenched with methanol (0.3 eq, 0.034 wt) and the solution was allowed to warm to 0°C. The solution was transferred to a solution of 30% by weight aqueous Rochelle Salt (10 wt) and sodium bicarbonate (1 wt) at such a rate that the temperature was maintained below 25°C. The mixture was stirred vigorously, resulting in a biphasic solution. The layers were separated and the aqueous layer was extracted with MTBE (5 v). The combined organic layers were washed successively with water (2.5 wt) and saturated brine (2.5 wt). The organics were concentrated and solvent exchanged with TFH to give 2b (0.98 wt, calc.) as a solution in TFH (5 v).
冷却2b溶液至5℃,加入乙酸(2.9当量,0.51份体积)。加入水(1.0当量,0.055份体积),在0℃-5℃下搅拌溶液。根据需要,另外加入至多两等分乙酸和一等分水以促进甲硅烷基脱保护。以使温度保持低于20℃的速度加入三乙胺(12当量,3.6份重量)和DMAP(0.05当量,0.02份重量)。加入乙酐(6当量,2.0份重量),室温下搅拌反应液。将反应液冷却至5℃,以使温度保持低于30℃的速度加入饱和碳酸氢钠水溶液(10份体积)。搅拌所得混合物3-4小时,分离各层。用MTBE(5份体积)萃取水层。合并的有机物用水(5份体积)洗涤。通过蒸馏使用IPA对萃取液进行溶剂交换,得到2c的IPA(3份体积)溶液。将该溶液冷却至5℃,对所得的结晶进行过滤。浓缩母液,重结晶后获得二次收获,得到白色固体结晶状的2c(0.87份重量)。The 2b solution was cooled to 5°C and acetic acid (2.9 eq, 0.51 vol) was added. Water (1.0 equiv, 0.055 vol) was added and the solution was stirred at 0°C-5°C. Additional additions of up to two aliquots of acetic acid and one aliquot of water were added as needed to facilitate silyl deprotection. Triethylamine (12 eq, 3.6 wt) and DMAP (0.05 eq, 0.02 wt) were added at such a rate that the temperature was kept below 20°C. Acetic anhydride (6 eq, 2.0 wt) was added, and the reaction solution was stirred at room temperature. The reaction was cooled to 5°C and saturated aqueous sodium bicarbonate (10 vol) was added at such a rate that the temperature was kept below 30°C. The resulting mixture was stirred for 3-4 hours and the layers were separated. The aqueous layer was extracted with MTBE (5 v). The combined organics were washed with water (5 vol.). The extract was solvent exchanged with IPA by distillation to give 2c as a solution in IPA (3 v). The solution was cooled to 5°C, and the resulting crystals were filtered. The mother liquor was concentrated and a second crop was obtained after recrystallization to give 2c (0.87 wt) as a crystalline white solid.
将2c(1份重量)溶解于乙腈(6份体积)中,先后加入3-三甲基甲硅烷基戊-4-烯酸甲酯(3.0当量,1.86份重量)和TFAA(0.2当量,0.083份体积)。然后以使温度保持低于25℃的速度向溶液中加入BF3OEt2(1.0当量,0.42份体积)。在反应液中加入饱和碳酸氢钠水溶液(10份体积),搅拌所得混合物1 5分钟。混合物先后用庚烷(10份体积)和MTBE(5份体积)萃取,对合并的萃取液进行浓缩,得到橙色油状的3(0.72份重量,计算值)。2c (1 wt) was dissolved in acetonitrile (6 vol), and methyl 3-trimethylsilylpent-4-enoate (3.0 eq, 1.86 wt) was added followed by TFAA (0.2 eq, 0.083 portion volume). BF3OEt2 ( 1.0 equiv, 0.42 vol) was then added to the solution at such a rate that the temperature was kept below 25 °C. Saturated aqueous sodium bicarbonate solution (10 vol.) was added to the reaction solution, and the resulting mixture was stirred for 15 minutes. The mixture was extracted with heptane (10 v) followed by MTBE (5 v) and the combined extracts were concentrated to give 3 (0.72 wt, calculated) as an orange oil.
以使温度保持低于25℃的速度,用甲醇钠(25%重量/重量甲醇溶液(1.5当量,2.2份重量))处理3(1份重量)的THF(9份体积)溶液。加入1N盐酸(10份体积)使反应猝灭。分离有机层,水层用MTBE(10份体积)萃取。合并的有机物用水(2.5份体积)、饱和碳酸氢钠(2.5份体积)和水(2.5份体积)洗涤。浓缩溶液,得到4(0.88份重量,计算值)的THF(2.5份体积)溶液。该溶液直接用于下一步骤。A solution of 3 (1 wt) in THF (9 v) was treated with sodium methoxide (25% w/w in methanol (1.5 eq, 2.2 wt)) at such a rate that the temperature was kept below 25 °C. The reaction was quenched by the addition of 1N hydrochloric acid (10 vol.). The organic layer was separated and the aqueous layer was extracted with MTBE (10 vol). The combined organics were washed with water (2.5 vol), saturated sodium bicarbonate (2.5 vol) and water (2.5 vol). The solution was concentrated to give a solution of 4 (0.88 wt, calculated) in THF (2.5 vol). This solution was used directly in the next step.
在4(1份重量)的四氢呋喃(2.5份体积)溶液中加入甲醇(5份体积)。加入1N盐酸(0.75当量,2份体积),使反应液升温至60-80℃。冷却反应液至室温,加入饱和碳酸氢盐水溶液。混合物用DCM(3×2.5份体积)萃取,合并的DCM萃取液与乙酸乙酯进行溶剂交换,得到5的乙酸乙酯(3份体积)溶液。加入庚烷(2份体积)以诱导结晶,将所得悬浮液冷却至0℃。过滤收集固体,滤饼用冷的乙酸乙酯/庚烷(1∶1体积比)洗涤,经干燥得到白色粉末状的5(0.55份重量)。To a solution of 4 (1 wt) in tetrahydrofuran (2.5 vol) was added methanol (5 vol). 1N Hydrochloric acid (0.75 eq, 2 v) was added and the reaction was allowed to warm to 60-80 °C. The reaction solution was cooled to room temperature, and saturated aqueous bicarbonate solution was added. The mixture was extracted with DCM (3 x 2.5 v) and the combined DCM extracts were solvent exchanged with ethyl acetate to give a solution of 5 in ethyl acetate (3 v). Heptane (2 vol.) was added to induce crystallization and the resulting suspension was cooled to 0°C. The solid was collected by filtration, the filter cake was washed with cold ethyl acetate/heptane (1:1 v/v), and dried to give 5 (0.55 wt) as a white powder.
将化合物5(1份重量)溶解于乙腈(10份体积)中,然后依次加入2-乙酸基-2-甲基溴丙烷(2-acetoxy-2-methylpropanyl bromide)(4.0当量,2.2份重量)和水(1当量,0.067份重量)。室温下搅拌所得混合物,然后冷却至5-10℃。加入NaOMe(25%重量/重量甲醇溶液,8当量,6.2份重量),使反应液升温至室温。加入饱和碳酸氢钠(10份体积)猝灭反应液,用MTBE(2×10份体积)萃取。通过常压蒸馏与甲醇进行溶剂交换,得到6(0.91份重量,计算值)的甲醇(10份体积)溶液。Compound 5 (1 wt) was dissolved in acetonitrile (10 vol), followed by the addition of 2-acetoxy-2-methylpropanyl bromide (4.0 eq, 2.2 wt) and water (1 equiv, 0.067 wt). The resulting mixture was stirred at room temperature, then cooled to 5-10°C. NaOMe (25% w/w in methanol, 8 eq, 6.2 wt) was added and the reaction was allowed to warm to room temperature. The reaction was quenched by the addition of saturated sodium bicarbonate (10 vol) and extracted with MTBE (2 x 10 vol). Solvent exchange with methanol by atmospheric distillation afforded 6 (0.91 wt, calculated) as a solution in methanol (10 v).
将6(1份重量)的甲醇(10份体积)溶液加热至55℃。分6次加入硼氢化钠(5当量,0.68份重量),冷却反应液至5℃,用1N盐酸(10份体积)进行猝灭。加入盐水(5份体积),用乙酸乙酯(2×10份体积)萃取反应液。合并萃取液,经浓缩得到7,为褐色残渣。A solution of 6 (1 wt) in methanol (10 v) was heated to 55°C. Sodium borohydride (5 eq, 0.68 wt) was added in 6 portions, the reaction was cooled to 5°C and quenched with 1N hydrochloric acid (10 v). Brine (5 vol) was added and the reaction was extracted with ethyl acetate (2 x 10 vol). The combined extracts were concentrated to give 7 as a brown residue.
将化合物7(1份重量)溶解于CH2Cl2(10份体积)中,然后在室温下加入DMAP(0.1当量,0.054份重量)、三乙胺(3.0当量,1.85份体积)和TBDPSCl(1.2当量,1.38份体积)。加入碳酸氢钠(10份体积),分离有机层。水层再次用CH2Cl2(10份体积)萃取。合并有机萃取液,经浓缩得到无色油状的8(1.8份重量,计算值)。Compound 7 (1 wt) was dissolved in CH2Cl2 (10 v), then DMAP (0.1 eq, 0.054 wt), triethylamine ( 3.0 eq, 1.85 v) and TBDPSCl ( 1.2 eq, 1.38 vol). Sodium bicarbonate (10 vol) was added and the organic layer was separated. The aqueous layer was extracted again with CH2Cl2 ( 10 vol). The organic extracts were combined and concentrated to afford 8 (1.8 wt, calculated) as a colorless oil.
室温下,在8(1份重量)的THF(10体积)溶液中加入LDA(1.5M环己烷溶液,4当量,6份体积)。使该溶液升温至50℃后用1N盐酸(5份体积)进行猝灭,用MTBE(10份体积)萃取。浓缩萃取液得到油状的9(0.9份重量)。To a solution of 8 (1 wt) in THF (10 vol) was added LDA (1.5M in cyclohexane, 4 eq, 6 vol) at room temperature. The solution was allowed to warm to 50°C and quenched with 1N hydrochloric acid (5 vol) and extracted with MTBE (10 vol). Concentration of the extract gave 9 (0.9 wt) as an oil.
将9(1份重量)的二氯甲烷(5份体积)和甲醇(5份体积)溶液冷却至-60℃,保持温度低于-50℃条件下,用O3进行处理。用氮气吹扫反应液,加入NaBH4(0.5当量,0.04份重量),使混合物升温至0℃。另外分批加入NaBH4(1当量,0.08份重量),使反应液升温至室温。3小时后,用1N盐酸(10份体积)猝灭混合物,加入二氯甲烷(5份体积),使分层。水层用二氯甲烷(10份体积)再萃取,合并有机萃取液,经浓缩得到无色油状的10(0.97份重量)。A solution of 9 (1 wt) in dichloromethane (5 vol) and methanol (5 vol) was cooled to -60°C and treated with O3 keeping the temperature below -50°C. The reaction was purged with nitrogen, NaBH4 (0.5 eq, 0.04 wt) was added, and the mixture was allowed to warm to 0 °C. Additional NaBH 4 (1 eq, 0.08 wt) was added in portions, and the reaction solution was warmed to room temperature. After 3 hours, the mixture was quenched with 1N hydrochloric acid (10 vol), dichloromethane (5 vol) was added and the layers were allowed to separate. The aqueous layer was re-extracted with dichloromethane (10 v) and the combined organic extracts were concentrated to give 10 (0.97 wt) as a colorless oil.
将化合物10溶解于THF(10份体积)中,加入磷酸盐缓冲液(pH=7,5份体积)。加入NaIO4(2当量,0.854份重量),使反应液升温至室温。加入水(5份体积)和MTBE(10份体积),剧烈搅拌所得混合物10分钟。分离有机层,用10%重量/体积硫代硫酸钠水溶液(5份体积)、水(5份体积)和盐水(5份体积)洗涤,然后与THF共沸蒸馏干燥(约含水200ppm),得到11(0.93份重量,计算值)的THF(10份体积)溶液。该溶液直接用于下一步骤。Compound 10 was dissolved in THF (10 vol) and phosphate buffer (pH=7, 5 vol) was added. NaIO4 (2 eq, 0.854 wt) was added and the reaction was allowed to warm to room temperature. Water (5 vol) and MTBE (10 vol) were added and the resulting mixture was stirred vigorously for 10 minutes. The organic layer was separated, washed with 10% w/v aqueous sodium thiosulfate (5 vol), water (5 vol), and brine (5 vol), then dried azeotropically with THF (about 200 ppm water) to give 11 (0.93 wt, calculated) in THF (10 v). This solution was used directly in the next step.
在11(1份重量)的THF(10份体积)溶液中加入(甲酯基亚甲基)三苯膦(1份重量),加热至65℃。加入庚烷(40份体积),搅拌所得混合物30分钟。对所得沉淀物进行过滤,浓缩滤液至总体积为10份体积。加入SiO2(5份重量),悬浮液过滤通过SiO2垫(用MTBE(20-40份体积)洗脱)。用甲醇交换溶剂,得到12(0.95份重量,计算值)的甲醇(10份体积)溶液,直接用于下一步骤。To a solution of 11 (1 wt) in THF (10 v) was added (methoxymethylene)triphenylphosphine (1 wt) and heated to 65°C. Heptane (40 vol) was added and the resulting mixture was stirred for 30 minutes. The resulting precipitate was filtered and the filtrate was concentrated to a total volume of 10 vol. SiO2 (5 wt) was added and the suspension was filtered through a pad of SiO2 eluting with MTBE (20-40 v). The solvent was exchanged with methanol to give a solution of 12 (0.95 wt, calculated) in methanol (10 v) which was used directly in the next step.
在12(1份重量)的甲醇(10份体积)溶液中加入10%重量/重量钯碳(0.23当量,0.37份重量),并用氢气处理。过滤悬浮液,同时用THF(10份体积)冲洗滤饼。用THF交换溶剂,得到13(0.95份重量,计算值)的THF(10份体积)溶液,直接用于下一步骤。To a solution of 12 (1 wt) in methanol (10 v) was added 10% w/w palladium on carbon (0.23 eq, 0.37 wt) and treated with hydrogen. The suspension was filtered while rinsing the filter cake with THF (10 v). Solvent exchange with THF gave 13 (0.95 wt, calculated) in THF (10 v) which was used directly in the next step.
将13(1份重量)的THF(10份体积)溶液冷却至0-5℃,以保持温度低于10℃的速度加入LAH(1M THF溶液,0.78当量,1.5份体积)。然后以保持温度低于10℃的速度加入水(1.7当量,0.06份体积)。以保持温度低于10℃的速度先后加入氢氧化钠10%重量/水溶液(0.16当量,0.06份体积)和水(4.98当量,0.17份体积),所得混合物在剧烈搅拌下升温至室温。过滤悬浮液,滤饼用THF(5份体积)冲洗。对滤液进行部分浓缩,得到14(0.9份重量,计算值)的THF(10份体积)溶液,直接用于下一步骤。A solution of 13 (1 wt) in THF (10 v) was cooled to 0-5 °C and LAH (1M in THF, 0.78 eq, 1.5 v) was added at a rate to keep the temperature below 10 °C. Water (1.7 equiv, 0.06 vol) was then added at a rate to maintain the temperature below 10°C. Sodium hydroxide 10% wt/water solution (0.16 eq, 0.06 vol) and water (4.98 eq, 0.17 vol) were added sequentially at a rate to maintain the temperature below 10°C, and the resulting mixture was allowed to warm to room temperature with vigorous stirring. The suspension was filtered and the filter cake was rinsed with THF (5 v). The filtrate was partially concentrated to give 14 (0.9 wt, calculated) in THF (10 v) which was used directly in the next step.
将14(1份重量)的THF(10份体积)溶液冷却至0℃,然后加入咪唑和TrCl(1.5当量,0.59份重量)。加入饱和碳酸氢钠水溶液(5份体积),用庚烷(10份体积)萃取混合物。萃取液用盐水(10份体积)洗涤,经浓缩得到15(1.35份重量)。A solution of 14 (1 wt) in THF (10 v) was cooled to 0°C, then imidazole and TrCl (1.5 eq, 0.59 wt) were added. Saturated aqueous sodium bicarbonate (5 vol) was added and the mixture was extracted with heptane (10 vol). The extract was washed with brine (10 v) and concentrated to give 15 (1.35 wt).
将化合物15(1份重量)溶解于THF(10份体积)中,用TBAF(1M,1.2当量,1.6份体积)进行处理。浓缩反应混合物至2份体积,然后加入庚烷(5份体积)和SiO2(5份体积)。过滤所得悬浮液,先后用庚烷(5份体积)和THF(10份体积)进行洗脱。收集THF洗脱液,得到16(0.61份重量,计算值)的THF(10份体积)溶液,直接用于下一步骤。Compound 15 (1 wt) was dissolved in THF (10 v) and treated with TBAF (1M, 1.2 eq, 1.6 v). The reaction mixture was concentrated to 2 vol, then heptane (5 vol) and SiO2 (5 vol) were added. The resulting suspension was filtered, eluting with heptane (5 vol) followed by THF (10 vol). The THF eluate was collected to give a solution of 16 (0.61 wt, calculated) in THF (10 v) which was used directly in the next step.
在16(1份重量)的THF(10份体积)溶液中加入PPh3(5当量,2.3份重量)、吡啶(10当量,1份体积)和NIS(3.0当量,1.1份重量)。然后加入20%重量/重量柠檬酸水溶液(10当量,14份重量),搅拌所得混合物10分钟。反应液用庚烷(10份体积)稀释,分离水层。有机层用水(5份体积)、10%重量/体积硫代硫酸钠水溶液(5份体积)、水(5份体积)和盐水(5份体积)洗涤。用乙醇交换溶剂,浓缩至5份体积。加入水(10份体积),对所得沉淀物进行过滤收集,得到白色固体状的17(0.65份重量)。To a solution of 16 (1 wt) in THF (10 v) was added PPh3 (5 eq, 2.3 wt), pyridine (10 eq, 1 v) and NIS (3.0 eq, 1.1 wt). Then 20% w/w aqueous citric acid (10 eq, 14 wt) was added and the resulting mixture was stirred for 10 minutes. The reaction was diluted with heptane (10 vol) and the aqueous layer was separated. The organic layer was washed with water (5 vol), 10% w/v aqueous sodium thiosulfate (5 vol), water (5 vol), and brine (5 vol). The solvent was exchanged with ethanol and concentrated to 5 volumes. Water (10 v) was added and the resulting precipitate was collected by filtration to afford 17 (0.65 wt) as a white solid.
将化合物17(1份重量)和氰化钾(6当量,0.54份体积)悬浮于乙醇(5份体积)和水(10份体积)中,将所得悬浮液加热至80℃。反应液用水(5份体积)和乙酸乙酯(10份体积)稀释,混合10分钟。去除水层,有机层用水(5份体积)和盐水(5份体积)洗涤。用乙醇交换溶剂,得到18(0.75份重量)的乙醇(10份体积)溶液,直接用于下一步骤。Compound 17 (1 wt) and potassium cyanide (6 eq, 0.54 vol) were suspended in ethanol (5 vol) and water (10 vol), and the resulting suspension was heated to 80°C. The reaction was diluted with water (5 vol) and ethyl acetate (10 vol) and mixed for 10 minutes. The aqueous layer was removed and the organic layer was washed with water (5 vol) and brine (5 vol). Solvent exchange with ethanol gave a solution of 18 (0.75 wt) in ethanol (10 v) which was used directly in the next step.
在18(1份重量)的乙醇(10份体积)溶液中加入锌(37当量,3.9份重量),加热混合物至75-80℃。将反应液部分浓缩至2-3份体积,冷却至室温,用MTBE(10份体积)和水(5份体积)使之分层。去除水层,有机层用饱和碳酸氢钠(5份体积)、水(5份体积)和盐水(5份体积)洗涤。然后经THF共沸蒸馏干燥至含水约200ppm,得到19(0.81份重量)的THF(10份体积)溶液。所得溶液直接用于下一步骤。To a solution of 18 (1 wt) in ethanol (10 v) was added zinc (37 eq, 3.9 wt) and the mixture was heated to 75-80°C. The reaction was partially concentrated to 2-3 vol, cooled to room temperature and partitioned between MTBE (10 vol) and water (5 vol). The aqueous layer was removed and the organic layer was washed with saturated sodium bicarbonate (5 vol), water (5 vol) and brine (5 vol). It was then dried by azeotropic distillation in THF to about 200 ppm water to give a solution of 19 (0.81 wt) in THF (10 vol). The resulting solution was used directly in the next step.
-78℃下,在19(1份重量)的THF(10份体积)溶液中加入LDA(1.0M THF溶液,1.2当量,2.4份体积)。搅拌所得混合物10分钟,然后在-78℃下,向甲基碘(1.5当量,0.19份体积)的THF(5份体积)溶液中加入该烯醇化物溶液。将反应液加至饱和碳酸氢钠(10份体积)中进行逆猝灭,用MTBE(15份体积)萃取。萃取液用盐水(5份体积)洗涤,浓缩后经色谱纯化得到20(0.86份重量)。To a solution of 19 (1 wt) in THF (10 vol) was added LDA (1.0M in THF, 1.2 eq, 2.4 vol) at -78°C. The resulting mixture was stirred for 10 min, then the enolate solution was added to a solution of methyl iodide (1.5 eq, 0.19 v) in THF (5 v) at -78 °C. The reaction was back-quenched by adding saturated sodium bicarbonate (10 vol) and extracted with MTBE (15 vol). The extract was washed with brine (5 v), concentrated and purified by chromatography to give 20 (0.86 wt).
0℃下,在盐酸二甲基羟胺(1份重量)的二氯甲烷(2.5份体积)悬浮液中加入AlMe3(2M甲苯溶液,1.5当量,1.5份体积)。以保持反应温度低于5℃的速度加入20(1份重量)的二氯甲烷(5份体积)溶液。然后在保持温度低于10℃条件下,向酒石酸钠水溶液(1.3M,20份体积)中加入反应混合物。使分层并进行分离,有机层经硫酸钠(5份重量)干燥。对所得悬浮液进行过滤,浓缩滤液。将残渣溶解于DMF(2份体积)中,然后加入咪唑(0.19份重量)和TBSCl(0.29份重量)。反应液用水(5份体积)和MTBE(10份体积)稀释,搅拌10分钟。去除水层,有机层用水(5份体积)洗涤。在氢氧化钠水溶液(1N,0.78份体积)和甲醇(0.7份体积)的溶液中加入萃取液。搅拌反应液后去除水层,有机层用盐水(2.5份体积)洗涤,经浓缩得到21(1.2份重量)。To a suspension of dimethylhydroxylamine hydrochloride (1 wt) in dichloromethane (2.5 vol) was added AlMe3 (2M in toluene, 1.5 eq, 1.5 vol) at 0°C. A solution of 20 (1 wt) in dichloromethane (5 vol) was added at a rate to maintain the reaction temperature below 5°C. The reaction mixture was then added to aqueous sodium tartrate (1.3M, 20 vol) while maintaining the temperature below 10°C. The layers were allowed to separate and the organic layer was dried over sodium sulfate (5 wt). The resulting suspension was filtered and the filtrate was concentrated. The residue was dissolved in DMF (2 v) followed by the addition of imidazole (0.19 wt) and TBSCl (0.29 wt). The reaction was diluted with water (5 vol) and MTBE (10 vol) and stirred for 10 minutes. The aqueous layer was removed and the organic layer was washed with water (5 vol). The extract was added to a solution of aqueous sodium hydroxide (1 N, 0.78 vol) and methanol (0.7 vol). After stirring the reaction, the aqueous layer was removed and the organic layer was washed with brine (2.5 vol) and concentrated to give 21 (1.2 wt).
以保持反应温度低于0℃的速度,在21(1份重量)的无水THF(1.11份重量,1.25份体积)溶液中加入甲基氯化镁(3.0M,59份重量,1.2当量)。0℃下搅拌后,将反应液加至饱和氯化铵(2.5份体积)和水(2.3份体积)中进行逆猝灭。所得混合物用MTBE(10份体积)稀释,剧烈搅拌。分离水层,有机层用盐水(2.5份体积)洗涤,经浓缩得到22(0.84份重量)。To a solution of 2 l (1 wt) in anhydrous THF (1.11 wt, 1.25 vol) was added methylmagnesium chloride (3.0 M, 59 wt, 1.2 eq) at such a rate as to keep the reaction temperature below 0 °C. After stirring at 0°C, the reaction was backquenched by adding saturated ammonium chloride (2.5 vol) and water (2.3 vol). The resulting mixture was diluted with MTBE (10 v) and stirred vigorously. The aqueous layer was separated and the organic layer was washed with brine (2.5 vol) and concentrated to give 22 (0.84 wt).
将化合物22(1份重量)溶解于THF(4份体积)中,冷却至-78℃。保持温度低于-60℃条件下,加入KHMDS(1.5M甲苯溶液,1.01当量,2.78份重量)。加入Tf2NPh(0.62份重量,1.1当量)的THF(1.5份体积)溶液,使反应液升温至-20℃。加入饱和氯化铵(2.5份体积)、水(2.5份体积)和正庚烷(2.5份体积),混合物升温至室温。使分层,去除水层。有机萃取液用饱和碳酸氢钠水溶液(3×2.5份体积)和盐水(2.5份体积)洗涤,然后经真空浓缩得到23(1.1份重量)。Compound 22 (1 wt) was dissolved in THF (4 vol) and cooled to -78°C. KHMDS (1.5M in toluene, 1.01 equiv, 2.78 wts) was added keeping the temperature below -60°C. A solution of Tf 2 NPh (0.62 wt, 1.1 eq) in THF (1.5 vol) was added and the reaction was allowed to warm to -20°C. Sat. ammonium chloride (2.5 vol), water (2.5 vol) and n-heptane (2.5 vol) were added and the mixture was allowed to warm to room temperature. Separate the layers and remove the aqueous layer. The organic extract was washed with saturated aqueous sodium bicarbonate (3 x 2.5 vol) and brine (2.5 vol), then concentrated in vacuo to give 23 (1.1 wt).
将化合物23溶解于甲醇(2.5份体积)中,冷却至15℃。加入盐酸(5N IPA溶液,1.30当量,1.18份重量),所得溶液升温至25℃。冷却反应液至0℃,加入碳酸氢钠(3当量,0.33份重量)。搅拌反应液15分钟,过滤去除所得沉淀物。滤饼用ACS级甲醇(1份体积)洗涤,合并滤液并进行浓缩。粗浓缩物经色谱纯化得到ER-806730(24)(0.5份重量)。Compound 23 was dissolved in methanol (2.5 vol) and cooled to 15°C. Hydrochloric acid (5N in IPA, 1.30 equiv, 1.18 wt) was added and the resulting solution warmed to 25°C. The reaction solution was cooled to 0°C, and sodium bicarbonate (3 eq, 0.33 wt) was added. The reaction was stirred for 15 minutes, and the resulting precipitate was removed by filtration. The filter cake was washed with ACS grade methanol (1 vol), and the combined filtrates were concentrated. The crude concentrate was purified by chromatography to give ER-806730(24) (0.5 wt).
实施例4aExample 4a
采用以上方案V所阐述的通用方案下,实施例4a提供另一种制备式A的化合物(制备F2的中间体)的方法。该方法以ER-812935为中间体(根据实施例3(化合物4)进行制备)。Using the general scheme set forth in Scheme V above, Example 4a provides an alternative method for the preparation of compounds of formula A (intermediate for the preparation of F2). This method uses ER-812935 as an intermediate (prepared according to Example 3 (compound 4)).
将ER-812935(1份重量)溶解于THF(10份体积)中,冷却至0℃。保持温度低于5℃条件下,加入LAH(1.0M THF溶液,0.70当量,2.0份体积)。剧烈搅拌下,用水(0.078份体积)猝灭过量的试剂,期间保持温度低于5℃。边保持剧烈搅拌,边先后加入氢氧化钠(15%重量/重量水溶液(0.078份体积))和水(0.18份体积)。加入Celite(2份重量)后过滤悬浮液,用THF(5份体积)冲洗滤饼。将ER-817633(0.92份重量,基于100%转化率的计算值)浓缩至5份体积,直接用于下一步骤。ER-812935 (1 wt) was dissolved in THF (10 vol) and cooled to 0°C. LAH (1.0 M in THF, 0.70 equiv, 2.0 vol) was added keeping the temperature below 5°C. With vigorous stirring, the excess reagent was quenched with water (0.078 vol) while maintaining the temperature below 5°C. While maintaining vigorous stirring, sodium hydroxide (15% w/w in water (0.078 vol)) was added followed by water (0.18 vol). After addition of Celite( R ) (2 wt) the suspension was filtered and the filter cake was rinsed with THF (5 v). ER-817633 (0.92 wt, calculated based on 100% conversion) was concentrated to 5 volumes and used directly in the next step.
用THF(5份体积)稀释前面所制备的ER-816961溶液(1份重量溶于5份体积THF),冷却至5℃,加入三乙胺(3当量,0.94份重量)。以保持温度低于10℃的速度加入MsCl(1.05当量,0.25份体积)。加入水(5份重量),使反应猝灭。加入庚烷(8份体积),使混合物分层。分离水相并用MTBE(2份体积)萃取。合并的有机萃取液用饱和碳酸氢钠(5份体积)和水(1.9份体积)洗涤。浓缩有机层,用乙醇交换溶剂以制备ER-818937(1.23份重量,基于100%转化率的计算值)的乙醇(1份体积)溶液,直接用于下一步骤。A previously prepared solution of ER-816961 (1 wt in 5 v THF) was diluted with THF (5 v), cooled to 5°C, and triethylamine (3 eq, 0.94 wt) was added. MsCl (1.05 eq, 0.25 vol) was added at a rate to keep the temperature below 10 °C. Water (5 wt) was added to quench the reaction. Heptane (8 vol) was added and the mixture was separated. The aqueous phase was separated and extracted with MTBE (2 v). The combined organic extracts were washed with saturated sodium bicarbonate (5 vol) and water (1.9 vol). The organic layer was concentrated, and the solvent was exchanged with ethanol to prepare a solution of ER-818937 (1.23 wt, calculated based on 100% conversion) in ethanol (1 vol), which was used directly in the next step.
用乙醇(190标准强度,9份体积)稀释前面所制备的ER-818937溶液(1份重量溶于0.8份体积乙醇)。加入氰化钾(3当量,0.41份重量),加热悬浮液至70-80℃。冷却反应液至室温,先后加入水(10份体积)和MTBE(10份体积)。分离各层,水层用MTBE(5份体积)萃取。合并的有机物用水(2份体积)和饱和盐水(4份重量)洗涤。浓缩萃取液,直接用于下一步骤。A previously prepared solution of ER-818937 (1 wt in 0.8 vol ethanol) was diluted with ethanol (190 proof strength, 9 vol). Potassium cyanide (3 equiv, 0.41 wt) was added and the suspension was heated to 70-80°C. The reaction was cooled to room temperature and water (10 vol) was added followed by MTBE (10 vol). The layers were separated and the aqueous layer was extracted with MTBE (5 v). The combined organics were washed with water (2 v) and saturated brine (4 wt). The extract was concentrated and used directly in the next step.
将ER-818950溶解于乙酸(5份体积)中,加入盐酸(1.0M,1当量,3份体积),室温下搅拌反应液。冷却反应液至0℃,以保持温度低于10℃的速度加入氢氧化钠(50重量%,30当量,7份重量)。用庚烷(2×10份体积)萃取溶液。水相用氯化钠饱和,用乙腈(2×10份体积)萃取。浓缩合并的乙腈萃取液,通过常压蒸馏,与乙酸乙酯进行溶剂交换,得到ER-817664的乙酸乙酯(3份体积)溶液。从热溶液中滤出盐后冷却至0℃。过滤悬浮液得到白色固体结晶状的ER-817664。ER-818950 was dissolved in acetic acid (5 vol), hydrochloric acid (1.0 M, 1 eq, 3 vol) was added, and the reaction was stirred at room temperature. The reaction was cooled to 0°C and sodium hydroxide (50 wt%, 30 eq, 7 wts) was added at a rate to keep the temperature below 10°C. The solution was extracted with heptane (2 x 10 vol). The aqueous phase was saturated with sodium chloride and extracted with acetonitrile (2 x 10 vol). The combined acetonitrile extracts were concentrated, solvent exchanged with ethyl acetate by atmospheric distillation to give a solution of ER-817664 in ethyl acetate (3 vol.). The salt was filtered off from the hot solution and cooled to 0°C. Filtration of the suspension afforded ER-817664 as a crystalline white solid.
实施例4bExample 4b
实施例4b提供另一种用以上方案Vb和Vc所述的通用方案制备式F-2的化合物的方法。该方法以ER-817664(按照以上实施例4a进行制备)作为中间体。Example 4b provides an alternative method for preparing compounds of formula F-2 using the general scheme described in Schemes Vb and Vc above. This method uses ER-817664 (prepared according to Example 4a above) as an intermediate.
将ER-817664(1份重量)溶解于乙腈(10份体积)中,冷却悬浮液至0℃,先后加入2-乙酸基-2-甲基溴丙烷(4.0当量,2.4份体积)和水(1.0当量,0.07份体积)。0℃下搅拌所得混合物2小时。0℃下,缓慢加入碳酸氢钠(饱和水溶液,8.0当量,40份体积)。室温下搅拌所得混合物30分钟,然后用MTBE(2×20份体积)进行萃取。有机层用盐水(5份体积)洗涤,经浓缩得到无色油状产物。ER-817664 (1 wt) was dissolved in acetonitrile (10 vol), the suspension was cooled to 0°C, and 2-acetoxy-2-methylbromopropane (4.0 eq, 2.4 vol) was added followed by water ( 1.0 eq, 0.07 vol). The resulting mixture was stirred at 0°C for 2 hours. At 0°C, sodium bicarbonate (sat. aq., 8.0 equiv, 40 vol) was added slowly. The resulting mixture was stirred at room temperature for 30 min, then extracted with MTBE (2 x 20 v). The organic layer was washed with brine (5 vol) and concentrated to give the product as a colorless oil.
将刚刚在上面描述的溴起始物(1份重量)溶解于甲苯(10份体积)中。加入DBU(1.8当量,0.73份体积),80℃下,对混合物进行加热。冷却混合物至室温,用MTBE(20份体积)稀释,用水(5份体积)和盐水(5份体积)洗涤。然后浓缩有机层得到灰白色粉末状产物。The bromine starter described immediately above (1 wt) was dissolved in toluene (10 vol). DBU (1.8 eq, 0.73 vol) was added and the mixture was heated at 80°C. The mixture was cooled to room temperature, diluted with MTBE (20 vol), washed with water (5 vol) and brine (5 vol). The organic layer was then concentrated to give the product as an off-white powder.
将起始烯烃化合物(1份重量)(刚在上面描述)溶解于二氯甲烷(5份体积)和甲醇(5份体积)中,冷却至-40℃至-45℃。用O3处理溶液。通过氮气吹扫除去过量的O3,使溶液升温至-15℃。加入NaBH4(1.0当量,0.18份重量),使混合物升温至0℃。加入碳酸钾(1.3当量),室温下搅拌悬浮液。0℃下,用1N盐酸(约4当量,约20份体积)中和反应液,溶液用MTBE(10份体积)萃取以除去亲脂物质。浓缩水层以除去二氯甲烷和甲醇。先后加入THF(4份体积)和NaIO4(2当量,2份重量)。反应液用MTBE(10份体积)和n-BuOH(10份体积)萃取。对合并的有机萃取液进行浓缩,所得粉末经乙酸乙酯研制。过滤后分离得到浅黄色粉末状的内半缩醛。The starting olefinic compound (1 wt) (described immediately above) was dissolved in dichloromethane (5 vol) and methanol (5 vol) and cooled to -40°C to -45°C. Treat the solution with O3 . Excess O3 was removed by nitrogen purge and the solution was allowed to warm to -15°C. NaBH4 (1.0 equiv, 0.18 wt) was added and the mixture was allowed to warm to 0 °C. Potassium carbonate (1.3 equiv) was added and the suspension was stirred at room temperature. The reaction was neutralized with 1N hydrochloric acid (about 4 equiv, about 20 vol) at 0°C, and the solution was extracted with MTBE (10 vol) to remove lipophilic material. The aqueous layer was concentrated to remove dichloromethane and methanol. THF (4 vol) was added followed by NaIO4 (2 eq, 2 wt). The reaction was extracted with MTBE (10 vol) and n-BuOH (10 vol). The combined organic extracts were concentrated and the resulting powder was triturated with ethyl acetate. After filtration, lactol was isolated as light yellow powder.
将ER-818638(1份重量)与LiCl(2当量,0.35份重量)搅拌于乙腈(8.7份体积)中。25℃下,加入Hunigs碱(1.5当量)。加入1N盐酸(5份体积),用MTBE(10份体积)萃取混合物。浓缩有机物得到ER-818640,用于下一步骤。ER-818638 (1 wt) and LiCl (2 eq, 0.35 wt) were stirred in acetonitrile (8.7 vol). At 25°C, Hunigs base (1.5 eq.) was added. 1N Hydrochloric acid (5 vol) was added and the mixture was extracted with MTBE (10 vol). The organics were concentrated to give ER-818640, which was used in the next step.
将起始α-烯酯化合物(1份重量)(刚在上面描述)溶解于甲醇(10份体积)中,氮气下加入10重量%钯碳(0.09当量,约0.33份重量)。然后在氢气下搅拌该悬浮液。悬浮液过滤通过Celite垫(20份重量),用甲醇(20份体积)冲洗滤饼。浓缩滤液,经快速色谱纯化得到无色油状产物(产率94.3%)。The starting α-enester compound (1 wt) (described immediately above) was dissolved in methanol (10 v) and 10 wt% palladium on carbon (0.09 eq, about 0.33 wt) was added under nitrogen. The suspension was then stirred under hydrogen. The suspension was filtered through a pad of Celite (R ) (20 wt), rinsing the filter cake with methanol (20 vol). The filtrate was concentrated and purified by flash chromatography to give the product as a colorless oil (94.3% yield).
在酯(1份重量)的THF(15份体积)溶液中分别加入吡啶(10当量)、Ph3P(7当量)和NIS(4当量)。室温下搅拌反应混合物。加入柠檬酸水溶液(20重量%,10当量),用TBME(30份体积)稀释混合物。分离水层,有机层用水(5份体积)、硫代硫酸钠水溶液(10%重量/体积,5份体积)、水(5份体积)和盐水(5份体积)洗涤。浓缩有机层,经快速色谱纯化得到无色油状产物。To a solution of the ester (1 wt) in THF (15 v) was added pyridine (10 eq), Ph3P (7 eq) and NIS (4 eq) respectively. The reaction mixture was stirred at room temperature. Aqueous citric acid (20 wt%, 10 equiv) was added and the mixture was diluted with TBME (30 v). The aqueous layer was separated and the organic layer was washed with water (5 vol), aqueous sodium thiosulfate (10% w/v, 5 vol), water (5 vol) and brine (5 vol). The organic layer was concentrated and purified by flash chromatography to give the product as a colorless oil.
将碘起始物(1份重量)溶解于甲醇(30份体积)中,加热至55℃。55℃下,分6次经80分钟加入NaBH4(47当量)。冷却反应液至0℃,用1N盐酸(30份体积)进行猝灭。搅拌5分钟后,混合物用盐水(30分体积)稀释,用DCM(50份体积×2)萃取。有机层经硫酸钠干燥、浓缩。粗产物直接用于下一步骤。The iodine starter (1 wt) was dissolved in methanol (30 vol) and heated to 55°C. At 55°C, NaBH 4 (47 equiv) was added in 6 portions over 80 minutes. The reaction was cooled to 0°C and quenched with 1N hydrochloric acid (30 vol). After stirring for 5 min, the mixture was diluted with brine (30 vol) and extracted with DCM (50 vol x 2). The organic layer was dried over sodium sulfate and concentrated. The crude product was used directly in the next step.
将醇起始物(1份重量)(刚在上面描述)溶解于乙醇(70份体积)中,加入Zn(165当量)。75-80℃下,对悬浮液进行回流。冷却反应混合物至室温,加入1N盐酸(70份体积)。用DCM(3×100份体积)萃取混合物,有机层用盐水洗涤并进行浓缩。The alcoholic starter (1 wt) (described immediately above) was dissolved in ethanol (70 vol) and Zn (165 eq) was added. The suspension was refluxed at 75-80°C. The reaction mixture was cooled to room temperature and 1N hydrochloric acid (70 vol) was added. The mixture was extracted with DCM (3 x 100 vol), the organic layer was washed with brine and concentrated.
将内酯起始物(刚在上面描述)溶解于DCM(50份体积)中,在氮气下,室温下分别加入三乙胺(5.0当量)、DMAP(0.3当量)和TBDPSCl(1.5当量),室温下搅拌所得溶液2-3小时。反应完全后,混合物用TBME(100份体积)稀释,用饱和碳酸氢钠水溶液(10份体积)、水(10份体积)和盐水(10份体积)洗涤。浓缩有机层,经快速色谱纯化得到无色油状产物。The lactone starting material (described immediately above) was dissolved in DCM (50 vol) and triethylamine (5.0 eq), DMAP (0.3 eq) and TBDPSCl (1.5 eq) were added separately at room temperature under nitrogen, The resulting solution was stirred at room temperature for 2-3 hours. After the reaction was complete, the mixture was diluted with TBME (100 vol), washed with saturated aqueous sodium bicarbonate (10 vol), water (10 vol), and brine (10 vol). The organic layer was concentrated and purified by flash chromatography to give the product as a colorless oil.
实施例4cExample 4c
采用以上方案VII所述的通用方案,实施例4c提供另一种制备式F-2的化合物的方法。该方法以ER-811510(按照实施例3制备,其中用丙酮代替环己酮)作为中间体。Using the general scheme described in Scheme VII above, Example 4c provides an alternative method for the preparation of compounds of formula F-2. This method uses ER-811510 (prepared according to Example 3, wherein acetone is used instead of cyclohexanone) as an intermediate.
将ER-811510(1份重量,1当量)溶解于二氯甲烷(6.3份体积)中,冷却至-5℃。保持温度低于0℃条件下,先后加入吡啶(0.41份体积,1.1当量)和溴乙酰溴(0.44份体积,1.1当量)。搅拌反应液1小时,升温至室温。加入水(8份体积),使分层。有机层依次用五水硫酸铜水溶液(1.0M,10份体积)、水(8份体积)和盐水(10份体积)洗涤,经硫酸镁干燥、过滤以及真空浓缩,得到褐色固体状的ER-812771。ER-811510 (1 wt, 1 eq) was dissolved in dichloromethane (6.3 vol) and cooled to -5°C. Pyridine (0.41 vol, 1.1 eq) was added followed by bromoacetyl bromide (0.44 vol, 1.1 eq) keeping the temperature below 0°C. The reaction was stirred for 1 hour and allowed to warm to room temperature. Water (8 vol) was added and the layers were allowed to separate. The organic layer was washed sequentially with aqueous copper sulfate pentahydrate (1.0 M, 10 vol), water (8 vol), and brine (10 vol), dried over magnesium sulfate, filtered, and concentrated in vacuo to afford ER- 812771.
将ER-812771(1份重量,1当量)溶解于乙腈(6份体积)中,加入三苯膦,加热反应液至50℃,保持45分钟。冷却反应液至-10℃后加入1,8-二氮杂双环[5.4.0]十一碳-7-烯(DBU,0.35份体积,0.8当量)。搅拌反应液15分钟,加热至80℃,保持45分钟,然后冷却至室温。加入氯化铵(饱和水溶液,10份体积),水层用乙酸乙酯(3×10份体积)萃取。合并的有机层经硫酸镁干燥,真空浓缩。粗产物经色谱纯化得到白色固体状的ER-812772。ER-812771 (1 wt, 1 eq) was dissolved in acetonitrile (6 vol), triphenylphosphine was added, and the reaction was heated to 50°C for 45 minutes. After cooling the reaction solution to -10°C, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 0.35 vol, 0.8 eq) was added. The reaction was stirred for 15 minutes, heated to 80°C, held for 45 minutes, then cooled to room temperature. Ammonium chloride (sat aq, 10 vol) was added and the aqueous layer was extracted with ethyl acetate (3 x 10 vol). The combined organic layers were dried over magnesium sulfate and concentrated in vacuo. The crude product was purified by chromatography to afford ER-812772 as a white solid.
将ER-812772(1份重量,1当量)溶解于乙酸乙酯(8份体积)中,加入10%钯碳(0.05份重量,0.01当量),用氮气吹扫反应液后在氢气氛下搅拌2小时。在乙酸乙酯洗涤下,通过硅藻土过滤脱除催化剂。对合并的滤液进行真空浓缩得到白色固体状的ER-812829。ER-812772 (1 weight, 1 equivalent) was dissolved in ethyl acetate (8 volumes), and 10% palladium carbon (0.05 weight, 0.01 equivalent) was added, and the reaction solution was purged with nitrogen and stirred under a hydrogen atmosphere 2 hours. The catalyst was removed by filtration through celite, washing with ethyl acetate. The combined filtrates were concentrated in vacuo to afford ER-812829 as a white solid.
实施例5Example 5
F-3a的制备Preparation of F-3a
在反应容器中加入D-古洛糖酸内酯(1份重量,1当量)、环己酮(2-3当量)、甲苯(6份体积)和对甲苯磺酸(0.021份重量,0.02当量)。搅拌下,加热反应液至回流。共沸脱除水分后反应完全。将反应混合物冷却至85-90℃,搅拌加剧。搅拌下,经20-30分钟加入庚烷(5.2份体积)。冷却至65-70℃,在65-70℃下搅拌30分钟。在65-70℃下过滤固体产物,同时保持母液温度>35℃。35-40℃下进行再过滤,母液保持室温30分钟。再过滤母液。滤饼用庚烷(2×1.7份体积)洗涤两次后经干燥得到ER-805715(产率84%,1.6份重量)。Into a reaction vessel was added D-gulonolactone (1 wt, 1 eq), cyclohexanone (2-3 eq), toluene (6 vol), and p-toluenesulfonic acid (0.021 wt, 0.02 eq ). While stirring, the reaction solution was heated to reflux. After azeotropic removal of water, the reaction was complete. The reaction mixture was cooled to 85-90°C with intensified stirring. With stirring, heptane (5.2 vol) was added over 20-30 minutes. Cool to 65-70°C and stir at 65-70°C for 30 minutes. The solid product was filtered at 65-70°C while maintaining the temperature of the mother liquor >35°C. Filter again at 35-40°C, and keep the mother liquor at room temperature for 30 minutes. Filter the mother liquor again. The filter cake was washed twice with heptane (2 x 1.7 v) and dried to give ER-805715 (84% yield, 1.6 wt).
制备ER-805715的另一种方法中,将D-古洛糖酸内酯(1份重量)、环己酮(1.32份重量,2.4当量)、对甲苯磺酸一水合物(0.02份重量,0.02当量)和甲苯(12份体积)一起回流19小时,同时共沸脱除水分。混合物先后用5%碳酸氢钠水溶液(4份体积)和饱和氯化钠水溶液(2份体积×2,pH=7)洗涤。蒸馏浓缩有机相(剩余4.5份计算体积甲苯),冷却至100℃后,在保持内温>80℃条件下加入庚烷(10份体积)。加热混合物至回流,保持至少1小时,然后冷却至85℃老化3小时,至80℃老化3小时后冷却至40℃老化12小时。过滤收集产物,滤饼用庚烷(2份体积)洗涤。气流干燥滤饼,得到ER-805715(产率78%,1.48份重量)。In another method for preparing ER-805715, D-gulonolactone (1 wt), cyclohexanone (1.32 wt, 2.4 eq), p-toluenesulfonic acid monohydrate (0.02 wt, 0.02 equiv) and toluene (12 v) were refluxed for 19 h with simultaneous azeotropic removal of water. The mixture was washed successively with 5% aqueous sodium bicarbonate (4 vol) and saturated aqueous sodium chloride (2 vol x 2, pH=7). The organic phase was concentrated by distillation (4.5 vol calculated toluene remaining), and after cooling to 100°C, heptane (10 vol) was added while maintaining the internal temperature >80°C. Heat the mixture to reflux for at least 1 hour, then cool to 85°C and age for 3 hours, to 80°C for 3 hours, then cool to 40°C and age for 12 hours. The product was collected by filtration and the filter cake was washed with heptane (2 vol.). The filter cake was air-dried to afford ER-805715 (78% yield, 1.48 wt).
在反应容器中加入ER-805715(1份重量,1当量),使之溶解于无水THF(3.34份体积)和无水甲苯(2.5份体积)中。冷却混合物至-15℃--10℃。-15℃--10℃下,经1小时加入DIBALH(1.5M甲苯溶液,2.4份体积,1.2当量)并搅拌混合物15-30分钟。10℃下,将反应液加入酒石酸钾钠溶液(1份重量酒石酸钾钠溶于2.9份重量水)中进行逆猝灭,使所得混合物升温至室温,搅拌4小时。过滤混合物后分层,用MTBE(2份体积)萃取。合并有机层,真空脱除溶剂,得到ER-805814(1.02份重量,产率100%)。ER-805715 (1 wt, 1 eq) was added to a reaction vessel and dissolved in anhydrous THF (3.34 vol) and anhydrous toluene (2.5 vol). Cool the mixture to -15°C - 10°C. -15°C to -10°C, DIBALH (1.5M in toluene, 2.4 vol, 1.2 eq) was added over 1 hour and the mixture was stirred for 15-30 minutes. At 10°C, the reaction solution was added to a sodium potassium tartrate solution (1 part by weight of sodium potassium tartrate was dissolved in 2.9 parts by weight of water) for inverse quenching, and the resulting mixture was warmed to room temperature and stirred for 4 hours. The mixture was filtered and the layers were separated and extracted with MTBE (2 v). The organic layers were combined and the solvent was removed in vacuo to afford ER-805814 (1.02 wt, 100% yield).
将ER-805814(1份重量)溶解于无水THF(3.3份体积),用(甲氧基甲基)三苯基氯化膦(2.11份重量,2.1当量)处理。加热反应混合物至28-32℃,然后在保持反应温度为30-35℃条件下,经100-140分钟加入KOtBu(0.66份重量,2当量)的无水THF(2.64份体积)溶液。5小时后冷却反应液至20-25℃,加入MTBE(5.11份体积),搅拌混合物。加入盐水(3份重量)和水(3份重量)(加料开始就出现放热,用水浴控制在20-25℃)。分离有机层,用马来酸酐(0.27份重量)的MTBE/THF(1/1体积比,1.78份体积)溶液进行处理。向反应混合物中缓慢加入氢氧化钠溶液(0.88份重量溶于2.5份体积水)。浓缩有机层,得到粗品ER-805815(0.985份重量)。残渣用MTBE/庚烷(1/4体积比,6.6份体积)研制三次。MTBE/庚烷(1/2体积比,45份体积)洗脱下,萃取液过滤通过SiO2(3份重量)。浓缩滤液得到ER-805815(0.88份重量,产率81%)。ER-805814 (1 wt) was dissolved in anhydrous THF (3.3 vol) and treated with (methoxymethyl)triphenylphosphine chloride (2.11 wt, 2.1 eq). The reaction mixture was heated to 28-32°C, then a solution of KOtBu (0.66 wt, 2 eq) in anhydrous THF (2.64 vol) was added over 100-140 min maintaining the reaction temperature at 30-35°C. After 5 hours the reaction was cooled to 20-25°C, MTBE (5.11 vol) was added and the mixture was stirred. Brine (3 wts) and water (3 wts) were added (addition started exothermic, water bath controlled at 20-25°C). The organic layer was separated and treated with a solution of maleic anhydride (0.27 wt) in MTBE/THF (1/1 vol, 1.78 vol). Sodium hydroxide solution (0.88 wt in 2.5 volumes of water) was slowly added to the reaction mixture. The organic layer was concentrated to afford crude ER-805815 (0.985 wt). The residue was triturated three times with MTBE/heptane (1/4 v, 6.6 v). The extract was filtered through SiO2 (3 wt) eluting with MTBE/heptane (1/2 v/v, 45 v). The filtrate was concentrated to afford ER-805815 (0.88 wt, 81% yield).
在制备ER-805815的另一种方法中,保持反应温度为0-10℃条件下,在(甲氧基甲基)三苯基氯化膦(3.12份重量,3.1当量)的THF(1.78份重量)悬浮液中加入t-BuOK(0.989份重量,3当量)的THF(4份重量)溶液。用THF(2×0.7份重量)冲洗该加样容器(additionvessel)。保持0-10℃下,向反应液中加入ER-805814(1份重量,1当量)的THF(1.42份重量)溶液。用THF(2×0.7份重量)冲洗该加样容器。20-30℃下搅拌混合物过夜,30-35℃下搅拌3小时。冷却反应液至30℃以下,先后用MTBE(3.7份重量)和10重量%氯化钠水溶液(4份重量)稀释。搅拌混合物30分钟,分离各层。加入马来酸酐(0.63份重量,2.2当量),室温下搅拌混合物30分钟。保持反应液低于15℃条件下,滴加水(6份重量)和氢氧化钠溶液(48重量%,0.64份重量,2.6当量)。低于15℃下搅拌后,分离下层。先后加入水(6份重量)和氢氧化钠溶液(48重量%,0.64份重量,2.6当量),加样期间保持混合物低于15℃。低于15℃下搅拌后分离下层。有机层用15重量%氯化钠水溶液(3×4份重量)洗涤三次。真空浓缩有机层。残渣用MTBE(1份重量)稀释并进行真空浓缩。40-50℃下,经30分钟滴加IPE(3份重量)对残渣进行稀释。40-50℃下,搅拌悬浮液1小时,缓慢冷却至0-10℃,搅拌1小时。过滤固体,滤饼用IPE(2份重量)洗涤。真空浓缩滤液和洗涤液。残渣用甲醇(2.37份重量)和水(0.4份重量)处理,用庚烷(2.74份重量)萃取。下层用庚烷(2.05份)萃取9次。合并萃取液,经真空浓缩得到ER-805815(1.07份重量,98.6%)。In another method for preparing ER-805815, (methoxymethyl)triphenylphosphine chloride (3.12 wt., 3.1 eq.) in THF (1.78 wt. wt) suspension was added a solution of t-BuOK (0.989 wt, 3 eq) in THF (4 wt). The addition vessel was rinsed with THF (2 x 0.7 wt). A solution of ER-805814 (1 wt, 1 eq) in THF (1.42 wt) was added to the reaction mixture while maintaining the temperature at 0-10°C. The sample container was rinsed with THF (2 x 0.7 wt). The mixture was stirred overnight at 20-30°C and 3 hours at 30-35°C. The reaction liquid was cooled to below 30° C., and diluted with MTBE (3.7 parts by weight) and 10% by weight aqueous sodium chloride solution (4 parts by weight) successively. The mixture was stirred for 30 minutes and the layers were separated. Maleic anhydride (0.63 wt, 2.2 eq) was added and the mixture was stirred at room temperature for 30 minutes. Keeping the reaction solution below 15°C, water (6 wt.) and sodium hydroxide solution (48 wt%, 0.64 wt., 2.6 eq.) were added dropwise. After stirring below 15°C, the lower layer was separated. Water (6 wts) was added followed by sodium hydroxide solution (48 wt%, 0.64 wts, 2.6 equiv), keeping the mixture below 15°C during addition. After stirring below 15°C, the lower layer was separated. The organic layer was washed three times with 15% by weight aqueous sodium chloride (3 x 4 wt). The organic layer was concentrated in vacuo. The residue was diluted with MTBE (1 wt) and concentrated in vacuo. The residue was diluted with IPE (3 wt) dropwise over 30 minutes at 40-50°C. Stir the suspension for 1 hour at 40-50°C, slowly cool to 0-10°C, and stir for 1 hour. The solid was filtered and the filter cake was washed with IPE (2 wt). The filtrate and washings were concentrated in vacuo. The residue was treated with methanol (2.37 wt) and water (0.4 wt) and extracted with heptane (2.74 wt). The lower layer was extracted 9 times with heptane (2.05 parts). The combined extracts were concentrated in vacuo to give ER-805815 (1.07 wt, 98.6%).
ER-805815的另一种后处理方法中,盐水洗涤和浓缩后所制得的粗有机层用MTBE(2.86份重量)和硅藻土(0.5份重量)处理。搅拌2.5小时后,经2小时加入庚烷(1.46份重量),搅拌混合物过夜。过滤沉淀物。滤饼用MTBE/庚烷(1∶1,5份重量)洗涤。真空浓缩滤液直至体积减小至约3份体积。残渣用甲醇(2份重量)和水(6份重量)溶解,用庚烷/MTBE(5∶1,3×6份重量)萃取混合物。分离有机层,经浓缩得到ER-805815,用于下一步骤。In another workup of ER-805815, the crude organic layer obtained after brine washing and concentration was treated with MTBE (2.86 wt) and Celite (0.5 wt). After stirring for 2.5 hours, heptane (1.46 wt) was added over 2 hours and the mixture was stirred overnight. Filter the precipitate. The filter cake was washed with MTBE/heptane (1:1, 5 wt). The filtrate was concentrated in vacuo until the volume was reduced to about 3 vol. The residue was dissolved in methanol (2 wts) and water (6 wts), and the mixture was extracted with heptane/MTBE (5:1, 3 x 6 wts). The organic layer was separated and concentrated to give ER-805815, which was used in the next step.
将ER-805815(1份重量)溶解于丙酮(2.4份体积)和水(0.4份体积)中。加入N-甲基吗啉N-氧化物(0.62份重量,2当量),冷却混合物至0-5℃。加入OsO4(0.15M水溶液,0.065份体积),反应液保持在0-5℃。0-5℃下搅拌反应混合物12小时。0-2℃下,经1小时加入水(0.2份体积)。0-5℃下搅拌混合物1小时。过滤产物,用预冷(0-5℃)的丙酮/水(1/1,体积比,2×0.7份体积)洗涤固体两次。干燥产物,得到ER-805816(0.526份重量,52%产率,残留Os<17ppm)。ER-805815 (1 wt) was dissolved in acetone (2.4 vol) and water (0.4 vol). N-methylmorpholine N-oxide (0.62 wt, 2 eq) was added and the mixture was cooled to 0-5°C. OsO4 (0.15M in water, 0.065 vol) was added and the reaction was maintained at 0-5°C. The reaction mixture was stirred at 0-5°C for 12 hours. Water (0.2 vol) was added over 1 hour at 0-2°C. The mixture was stirred at 0-5°C for 1 hour. The product was filtered and the solid was washed twice with pre-cooled (0-5°C) acetone/water (1/1, vol ratio, 2 x 0.7 vol). The product was dried to afford ER-805816 (0.526 wt, 52% yield, residual Os < 17 ppm).
制备ER-805816的另一种方法中,在四颈烧瓶中加入ER-805815(1份重量,1当量)的丙酮(4份体积)溶液,然后在室温下加入水(0.5份重量)。在混合物中加入无水N-甲基吗啉-N-氧化物(0.38份重量,1.2当量)。25-35℃下,边用水冷却,边分批加入二水锇酸钾(0.003份重量,0.003当量)。将混合物在该温度下保持4小时。室温下加入硫代硫酸钠(0.075份重量,0.49当量)的水(0.5份重量)溶液,然后搅拌混合物0.5小时。将混合物冷却至0-5℃,搅拌2小时。收集所得的沉淀物,湿的滤饼用甲醇(0.6份重量)和水(1.5份重量)洗涤得到粗产物(1.25份重量)。对粗产物样品进行干燥(0.611份重量)。在水(3.05份重量)中加入粗品ER-805816(1.25份重量),约25℃下搅拌2小时。过滤沉淀物,用水(1.53份重量)洗涤,得到粗品湿滤饼(1.05份重量)。对粗产物样品进行干燥和取样,ICP Os=37ppm。在水(2.81份重量)中加入粗品ER-805816(1.05份重量),约25℃下搅拌2小时。过滤沉淀物,用水(1.4份重量)和甲醇(0.45份重量)洗涤,得到粗品ER-805816(0.736份重量)。对湿的滤饼进行干燥得到粗产物(0.56份重量,ICP(Os)=28ppm)。45-55℃下,将ER-80581 6(0.56份重量)溶解于丙酮(1.76份重量)中。在溶液中加入活性碳(0.027份重量),相同温度下搅拌0.5小时。过滤混合物,滤饼用热丙酮(0.214份重量)洗涤。滤液保持在45-50℃,经10分钟加入水(0.83份重量),加水过程中温度保持在40-50℃。冷却混合物至0-5℃,搅拌1.5小时。过滤白色沉淀物,用丙酮(0.17份重量)和水(0.22份重量)的溶液洗涤后干燥,得到ER-805816(0.508份重量,0.49当量,KF5.0%,ICP(Os)9.6ppm)。In an alternative method for preparing ER-805816, a solution of ER-805815 (1 wt, 1 eq) in acetone (4 vol) was added to a four-neck flask, followed by water (0.5 wt) at room temperature. To the mixture was added anhydrous N-methylmorpholine-N-oxide (0.38 wt, 1.2 eq). At 25-35°C, potassium osmate dihydrate (0.003 wt, 0.003 eq) was added in batches while cooling with water. The mixture was kept at this temperature for 4 hours. A solution of sodium thiosulfate (0.075 wt, 0.49 eq) in water (0.5 wt) was added at room temperature, and the mixture was stirred for 0.5 hr. The mixture was cooled to 0-5°C and stirred for 2 hours. The resulting precipitate was collected and the wet filter cake was washed with methanol (0.6 wt) and water (1.5 wt) to give the crude product (1.25 wt). A sample of the crude product was dried (0.611 wt). Crude ER-805816 (1.25 wt) was added to water (3.05 wt) and stirred at about 25°C for 2 hours. The precipitate was filtered and washed with water (1.53 wt) to give a crude wet cake (1.05 wt). A crude product sample was dried and sampled, ICPOs = 37 ppm. Crude ER-805816 (1.05 wt) was added to water (2.81 wt) and stirred at about 25°C for 2 hours. The precipitate was filtered, washed with water (1.4 wt) and methanol (0.45 wt) to afford crude ER-805816 (0.736 wt). The wet filter cake was dried to give the crude product (0.56 wt, ICP(Os)=28 ppm). ER-805816 (0.56 wt) was dissolved in acetone (1.76 wt) at 45-55°C. Activated carbon (0.027 parts by weight) was added to the solution, and stirred at the same temperature for 0.5 hours. The mixture was filtered and the filter cake was washed with hot acetone (0.214 wt). The filtrate was kept at 45-50°C, and water (0.83 wt) was added over 10 minutes, maintaining the temperature at 40-50°C during the addition. The mixture was cooled to 0-5°C and stirred for 1.5 hours. The white precipitate was filtered, washed with a solution of acetone (0.17 wt) and water (0.22 wt) and dried to give ER-805816 (0.508 wt, 0.49 equiv, KF 5.0%, ICP(Os) 9.6 ppm).
将ER-805816(1份重量)悬浮于乙酸(0.89份体积,5.8当量)和乙酸酐(3.57份重量,13当量)中。加入无水氯化锌(0.2份重量,0.54当量)。18-22℃下搅拌反应混合物24小时。反应液在冰(5份重量)和水(5份体积)中进行猝灭。搅拌下加入乙酸乙酯(10份体积),分离水层。水层用乙酸乙酯(10份体积)反萃取。合并的有机层依次用盐水(10份体积)、5%乙醇钠水溶液(6份体积)和盐水(6份体积)洗涤。浓缩有机层。将粗浓缩物溶解于25%EtOAc/hex(4份体积)中,经SiO2过滤。滤垫用25%EtOAc/hex(2×12份体积)洗涤,进一步用25%EtOAc/hex(48份体积)洗涤。浓缩有机层,得到ER-805819(1份重量,81%)。ER-805816 (1 wt) was suspended in acetic acid (0.89 vol, 5.8 eq) and acetic anhydride (3.57 wt, 13 eq). Anhydrous zinc chloride (0.2 wt, 0.54 equiv) was added. The reaction mixture was stirred at 18-22°C for 24 hours. The reaction was quenched between ice (5 wt) and water (5 v). Ethyl acetate (10 vol) was added with stirring and the aqueous layer was separated. The aqueous layer was back extracted with ethyl acetate (10 vol). The combined organic layers were washed sequentially with brine (10 vol), 5% aqueous sodium ethoxide (6 vol), and brine (6 vol). The organic layer was concentrated. The crude concentrate was dissolved in 25% EtOAc/hex (4 v) and filtered through SiO2 . The filter pad was washed with 25% EtOAc/hex (2 x 12 vol) and further washed with 25% EtOAc/hex (48 vol). The organic layer was concentrated to afford ER-805819 (1 wt, 81%).
制备ER-805819的另一种方法中,将氯化锌(0.2份重量,0.54当量)、乙酸酐(2.75份重量,10当量)和乙酸(1份重量,6当量)混合。冷却混合物至15-20℃。保持15-30℃内温条件下,加入ER-805816(1份重量,1当量)。然后在35-40℃下搅拌混合物6小时。冷却反应混合物至25℃以下。保持反应温度低于25℃条件下,滴加甲醇(3.2份重量,4份体积)。加入庚烷(2.7份重量,4份体积)。保持反应温度低于25℃条件下,加入水(4份重量,4份体积)。搅拌混合物15分钟,然后分离各相。下层用庚烷(2.7份重量,4份体积)洗涤两次,弃去庚烷层。下层用甲苯(6.1份重量,8份体积)萃取两次。合并的甲苯层用17重量%碳酸氢钾水溶液(0.82份重量碳酸氢钾溶于3.98重量份水,4.36份体积)洗涤两次,用水(4份重量)洗涤两次并进行浓缩。25-30℃下加入甲醇(3.95份重量,5份体积),搅拌混合物10分钟。25-30℃下加入水(0.3份重量)。冷却混合物至0℃,加入晶种。0℃下搅拌混合物1小时,经1小时滴加水(0.7份重量)。经1小时滴加水(4份重量)。过滤所得的沉淀物,滤饼用0℃的甲醇(1.03份重量)和水(0.7份重量)的溶液洗涤两次。干燥滤饼得到ER-805819(0.99份重量,0.84当量)。In an alternate method of preparing ER-805819, zinc chloride (0.2 wt, 0.54 eq), acetic anhydride (2.75 wt, 10 eq) and acetic acid (1 wt, 6 eq) were combined. The mixture was cooled to 15-20°C. ER-805816 (1 wt, 1 eq) was added while maintaining an internal temperature of 15-30°C. The mixture was then stirred at 35-40°C for 6 hours. Cool the reaction mixture to below 25°C. Methanol (3.2 wt, 4 vol) was added dropwise keeping the reaction temperature below 25°C. Heptane (2.7 wt, 4 vol) was added. Water (4 wt, 4 vol) was added maintaining the reaction temperature below 25°C. The mixture was stirred for 15 minutes, then the phases were separated. The lower layer was washed twice with heptane (2.7 wt, 4 vol), and the heptane layer was discarded. The lower layer was extracted twice with toluene (6.1 wt, 8 vol). The combined toluene layers were washed twice with 17 wt% aqueous potassium bicarbonate (0.82 wt potassium bicarbonate dissolved in 3.98 wt water, 4.36 vol), twice with water (4 wt) and concentrated. Methanol (3.95 wt, 5 vol) was added at 25-30°C and the mixture was stirred for 10 minutes. Water (0.3 wt) was added at 25-30°C. The mixture was cooled to 0°C and seeded. The mixture was stirred at 0°C for 1 hour, and water (0.7 wt) was added dropwise over 1 hour. Water (4 wt) was added dropwise over 1 hour. The resulting precipitate was filtered, and the filter cake was washed twice with a solution of methanol (1.03 wt) and water (0.7 wt) at 0°C. The filter cake was dried to give ER-805819 (0.99 wt, 0.84 equiv).
将ER-805819(1份重量)溶解于无水乙腈(15份体积)中,用ER-803055(0.93份体积,2当量)处理。冷却反应混合物至0-5℃,经5分钟加入BF3-OEt2(0.54份体积,1.95当量),期间保持反应温度为0-5℃。0-5℃下搅拌反应混合物12小时。剧烈搅拌下,将反应液加至饱和碳酸氢钠(20份体积)中,进行猝灭。用乙酸乙酯(2×8份体积)萃取两次。合并的有机物用盐水(12份体积)洗涤,经浓缩得到ER-805821(1份重量,88%产率,直接使用)。ER-805819 (1 wt) was dissolved in anhydrous acetonitrile (15 vol) and treated with ER-803055 (0.93 vol, 2 eq). The reaction mixture was cooled to 0-5 °C and BF3- OEt2 (0.54 vol, 1.95 equiv) was added over 5 min while maintaining the reaction temperature at 0-5 °C. The reaction mixture was stirred at 0-5°C for 12 hours. The reaction was quenched by adding saturated sodium bicarbonate (20 vol) with vigorous stirring. Extracted twice with ethyl acetate (2 x 8 vol). The combined organics were washed with brine (12 vol) and concentrated to give ER-805821 (1 wt, 88% yield, used directly).
制备ER-805821的另一种方法中,将ER-805819(1份重量,1当量)和ER-803055(0.93份体积,2当量)溶解于无水乙腈(5.46份重量,7份体积)中。冷却反应混合物至0-5℃,经5分钟加入BF3-OEt2(0.54份体积,1.95当量),期间保持反应温度为0-5℃。0-5℃下搅拌反应混合物20小时,然后在0-5℃下加入庚烷(5.47份重量,8份体积)。分离各相,0-5℃下用庚烷(5.47份重量,8份体积)处理下层。保持反应温度为0-15℃条件下,滴加7.4%碳酸氢钾水溶液(0.64份重量碳酸氢钾溶于8份重量水中),使反应猝灭。加入甲苯(8.65份重量,10份体积),搅拌混合物30分钟。分离下层,上层有机层用水(10份体积)洗涤两次,经浓缩得到ER-805821粗品油(1.05份重量,0.935当量)。In an alternate method of preparing ER-805821, ER-805819 (1 wt, 1 eq) and ER-803055 (0.93 vol, 2 eq) were dissolved in anhydrous acetonitrile (5.46 wt, 7 vol) . The reaction mixture was cooled to 0-5 °C and BF3 - OEt2 (0.54 vol, 1.95 equiv) was added over 5 min while maintaining the reaction temperature at 0-5 °C. The reaction mixture was stirred at 0-5°C for 20 hours, then heptane (5.47 wt, 8 vol) was added at 0-5°C. The phases were separated and the lower layer was treated with heptane (5.47 wt, 8 vol) at 0-5°C. Keeping the reaction temperature at 0-15°C, 7.4% potassium bicarbonate aqueous solution (0.64 parts by weight of potassium bicarbonate dissolved in 8 parts by weight of water) was added dropwise to quench the reaction. Toluene (8.65 wt, 10 vol) was added and the mixture was stirred for 30 minutes. The lower layer was separated and the upper organic layer was washed twice with water (10 vol) and concentrated to give ER-805821 as a crude oil (1.05 wt, 0.935 eq).
将ER-805821(1份重量)溶解于无水THF(8.4份体积)和无水乙酸甲酯(2份体积)中。维持17-23℃反应下,经2分钟加入TritonB(OH)(3.6份体积)。搅拌反应液1.5小时。过滤反应混合物。浓缩滤液,通过SiO2垫(5份重量,20份体积乙酸乙酯洗脱)。滤液用盐水(2.2份体积)洗涤,经蒸发得到ER-805822(0.54份重量,72%产率)。ER-805821 (1 wt) was dissolved in anhydrous THF (8.4 vol) and anhydrous methyl acetate (2 vol). With the reaction maintained at 17-23°C, Triton B(OH) (3.6 vol) was added over 2 minutes. The reaction was stirred for 1.5 hours. The reaction mixture was filtered. The filtrate was concentrated and passed through a pad of SiO2 (5 wt, 20 vol ethyl acetate eluting). The filtrate was washed with brine (2.2 vol) and evaporated to give ER-805822 (0.54 wt, 72% yield).
制备ER-805822的另一种方法中,将ER-805821(1份重量,1当量,11.18g,21.81mmol)溶解于无水MTBE(4.4份重量,6份体积)中,冷却至0-5℃。0-5℃下,向混合物中经1小时加入甲醇钠(28重量%甲醇溶液,0.564份重量,1.5当量),相同温度范围下搅拌3小时。加入乙酸(0.188份重量,1.6当量)猝灭反应,加样期间保持0-5℃。搅拌混合物过夜,然后在0-5℃下,用5重量%碳酸氢钾水溶液(3份重量)和乙酸乙酯(3.6份重量,4份体积)进行处理,随后搅拌15分钟。相分离后,下层用乙酸乙酯(3.6份重量,4份体积)萃取两次。对合并的有机层进行浓缩。残渣中加入丙酮(2份重量,2.5份体积)和IPE(2份重量,2.7份体积),0-5℃下搅拌过夜。混合物过滤通过Celite(0.25份重量),用丙酮(2份重量)洗涤。浓缩滤液得到粗品油(0.55份重量)。在残渣中加入丙酮(0.2份重量,0.25份体积)和IPE(0.54份重量,0.75份体积)并40-50℃下搅拌1小时。室温下在溶液中加入ER-805822晶种,室温下搅拌过夜。室温下,经2小时向悬浮液中加入IPE(1.27份重量,1.75份体积)。室温下搅拌5小时后,过滤收集沉淀物,滤饼用丙酮/IPE(1/10)(2份体积)洗涤。所得滤饼在盘式腔室(tray-type chamber)中于30-40℃干燥过夜,得到目标产物ER-805822(0.286份重量,0.38当量,基于ER-805819的产率为38.0%)。In another method for preparing ER-805822, ER-805821 (1 wt, 1 eq, 11.18 g, 21.81 mmol) was dissolved in anhydrous MTBE (4.4 wt, 6 vol) and cooled to 0-5 ℃. At 0-5°C, sodium methoxide (28 wt% methanol solution, 0.564 wt, 1.5 eq) was added to the mixture over 1 hour, and stirred at the same temperature range for 3 hours. Acetic acid (0.188 wt, 1.6 eq) was added to quench the reaction, maintaining 0-5°C during addition. The mixture was stirred overnight and then treated with 5 wt% aqueous potassium bicarbonate (3 wt) and ethyl acetate (3.6 wt, 4 vol) at 0-5°C, followed by stirring for 15 min. After phase separation, the lower layer was extracted twice with ethyl acetate (3.6 wt, 4 vol). The combined organic layers were concentrated. Acetone (2 wt, 2.5 vol) and IPE (2 wt, 2.7 vol) were added to the residue and stirred overnight at 0-5°C. The mixture was filtered through Celite (R) (0.25 wt), washing with acetone (2 wt). The filtrate was concentrated to give a crude oil (0.55 wt). Acetone (0.2 wt, 0.25 vol) and IPE (0.54 wt, 0.75 vol) were added to the residue and stirred at 40-50°C for 1 hour. The solution was seeded with ER-805822 at room temperature and stirred overnight at room temperature. To the suspension was added IPE (1.27 wt, 1.75 vol) over 2 hours at room temperature. After stirring at room temperature for 5 hours, the precipitate was collected by filtration and the filter cake was washed with acetone/IPE (1/10) (2 vol.). The obtained filter cake was dried in a tray-type chamber at 30-40° C. overnight to obtain the target product ER-805822 (0.286 wt, 0.38 eq, 38.0% yield based on ER-805819).
粗品ER-805822的另一种后处理方法中,将浓缩最终的乙酸乙酯溶液后所得到的残渣溶解于IPA(2份重量)中,加热溶液至50℃。加入庚烷(5份重量),冷却混合物至20℃,并加入晶种。20℃下搅拌混合物过夜。加入庚烷(10份重量),30分钟内将混合物冷却至-5℃,在-5℃下搅拌5小时。过滤混合物,用庚烷(2份重量)洗涤滤饼。真空下对滤饼进行气流干燥,得到ER-805822(60%)。In an alternative workup of crude ER-805822, the residue obtained after concentrating the final ethyl acetate solution was dissolved in IPA (2 wt) and the solution was heated to 50°C. Heptane (5 wt) was added, the mixture was cooled to 20°C, and seeded. The mixture was stirred overnight at 20°C. Heptane (10 wt) was added, the mixture was cooled to -5°C over 30 minutes and stirred at -5°C for 5 hours. The mixture was filtered and the filter cake was washed with heptane (2 wt). The filter cake was air-dried under vacuum to afford ER-805822 (60%).
将ER-805822(1份重量)溶解于乙酸乙酯或其它适当的溶剂(5份体积)以及水(5份体积)中。保持反应温度为0-10℃条件下,经30分钟-1小时分批加入NaIO4(0.58份重量,1.05当量)。搅拌反应液至多2小时。0-10℃下用氯化钠(1份重量)处理反应混合物并搅拌30分钟。过滤反应混合物,滤饼用乙酸乙酯(2份体积)冲洗。分离各相,下层用乙酸乙酯(5份体积)萃取三次。合并的有机层用20%氯化钠水溶液(5份重量)洗涤。浓缩有机层得到ER804697(1份重量)。将残渣溶解于甲苯(2份体积)中,浓缩溶液。将残渣溶解于乙腈(7份体积)中,用于下一步骤。ER-805822 (1 wt) was dissolved in ethyl acetate or other appropriate solvent (5 vol) and water (5 vol). Keeping the reaction temperature at 0-10°C, NaIO 4 (0.58 wt, 1.05 eq) was added in portions over 30 min-1 h. The reaction was stirred for up to 2 hours. The reaction mixture was treated with sodium chloride (1 wt) at 0-10°C and stirred for 30 minutes. The reaction mixture was filtered and the filter cake was rinsed with ethyl acetate (2 vol.). The phases were separated and the lower layer was extracted three times with ethyl acetate (5 vol.). The combined organic layers were washed with 20% aqueous sodium chloride (5 wt). The organic layer was concentrated to give ER804697 (1 wt). The residue was dissolved in toluene (2 vol) and the solution was concentrated. The residue was dissolved in acetonitrile (7 vol) and used in the next step.
惰性气氛下,在反应容器中加入NiCl2(0.025份重量)和CrCl2(2.5份重量)。加入无水二氯甲烷(5份体积)。开始搅拌,冷却混合物至0-3℃。保持温度低于20℃条件下,加入无水DMSO(6.7份体积),同时剧烈搅拌45分钟。将ER-804697(1份重量)溶解于无水二氯甲烷(1份体积)中并加至反应容器中。使所得混合物升温至25℃,经20分钟加入ER-806643(2.58份重量)。保持反应温度低于45℃。加样完毕后,在25-35℃下搅拌反应液30分钟。加入甲醇(5份体积),搅拌混合物10分钟。加入MTBE(33份体积),将悬浮液转移至1N盐酸(25份体积)和水(10份体积)中。搅拌混合物5分钟。水层用MTBE(10份体积)反萃取,合并的有机层依次用0.2N盐酸(17份体积)、1%氯化钠溶液(2×17份体积,洗涤两次)和盐水(13份体积)洗涤。浓缩有机层,经纯化(SiO2,25份重量,10个柱体积的乙酸乙酯/己烷,1/3.5体积比)得到ER-804698(0.53份重量,61%)。Under an inert atmosphere, NiCl2 (0.025 wt) and CrCl2 (2.5 wt) were added to the reaction vessel. Anhydrous dichloromethane (5 vol.) was added. Stirring was started and the mixture was cooled to 0-3°C. Keeping the temperature below 20°C, anhydrous DMSO (6.7 vol) was added with vigorous stirring for 45 minutes. ER-804697 (1 wt) was dissolved in anhydrous dichloromethane (1 vol) and added to the reaction vessel. The resulting mixture was allowed to warm to 25°C and ER-806643 (2.58 wt) was added over 20 minutes. Keep the reaction temperature below 45°C. After adding the sample, the reaction solution was stirred at 25-35° C. for 30 minutes. Methanol (5 vol.) was added and the mixture was stirred for 10 minutes. MTBE (33 vol) was added and the suspension was transferred to 1N hydrochloric acid (25 vol) and water (10 vol). The mixture was stirred for 5 minutes. The aqueous layer was back extracted with MTBE (10 vol), and the combined organic layers were sequentially washed with 0.2N hydrochloric acid (17 vol), 1% NaCl solution (2 x 17 vol, washed twice) and brine (13 vol )washing. The organic layer was concentrated and purified ( SiO2 , 25 wt, 10 column volumes of ethyl acetate/hexane, 1/3.5 vol ratio) to afford ER-804698 (0.53 wt, 61%).
另一种方法中,该反应在手性配体ER-807363的存在下进行,其方法与下文所述的ER-118047制备方法基本相似。In another approach, the reaction is carried out in the presence of the chiral ligand ER-807363 in a substantially similar manner to the preparation of ER-118047 described hereinafter.
制备ER-804698的另一种方法中,对DMSO(7份体积)和乙腈(7份体积)进行脱气并冷却至0-10℃。使内温不超过20℃条件下,用CrCl2(10当量,3.47份重量)和NiCl2(0.1当量,0.037份重量)分批处理该溶液。0-10℃下,滴加ER-804697(1份重量,1当量)的乙腈(7份体积)溶液和ER-806643(5当量,2.5份重量),期间内温不得超过15℃。5-15℃下搅拌反应混合物过夜。在混合物中加入甲醇(5.5份重量)、水(7份重量)和MTBE(5.2份重量)。搅拌反应液1小时,分离下层(层1)。在上层中加入氯化钠(1.5份重量)与水(13.5份重量)的预混溶液。搅拌混合物1小时,分离下层(层2)。在上层中加入庚烷(4.8份重量)、甲醇(2.8份重量)以及氯化钠(1.5份重量)与水(13.5份重量)的预混溶液。搅拌混合物1小时,分离下层(层3)。上层经除水后保存(有机物1)。在反应器中加入层1、甲醇(2.8份重量)和MTBE(2.8份重量)。搅拌混合物过夜。分离并弃去下层。用层2处理上层。搅拌混合物1小时,分离并弃去下层。用层3和庚烷(4.8份重量)处理上层。搅拌混合物1小时,分离并弃去下层。上层经除水后保存(有机物2)。在反应器中加入层3、MTBE(0.8份重量)和庚烷(2.7份重量)。搅拌混合物1小时,分离并弃去下层。将上层与有机物1和有机物2合并。对合并的有机物进行过滤和减压浓缩,得到粗品ER-804698,经色谱纯化(SiO2,25份重量,10个柱体积的乙酸乙酯/己烷,体积比1/3.5)得到ER-804698(0.67份重量,57%产率)。In an alternative method to prepare ER-804698, DMSO (7 vol) and acetonitrile (7 vol) were degassed and cooled to 0-10°C. The solution was treated in batches with CrCl 2 (10 eq, 3.47 wt) and NiCl 2 (0.1 eq, 0.037 wt) with the internal temperature not exceeding 20°C. A solution of ER-804697 (1 wt, 1 eq) in acetonitrile (7 vol) and ER-806643 (5 eq, 2.5 wt) was added dropwise at 0-10°C, while the internal temperature did not exceed 15°C. The reaction mixture was stirred overnight at 5-15°C. Methanol (5.5 wt), water (7 wt) and MTBE (5.2 wt) were added to the mixture. The reaction was stirred for 1 hour and the lower layer (Layer 1) was separated. A premixed solution of sodium chloride (1.5 wt) and water (13.5 wt) was added to the upper layer. The mixture was stirred for 1 hour and the lower layer (Layer 2) was separated. Heptane (4.8 wt), methanol (2.8 wt), and a premixed solution of sodium chloride (1.5 wt) and water (13.5 wt) were added to the upper layer. The mixture was stirred for 1 hour and the lower layer (Layer 3) was separated. The upper layer was saved after dehydration (organic 1). Layer 1, methanol (2.8 wts) and MTBE (2.8 wts) were charged to the reactor. The mixture was stirred overnight. Separate and discard the lower layer. Treat the upper layer with layer 2. The mixture was stirred for 1 hour, the lower layer was separated and discarded. The upper layer was treated with layer 3 and heptane (4.8 wt). The mixture was stirred for 1 hour, the lower layer was separated and discarded. The upper layer was saved after dehydration (organic 2). Layer 3, MTBE (0.8 wt) and heptane (2.7 wt) were added to the reactor. The mixture was stirred for 1 hour, the lower layer was separated and discarded. The upper layer was combined with organoids 1 and 2. The combined organics were filtered and concentrated under reduced pressure to give crude ER-804698, which was purified by chromatography ( SiO2 , 25 wt, 10 column volumes of ethyl acetate/hexane, 1/3.5 by volume) to give ER-804698 (0.67 wt, 57% yield).
制备ER-804698的另一种方法中,粗物质不经过纯化直接用于下一步骤。In another method for the preparation of ER-804698, the crude material was used directly in the next step without purification.
用乙酸(4.2份重量)和水(4.2份重量)处理ER804698(1份重量,1当量)。加热混合物至90-97℃,保持100分钟。冷却混合物至15℃以下,然后在15℃以下用庚烷(2×2.7份重量)洗涤两次。相分离后,在使温度不超过15℃条件下,向下层滴加20重量%碳酸氢钾水溶液(7.7份重量,35当量)和MTBE(5.95份重量)的混合物。相分离后,上层依次用5重量%碳酸氢钾水溶液(0.2份重量)洗涤,用5重量%氯化钠水溶液(2×0.2份重量)洗涤两次。减压浓缩有机层,加入MTBE(1.49份重量)。将混合物加热至55℃,搅拌至溶解。在溶液中加入庚烷(1.00份重量),冷却溶液至40-45℃。在溶液中另外加入庚烷(4.47份重量),冷却溶液至5-15℃,然后搅拌过夜。过滤结晶体,用庚烷冲洗,得到ER-807023(0.58份重量,71%产率)。ER804698 (1 wt, 1 eq) was treated with acetic acid (4.2 wts) and water (4.2 wts). The mixture was heated to 90-97°C for 100 minutes. The mixture was cooled below 15°C, then washed twice with heptane (2 x 2.7 wts) below 15°C. After phase separation, a mixture of 20 wt% potassium bicarbonate aqueous solution (7.7 wt, 35 eq) and MTBE (5.95 wt) was added dropwise to the lower layer under the condition that the temperature did not exceed 15°C. After phase separation, the upper layer was washed sequentially with 5 wt % aqueous potassium bicarbonate (0.2 wt) and twice with 5 wt % aqueous sodium chloride (2 x 0.2 wt). The organic layer was concentrated under reduced pressure and MTBE (1.49 wt) was added. The mixture was heated to 55°C and stirred until dissolved. Heptane (1.00 parts by weight) was added to the solution and the solution was cooled to 40-45°C. Additional heptane (4.47 wt) was added to the solution and the solution was cooled to 5-15°C and then stirred overnight. The crystals were filtered and rinsed with heptane to afford ER-807023 (0.58 wt, 71% yield).
氮气氛下,在反应器中加入ER-807023(1份重量,1当量)和MTBE(7.43份重量)。在反应液中加入2,6-二甲基吡啶(2.15份重量,7.5当量)。0℃下,在混合物中滴加TBSOTf(2.47份重量,3.5当量)。0-10℃下搅拌反应混合物30分钟,然后经1小时升温至23℃,在23℃下保存16小时。保持温度低于30℃条件下,在反应混合物中依次滴加甲醇(0.21份重量,2.5当量)和水(14.8份重量)。相分离后,上层分别用1N盐酸水溶液(16.2份重量)、5%氯化钠水溶液(14.8份重量)、5%碳酸氢钠水溶液(14.8份重量)、5%氯化钠水溶液(14.8份重量)和5%氯化钠水溶液(14.8份重量)洗涤。通过减压蒸馏对上层有机层进行浓缩,得到粗品ER-804699。加入甲醇(7.91份重量),加热混合物至50℃,保持30分钟。经5小时将混合物冷却至0℃,然后在0℃下搅拌过夜。过滤固体,滤饼用冷甲醇(4份重量)洗涤,经干燥得到ER-804699(1.42份重量,74%产率)。Under nitrogen atmosphere, ER-807023 (1 wt, 1 eq) and MTBE (7.43 wt) were added to the reactor. 2,6-Lutidine (2.15 parts by weight, 7.5 equivalents) was added to the reaction solution. At 0°C, TBSOTf (2.47 wt, 3.5 eq) was added dropwise to the mixture. The reaction mixture was stirred at 0-10°C for 30 minutes, then warmed to 23°C over 1 hour and kept at 23°C for 16 hours. Methanol (0.21 wt, 2.5 eq) and water (14.8 wt) were sequentially added dropwise to the reaction mixture while keeping the temperature below 30°C. After phase separation, the upper layer was washed with 1N aqueous hydrochloric acid solution (16.2 parts by weight), 5% aqueous sodium chloride solution (14.8 parts by weight), 5% aqueous sodium bicarbonate solution (14.8 parts by weight), 5% aqueous sodium chloride solution (14.8 parts by weight), ) and 5% aqueous sodium chloride solution (14.8 wt.). The upper organic layer was concentrated by distillation under reduced pressure to obtain crude ER-804699. Methanol (7.91 wts) was added and the mixture was heated to 50°C for 30 minutes. The mixture was cooled to 0°C over 5 hours, then stirred at 0°C overnight. The solid was filtered and the filter cake was washed with cold methanol (4 wt) and dried to give ER-804699 (1.42 wt, 74% yield).
氮气氛下,在反应器中加入ER-804699(1份重量,1当量)的甲苯(2.60份重量)溶液。加入乙腈(4.72份重量)。加入TBSCl(0.011份重量,0.05当量)。使反应混合物升温至30℃,加入NIS(1.25份重量,4当量)。30℃下搅拌反应混合物22小时。冷却反应液至25℃,保持内温低于30℃下,经10分钟加入硫代硫酸钠水溶液和碳酸氢钠的混合物(10.35份重量)。25℃下,搅拌反应液30分钟。分离水层。上层用10%氯化钠水溶液(2×9.9份重量)洗涤两次。减压浓缩有机层,得到粗品ER-803895,经硅胶色谱纯化得到ER-803895(0.96份重量,89.5%产率)。Under a nitrogen atmosphere, a solution of ER-804699 (1 wt, 1 eq) in toluene (2.60 wts) was added to the reactor. Acetonitrile (4.72 wt) was added. TBSCl (0.011 wt, 0.05 eq) was added. The reaction mixture was allowed to warm to 30°C and NIS (1.25 wt, 4 eq) was added. The reaction mixture was stirred at 30°C for 22 hours. The reaction solution was cooled to 25°C, keeping the internal temperature below 30°C, and a mixture of aqueous sodium thiosulfate and sodium bicarbonate (10.35 wts) was added over 10 minutes. The reaction solution was stirred for 30 minutes at 25°C. Separate the aqueous layer. The upper layer was washed twice with 10% aqueous sodium chloride (2 x 9.9 wt). The organic layer was concentrated under reduced pressure to give crude ER-803895, which was purified by silica gel chromatography to give ER-803895 (0.96 wt, 89.5% yield).
实施例6Example 6
F-1a、F-2a和F-3a的组装及B-1939的制备Assembly of F-1a, F-2a and F-3a and preparation of B-1939
A.(R)或(S)N-[2-(4-异丙基-4,5-二羟基-唑-2-基)-6-甲基-苯基]-甲磺酰胺的制备A. Preparation of (R) or (S) N-[2-(4-isopropyl-4,5-dihydroxy-oxazol-2-yl)-6-methyl-phenyl]-methanesulfonamide
在预干燥的玻璃衬里的反应器中加入三光气(1份重量,1当量)和无水THF(2份体积),冷却至内温为-10℃。在第二个预干燥的玻璃衬里的反应器中加入ER-807244(1.27份重量,2.5当量)和无水THF(3份体积),冷却至内温为-10℃。以使内温不超过15℃的速度将第一个反应器的内容物转移至第二个反应器中。加样完毕后,在0℃内温下搅拌反应液1小时,然后逐渐升温至25℃。喷射氮气18小时以洗除过量的光气(用2N氢氧化钠溶液收集废气)。加入MTBE(3份体积),40-46℃氮气吹扫下蒸馏脱除溶剂,如果需要加入更多的MTBE。完成脱除光气后,将混合物冷却至内温为5-10℃,在MTBE(3份体积)洗涤下对溶液进行过滤,得到白色固体结晶状ER-807245(1.12份重量,0.97当量)。Triphosgene (1 wt, 1 eq) and anhydrous THF (2 vol) were added to a pre-dried glass-lined reactor and cooled to an internal temperature of -10°C. A second pre-dried glass-lined reactor was charged with ER-807244 (1.27 wt, 2.5 eq) and anhydrous THF (3 v) and cooled to an internal temperature of -10°C. The contents of the first reactor were transferred to the second reactor at such a rate that the internal temperature did not exceed 15°C. After adding the sample, the reaction solution was stirred at an internal temperature of 0°C for 1 hour, and then the temperature was gradually raised to 25°C. Nitrogen was sparged for 18 hours to wash off excess phosgene (the offgas was collected with 2N sodium hydroxide solution). MTBE (3 vol.) was added and the solvent was distilled off at 40-46° C. under a nitrogen purge, and more MTBE was added if necessary. After complete removal of phosgene, the mixture was cooled to an internal temperature of 5-10°C and the solution was filtered with MTBE (3 v) washes to afford ER-807245 (1.12 wt, 0.97 eq) as a white crystalline solid.
在预干燥的惰性反应器1中,加入ER-807245(1份重量,1当量)和无水DMF(4份体积)。搅拌下,将混合物加热至内温为95℃。加热反应器2至内温为90℃,在该反应器中,将D或L-缬氨醇(1.05当量,0.61份重量)溶解于无水DMF(1.3份体积)中。将反应器2的内容物转移至内温为90℃的反应器1中。发现有二氧化碳逸出,通过氮气流失排出反应液。90℃下搅拌反应溶液3小时后,冷却至内温为65℃。然后,在反应器1中加入氢氧化锂(0.47份重量,2当量)的水(2份体积)悬浮液,65℃内温下搅拌悬浮液1小时。在该反应器中加入水(5份体积),经3小时冷却至内温为约5℃。约5℃内温下,搅拌混合物8小时,在水(2×4份体积)和正庚烷(2×3份体积)依次洗涤下,过滤收集目标产物。真空下,35℃下用氮气流干燥产物24小时或直至KF≤250ppm,得到固体结晶状的ER-806628或ER-808056(0.80份重量,0.60当量)。In a pre-dried inert Reactor 1, ER-807245 (1 wt, 1 eq) and anhydrous DMF (4 vol) were charged. With stirring, the mixture was heated to an internal temperature of 95°C. In Reactor 2, D or L-valinol (1.05 equiv, 0.61 wt) was dissolved in anhydrous DMF (1.3 vol) by heating to an internal temperature of 90°C. The contents of Reactor 2 were transferred to Reactor 1 having an internal temperature of 90°C. Evolution of carbon dioxide was found and the reaction solution was vented by nitrogen loss. After stirring the reaction solution at 90°C for 3 hours, it was cooled to an internal temperature of 65°C. Then, a suspension of lithium hydroxide (0.47 wt, 2 eq) in water (2 v) was added to Reactor 1, and the suspension was stirred at an internal temperature of 65°C for 1 hour. Water (5 vol) was added to the reactor and cooled to an internal temperature of about 5°C over 3 hours. The mixture was stirred at an internal temperature of about 5°C for 8 hours, and the target product was collected by filtration, washed successively with water (2 x 4 vol.) and n-heptane (2 x 3 vol.). The product was dried under vacuum at 35° C. with nitrogen flow for 24 hours or until KF ≤ 250 ppm to give ER-806628 or ER-808056 (0.80 wt, 0.60 eq) as a solid crystal.
氮气下,在预干燥的惰性反应器中加入ER-806628或ER-808056(1份重量,1当量)、吡啶(3份重量,11.4当量)和DMAP(0.03份重量,0.05当量)。将反应液冷却至内温为-10℃后,以使内温低于15℃的速度加入甲磺酰氯(1.46份重量,3当量)。加样完毕后,在0-15℃内温下搅拌反应液1小时,然后经2小时缓慢升温至25℃。以使内温不超过35℃的速度先后加入MTBE(2.6份体积)和水(2份体积)。用6N盐酸(约1.9份体积)分批滴定两相混合物,直至水层的pH为约3-5。若pH低于3,加入30重量%碳酸钠水溶液进行反滴定以得到所需要的pH。各相分开,分离水相。将所有的有机物与水(0.7份体积)混合,弃去水相。将MTBE常压蒸馏至约2份体积,以得到55℃恒定沸点,且KF<500ppm。如果需要另外加入MTBE。冷却溶液至内温为5-10℃,需要时加入晶种诱导结晶。加入正庚烷(0.5份体积),5℃下搅拌混合物18小时,正庚烷(2×3份体积)洗涤下,过滤收集ER-806629或ER-807363。将滤液浓缩至1/2体积并冷却至0℃,得到第二批结晶。氮气下干燥滤饼18小时。在预干燥的反应器中加入粗称重的ER-806629,加入MTBE(3份体积)。将所得混合物加热至内温为45-50℃,保持45分钟,然后经3小时缓慢冷却至5℃,需要时可加入晶种。加入正庚烷(0.5份体积),5℃内温下搅拌混合物18小时。正庚烷(2×3份体积)洗涤下过滤收集固体产物,然后35℃下真空干燥24小时,得到固体结晶状的ER-806629或ER-807363(1.7份重量,0.57当量)。In a pre-dried inert reactor under nitrogen, ER-806628 or ER-808056 (1 wt, 1 eq), pyridine (3 wt, 11.4 eq) and DMAP (0.03 wt, 0.05 eq) were charged. After the reaction solution was cooled to an internal temperature of -10°C, methanesulfonyl chloride (1.46 parts by weight, 3 equivalents) was added at a rate such that the internal temperature was lower than 15°C. After adding the sample, the reaction solution was stirred at an internal temperature of 0-15°C for 1 hour, and then slowly raised to 25°C over 2 hours. MTBE (2.6 vol.) followed by water (2 vol.) was added at such a rate that the internal temperature did not exceed 35°C. The biphasic mixture was titrated in portions with 6N hydrochloric acid (ca. 1.9 vol.) until the pH of the aqueous layer was ca. 3-5. If the pH is below 3, add 30% by weight aqueous sodium carbonate for back titration to obtain the desired pH. The phases were separated and the aqueous phase was separated. All organics were mixed with water (0.7 vol) and the aqueous phase was discarded. MTBE was atmospherically distilled to about 2 volumes to obtain a constant boiling point of 55°C with a KF <500 ppm. Additional MTBE was added if necessary. Cool the solution to an internal temperature of 5-10°C, and add seeds to induce crystallization if necessary. n-Heptane (0.5 vol.) was added and the mixture was stirred at 5°C for 18 hours. ER-806629 or ER-807363 was collected by filtration under n-heptane (2 x 3 vol.) washes. The filtrate was concentrated to 1/2 volume and cooled to 0°C to obtain a second crop of crystals. The filter cake was dried under nitrogen for 18 hours. A crude weight of ER-806629 was added to the pre-dried reactor and MTBE (3 vol.) was added. The resulting mixture was heated to an internal temperature of 45-50°C for 45 minutes, then slowly cooled to 5°C over 3 hours, seeded if necessary. n-Heptane (0.5 vol.) was added and the mixture was stirred at an internal temperature of 5°C for 18 hours. The solid product was collected by filtration, washed with n-heptane (2 x 3 vol), and then dried under vacuum at 35°C for 24 hours to give ER-806629 or ER-807363 (1.7 wt, 0.57 eq) as a crystalline solid.
B.F-1a和F-2a的组装以及分子内醚的形成:B. Assembly of F-1a and F-2a and intramolecular ether formation:
在适当大小的反应器1中加入ER-807363(1.82份重量,3.55当量),进行氮气置换。加入无水THF(15份体积)。在反应器2中,对ER-806067(F-1a,1.14份重量,1.1当量)和ER-805973(F-2a,1份重量,1当量)进行混合,使之溶解于无水THF(6.3份体积)中。搅拌下,对该两个反应器喷射氮气30-45分钟。惰性气氛下,在反应器2中加入CrCl2(0.75份重量,3.55当量),然后加热至内温为30℃。以使内温不超过45℃的速度在反应器2中加入三乙胺(0.62份重量,3.55当量)。加样完毕后,保持30℃内温1小时。1小时后,将反应器2冷却至0℃,加入NiCl2(0.02份重量,0.1当量)形成惰性环境,加入反应器1的内容物后使反应液升温至室温。冷却反应器2至内温为0 ℃,然后以使内温不超过10℃的速度加入乙二胺(1.2份体积,10当量)。注意:发现放热。搅拌反应液1小时,然后加入水(8份体积)和正庚烷(20份体积),搅拌两相混合物4分钟,分层。分离有机层,水层用MTBE(20份体积)反萃取。将合并的有机层真空浓缩至粗品油,然后与无水THF(2×10.5份体积)形成共沸物。粗产物溶解于无水THF(4.5份体积)中,然后在-20℃下保存,直至用于下一步骤。ER-807363 (1.82 wt, 3.55 eq) was added to Reactor 1 of appropriate size for nitrogen displacement. Anhydrous THF (15 vol) was added. In Reactor 2, ER-806067 (F-1a, 1.14 wt, 1.1 eq) and ER-805973 (F-2a, 1 wt, 1 eq) were mixed and dissolved in anhydrous THF (6.3 part volume). Both reactors were sparged with nitrogen for 30-45 minutes with stirring. Under an inert atmosphere, CrCl 2 (0.75 wt, 3.55 eq) was added to Reactor 2, and then heated to an internal temperature of 30°C. Triethylamine (0.62 wt, 3.55 eq) was added to Reactor 2 at such a rate that the internal temperature did not exceed 45°C. After adding the sample, keep the internal temperature at 30°C for 1 hour. After 1 hour, Reactor 2 was cooled to 0° C., NiCl 2 (0.02 wt, 0.1 equiv) was added to make an inert environment, and the reaction solution was allowed to warm to room temperature after adding the contents of Reactor 1 . Reactor 2 was cooled to an internal temperature of 0°C, then ethylenediamine (1.2 vol, 10 eq) was added at such a rate that the internal temperature did not exceed 10°C. CAUTION: Found exothermic. The reaction was stirred for 1 hour, then water (8 vol) and n-heptane (20 vol) were added, the biphasic mixture was stirred for 4 minutes and the layers separated. The organic layer was separated and the aqueous layer was back extracted with MTBE (20 vol). The combined organic layers were concentrated in vacuo to a crude oil, which was then azeotroped with anhydrous THF (2 x 10.5 vol). The crude product was dissolved in anhydrous THF (4.5 vol) and stored at -20°C until used in the next step.
对前一步骤所得到的ER-808227/TFH溶液进行KF分析。若KF<1000ppm,则继续反应。若KF>1000ppm,则与无水THF(4.1份体积)进行真空共沸。重复共沸操作直至符合要求。符合要求的终溶液中含有溶于无水THF(4.1份体积)的粗品ER-808227。一旦符合要求,在适当大小的惰性反应器中加入无水THF(106份体积)和前一步骤所得到的ER-808227/TFH溶液。冷却反应器至内温为-15℃至-20℃,然后以使内温不超过-12℃的速度加入0.5M KHMDS的甲苯(9.1份重量,3.0当量)溶液。推进完全反应需要约4.5当量的KHMDS。0℃内温下,将反应液加至半饱和的氯化铵(40份体积)中进行逆猝灭。加入正庚烷(80份体积),搅拌2-5分钟后分层。分离有机层,水层用MTBE(70份体积)反萃取,然后合并有机层并用饱和氯化钠溶液(70份体积)洗涤。分离有机层并进行真空浓缩。在粗浓缩物中加入正庚烷(60份体积)。注意:ER-808373从溶液中沉淀出来。过滤所得的悬浮液,用正庚烷(20份体积)洗涤固体。真空浓缩滤液,得到棕色油状的粗品ER-806746(约4份重量)。注意:当另外的ER-808373从溶液中沉淀出来时,重复过滤操作。粗品ER-806746经SiO2柱色谱纯化得到亮黄色(clear yellowish)油状的ER-804027(1.16份重量,0.55当量)。色谱操作如下:首先用足量的MTBE冲洗柱子以除去水分,然后用庚烷冲洗柱子以除去MTBE。将ER-806746以庚烷溶液形式装柱,先后用庚烷/MTBE(5∶1)和庚烷/MTBE(4∶1)将其从柱中洗脱出来,用紫外检测器监测230nm处的级分。KF analysis was performed on the ER-808227/TFH solution obtained in the previous step. If KF<1000ppm, continue the reaction. If KF > 1000 ppm, vacuum azeotrope with anhydrous THF (4.1 vol). Repeat the azeotropic operation until the requirements are met. The satisfactory final solution contained crude ER-808227 in anhydrous THF (4.1 vol). Once satisfactory, anhydrous THF (106 vol) and the ER-808227/TFH solution from the previous step were added in an appropriately sized inert reactor. The reactor was cooled to an internal temperature of -15°C to -20°C, then a 0.5M solution of KHMDS in toluene (9.1 wts, 3.0 eq) was added at such a rate that the internal temperature did not exceed -12°C. About 4.5 equivalents of KHMDS are required to drive the complete reaction. At 0 °C internal temperature, the reaction solution was added to half-saturated ammonium chloride (40 vol.) for back quenching. Add n-heptane (80 vol) and stir for 2-5 minutes before separating the layers. The organic layer was separated, the aqueous layer was back extracted with MTBE (70 vol), and the combined organic layers were washed with saturated sodium chloride solution (70 vol). The organic layer was separated and concentrated in vacuo. To the crude concentrate was added n-heptane (60 vol). Note: ER-808373 precipitated out of solution. The resulting suspension was filtered and the solid was washed with n-heptane (20 vol). The filtrate was concentrated in vacuo to afford crude ER-806746 (ca. 4 wt) as a brown oil. NOTE: Repeat the filtration operation when additional ER-808373 precipitates out of solution. Crude ER-806746 was purified by SiO 2 column chromatography to give ER-804027 (1.16 wt, 0.55 eq) as a clear yellowish oil. Chromatography was performed as follows: the column was first flushed with sufficient MTBE to remove water, and then the column was flushed with heptane to remove MTBE. ER-806746 was packed into a column in the form of heptane solution, and it was eluted from the column with heptane/MTBE (5:1) and heptane/MTBE (4:1) successively. fraction.
在反应器中加入ER-804027(1份重量,1当量)和无水二氯甲烷(7.6份体积)。冷却反应器至内温为-78℃,然后以使内温不超过-60℃的速度加入1M DIBALH的二氯甲烷(3.0份重量,2.25当量)溶液。以使内温不超过-60℃的速度加入甲醇(0.1份体积)。注意:选出氢气,并用氮气流进行稀释。加样完毕后,使混合物升温至室温后加入1N盐酸(10.6份体积)和MTBE(25份体积)。搅拌混合物20分钟,分层。分离有机层,水层用MTBE(15.3份体积)反萃取。合并有机层,分别用水(3份体积)、饱和碳酸氢钠(3份体积)和饱和氯化钠(3份体积)洗涤后真空浓缩。粗浓缩物经SiO2柱色谱纯化得到白色泡沫状的ER-804028(0.84份重量,0.93当量)。The reactor was charged with ER-804027 (1 wt, 1 eq) and anhydrous dichloromethane (7.6 vol). The reactor was cooled to an internal temperature of -78°C, then a 1M solution of DIBALH in dichloromethane (3.0 wt, 2.25 equiv) was added at such a rate that the internal temperature did not exceed -60°C. Methanol (0.1 vol) was added at such a rate that the internal temperature did not exceed -60°C. NOTE: Hydrogen is selected and diluted with nitrogen flow. After the addition was complete, the mixture was allowed to warm to room temperature and 1 N hydrochloric acid (10.6 vol) and MTBE (25 vol) were added. The mixture was stirred for 20 minutes and the layers were separated. The organic layer was separated and the aqueous layer was back extracted with MTBE (15.3 vol). The combined organic layers were washed with water (3 vol), saturated sodium bicarbonate (3 vol), and saturated sodium chloride (3 vol), respectively, and concentrated in vacuo. The crude concentrate was purified by SiO2 column chromatography to afford ER-804028 (0.84 wt, 0.93 eq) as a white foam.
C.F-3a的并入以及转换成B-1939C. Incorporation of F-3a and conversion to B-1939
氩气氛下,将ER-803895(F-3a)溶解于无水甲苯(14份重量)中并冷却至<-75℃。然后以使内部反应温度<-70℃的速度加入DIBALH(1.5M甲苯溶液,0.95份重量,1.3当量)。搅拌所得的混合物30分钟后用无水甲醇(0.13份重量,3.2当量)进行猝灭,期间保持内部反应温度<-65℃。使反应混合物升温至-10℃,在MTBE(3.74份重量)冲洗下转移至含有1N盐水(10.2份重量)的后处理容器中。搅拌混合物30分钟,排除水层。有机相依次用1N盐酸(10.2份重量)、水(10份重量)、饱和碳酸氢钠水溶液(10份重量)和盐水(10份重量)洗涤,然后进行减压浓缩。浓缩物经硅胶柱色谱纯化得到ER-803896(0.96份重量,93%产率)。该产物在-20℃下保存于氩气下。Under argon atmosphere, ER-803895 (F-3a) was dissolved in anhydrous toluene (14 wts) and cooled to <-75°C. DIBALH (1.5M in toluene, 0.95 wt, 1.3 equiv) was then added at such a rate that the internal reaction temperature was <-70°C. The resulting mixture was stirred for 30 min and then quenched with anhydrous methanol (0.13 wt, 3.2 eq) while maintaining the internal reaction temperature <-65°C. The reaction mixture was allowed to warm to -10°C and transferred to a workup vessel containing 1N brine (10.2 wt) with a rinse of MTBE (3.74 wt). The mixture was stirred for 30 minutes and the aqueous layer was discarded. The organic phase was washed successively with 1N hydrochloric acid (10.2 wts), water (10 wts), saturated aqueous sodium bicarbonate (10 wts) and brine (10 wts), then concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography to obtain ER-803896 (0.96 wt, 93% yield). The product was stored under argon at -20°C.
0℃下,用正丁基锂(1.6M己烷溶液,1.02份重量,1.5份体积,2.05当量)以使内温不超过5℃的速度处理共沸干燥的砜ER-804028(1.0份重量,1当量)的无水四氢呋喃(5份体积,4.45份重量)溶液。0-5℃内温下搅拌混合物10分钟,然后冷却至<-75℃。将共沸干燥的醛ER-803896(1.07份重量,1.23当量)溶解于无水己烷(3.53份重量,5.35份体积)后冷却至<-75℃。在内温≤-65℃条件下,通过套管将醛溶液加至ER-804028阴离子液中。-78℃内温下,搅拌混合物45分钟,然后加入饱和氯化铵(5份体积)、甲基叔丁基醚(10份体积)和水(5份体积)进行猝灭。弃去水层,减压浓缩有机层。粗物质经C-18反相色谱纯化得到ER-804029(84%,1.57份重量)。At 0°C, azeotropically dried sulfone ER-804028 (1.0 wt. , 1 eq) in anhydrous THF (5 vol, 4.45 wt). The mixture was stirred at an internal temperature of 0-5°C for 10 minutes, then cooled to <-75°C. The azeotropically dried aldehyde ER-803896 (1.07 wt, 1.23 eq) was dissolved in anhydrous hexane (3.53 wt, 5.35 vol) and cooled to <-75°C. Under the condition of internal temperature ≤ -65°C, add the aldehyde solution to the ER-804028 anion solution through a cannula. The mixture was stirred at -78°C internal temperature for 45 minutes, then quenched by the addition of saturated ammonium chloride (5 vol), methyl tert-butyl ether (10 vol) and water (5 vol). The aqueous layer was discarded, and the organic layer was concentrated under reduced pressure. The crude material was purified by C-18 reverse phase chromatography to give ER-804029 (84%, 1.57 wt).
将砜-二醇ER-804029(1份重量,1当量)溶解于湿的二氯甲烷(7.4份体积,含水0.04重量%)中,置于20-25℃水浴中。一次加入Dess-Martin试剂(0.67份重量,2.5当量)。用饱和碳酸氢钠(10份体积)和10重量%亚硫酸钠水溶液(10份体积)猝灭反应混合物,搅拌30分钟。混合物用饱和氯化钠(10份体积)稀释,用MTBE(25份体积)萃取。弃去水层,浓缩有机层,经硅胶色谱纯化得到ER-804030(0.9份重量,90%)。-20℃下,该物质保存于惰性气氛下。Sulfone-diol ER-804029 (1 wt, 1 eq) was dissolved in wet dichloromethane (7.4 vol, 0.04 wt% water) and placed in a 20-25°C water bath. Dess-Martin reagent (0.67 wt, 2.5 eq) was added in one portion. The reaction mixture was quenched with saturated sodium bicarbonate (10 vol) and 10 wt% aqueous sodium sulfite (10 vol), and stirred for 30 minutes. The mixture was diluted with saturated NaCl (10 vol) and extracted with MTBE (25 vol). The aqueous layer was discarded, the organic layer was concentrated, and purified by silica gel chromatography to give ER-804030 (0.9 wt, 90%). At -20°C, the material was stored under an inert atmosphere.
惰性气氛下,在预干燥的反应器中加入二碘化钐溶液(2.5当量),将该溶液冷却至内温<-70℃。将ER-804030(1份重量)溶解于无水甲醇(4.1份重量)和无水THF(2.3份重量)中,然后冷却至<-70℃。以使内温不超过-70℃的速度在冷的钐溶液中加入ER-804030。内温不超过-65℃条件下,用碳酸钾/罗谢尔盐/水(1/10/100;重量/重量/体积,15份体积)和MTBE(5份体积)猝灭反应。后处理溶液加完后,使反应液升温至室温,用后处理溶液(20份体积,冲洗)和MTBE(20份体积,冲洗)将混合物转移至另一个容器中。弃去水层,蒸发有机层,残渣经硅胶色谱纯化得到ER-118049(0.77份重量,85%)。-20℃下该产物保存于惰性气氛下。Under an inert atmosphere, samarium diiodide solution (2.5 equivalents) was added to a pre-dried reactor, and the solution was cooled to an inner temperature <-70°C. ER-804030 (1 wt) was dissolved in anhydrous methanol (4.1 wt) and anhydrous THF (2.3 wt), then cooled to <-70°C. Add ER-804030 to the cold samarium solution at such a rate that the internal temperature does not exceed -70°C. The reaction was quenched with potassium carbonate/Rochelle salt/water (1/10/100; w/w/v, 15 vol) and MTBE (5 vol) without internal temperature exceeding -65°C. After the addition of the work-up solution was complete, the reaction was allowed to warm to room temperature and the mixture was transferred to another vessel with work-up solution (20 vol, rinse) and MTBE (20 vol, rinse). The aqueous layer was discarded, the organic layer was evaporated, and the residue was purified by silica gel chromatography to obtain ER-118049 (0.77 wt, 85%). Store the product under an inert atmosphere at -20°C.
在预干燥的反应器中加入(S)-配体ER-807363(2.05份重量),进行氮气置换。一次加入CrCl2(0.85份重量,10当量)后加入无水乙腈(21.5份重量),使混合物升温至并保持在30℃-35℃。一次加入三乙胺(0.7份重量,0.96份体积,10当量),搅拌混合物1小时。一次加入NiCl2(0.09份重量,1当量)后经30分钟加入酮醛ER-118049的无水THF(2.43份重量,2.73份体积)溶液。撤除热源,加入庚烷(20.5份重量,30份体积)和Celite(1.5份重量)。搅拌混合物5分钟,过滤通过Celite垫(15份重量)用庚烷(7.3份体积)和乙腈(5份体积)冲洗Celite垫。将滤液转移至另外一个漏斗中,除去下层。需要时,用乙腈(最多47.2份重量,最多60份体积)洗涤合并的庚烷层。减压蒸发庚烷层,产物经硅胶色谱纯化得到ER-118047/048(0.64份重量,70%)。(S)-ligand ER-807363 (2.05 wt.) was added to the pre-dried reactor for nitrogen replacement. CrCl2 (0.85 wt, 10 eq) was added in one portion followed by anhydrous acetonitrile (21.5 wt) and the mixture was allowed to warm to and maintain at 30°C-35°C. Triethylamine (0.7 wt, 0.96 vol, 10 eq) was added in one portion and the mixture was stirred for 1 hour. A solution of ketoaldehyde ER-118049 in anhydrous THF (2.43 wt, 2.73 vol) was added over 30 minutes after one addition of NiCl2 (0.09 wt, 1 eq). The heat was removed and heptane (20.5 wt, 30 vol) and Celite (R) (1.5 wt) were added. The mixture was stirred for 5 minutes, filtered through a pad of Celite (R) (15 wt) and the pad of Celite (R) was rinsed with heptane (7.3 vol) and acetonitrile (5 vol). The filtrate was transferred to another funnel and the lower layer was removed. The combined heptane layers were washed with acetonitrile (up to 47.2 wt, up to 60 vol) as needed. The heptane layer was evaporated under reduced pressure, and the product was purified by silica gel chromatography to obtain ER-118047/048 (0.64 wt, 70%).
将烯丙基醇ER-118047/048溶解于二氯甲烷(含0.04重量%水,9体积)中,将反应器至于水浴(20℃)中,用Dess-Martin试剂(0.48份重量,1.5当量)处理溶液。反应混合物用饱和碳酸氢钠水溶液(9份体积)和10%亚硫酸钠水溶液(9份体积)处理后搅拌20分钟,通过DCM(10份体积)转移至另一个漏斗中。弃去水层,蒸发有机层至残渣。粗物质经快速色谱纯化(用3个柱体积的DCM/庚烷(1∶1体积比)预处理,用1∶1DCM/庚烷将物质装柱,然后用10/10/1庚烷/DCM/MTBE进行洗脱)。浓缩含有产物的级分,-20℃下保存于惰性气氛下。Allyl alcohol ER-118047/048 was dissolved in dichloromethane (containing 0.04% by weight of water, 9 volumes), the reactor was placed in a water bath (20° C.), and Dess-Martin reagent (0.48 parts by weight, 1.5 eq. ) treatment solution. The reaction mixture was treated with saturated aqueous sodium bicarbonate (9 vol) and 10% aqueous sodium sulfite (9 vol), stirred for 20 min, and transferred to another funnel via DCM (10 vol). The aqueous layer was discarded and the organic layer was evaporated to a residue. The crude material was purified by flash chromatography (pretreated with 3 column volumes of DCM/heptane (1:1 volume ratio), the material was packed with 1:1 DCM/heptane, then 10/10/1 heptane/DCM /MTBE for elution). Fractions containing product were concentrated and stored at -20°C under an inert atmosphere.
或者,按如下方法将ER-118047/48氧化成二酮ER-118046。在烧瓶中加入ER-118047/48(1份重量,1.0当量),室温下加入甲苯(10份体积)和DMSO(0.15份重量,2.5当量)。加入三乙胺(0.31份重量,4.0当量),将溶液冷却至-15℃。加入纯净TCAA(0.33份重量,1.4当量),使反应液升温至0℃。然后在0℃下搅拌10分钟。再次搅拌反应液10分钟后用IPA(0.15份体积)进行猝灭。0℃下搅拌反应液10分钟。经2分钟加入1N盐酸(5份体积),使反应液升温至室温并用MTBE(5份体积)稀释。形成两个透明层,移除水层。有机层用5份体积的5%碳酸氢盐(水溶液)洗涤,用旋转蒸发仪浓缩至深黄色油,经硅胶色谱纯化(91%分离产率)。Alternatively, ER-118047/48 was oxidized to the diketone ER-118046 as follows. A flask was charged with ER-118047/48 (1 wt, 1.0 eq) and toluene (10 v) and DMSO (0.15 wt, 2.5 eq) were added at room temperature. Triethylamine (0.31 wt, 4.0 eq) was added and the solution was cooled to -15°C. Neat TCAA (0.33 wt, 1.4 eq) was added and the reaction was allowed to warm to 0°C. It was then stirred at 0°C for 10 minutes. The reaction was stirred again for 10 minutes and then quenched with IPA (0.15 vol). The reaction was stirred at 0°C for 10 minutes. 1 N Hydrochloric acid (5 vol) was added over 2 minutes, the reaction was allowed to warm to room temperature and diluted with MTBE (5 vol). Two clear layers formed and the aqueous layer was removed. The organic layer was washed with 5 volumes of 5% bicarbonate (aq), concentrated on a rotary evaporator to a dark yellow oil, and purified by silica gel chromatography (91% isolated yield).
室温下,在适当大小的反应容器(容器A)中先后加入盐酸咪唑(0.39份重量,5当量)和1M TBAF的THF溶液(7.6份体积,10当量)。搅拌所得的混合物直至均匀(15-30分钟)。在第二个反应容器(容器B)中加入ER-118046(1份重量,1当量)和THF(33份体积)。将容器B的内容物置于惰性气氛下并进行搅拌直至ER-118046完全溶解。在烧瓶B(ER-118046/THF)中一次加入烧瓶A的内容物(TBAF/咪唑)。3-4天后,将反应溶液装柱,进行硅胶色谱纯化。In an appropriately sized reaction vessel (vessel A) was added imidazole hydrochloride (0.39 wt, 5 eq) followed by 1 M TBAF in THF (7.6 vol, 10 eq) at room temperature. The resulting mixture was stirred until homogeneous (15-30 minutes). In a second reaction vessel (vessel B) was charged ER-118046 (1 wt, 1 eq) and THF (33 vol). The contents of Vessel B were placed under an inert atmosphere and stirred until ER-118046 was completely dissolved. In flask B (ER-118046/THF) was added the contents of flask A (TBAF/imidazole) in one portion. After 3-4 days, the reaction solution was packed into a column and purified by silica gel chromatography.
氮气氛下,将干燥的ER-118064(F-12,其中R1为甲氧基)残渣溶解于无水二氯甲烷(28份体积)中,用PPTS(1.0份重量,5.2当量)一次处理。30-90分钟后,将反应混合物直接从顶部装载入合适的柱子中,进行硅胶色谱纯化。真空浓缩目标级分ER-076349。对所有的纯级分进行浓缩,所得到的物质在甲苯(20份体积)中共沸两次,得到易碎的无色固体/泡沫状的ER-076349(0.44份重量,0.79当量(对残留甲苯校正后))。Under nitrogen atmosphere, the dried residue of ER-118064 (F-12, where R is methoxy) was dissolved in anhydrous dichloromethane (28 v) and treated once with PPTS (1.0 wt, 5.2 eq) . After 30-90 minutes, the reaction mixture was loaded directly from the top onto a suitable column and purified by chromatography on silica gel. The target fraction ER-076349 was concentrated in vacuo. All pure fractions were concentrated and the resulting material was azeotroped twice in toluene (20 v) to give ER-076349 as a friable colorless solid/foam (0.44 wt, 0.79 eq (p to residual toluene after correction)).
在清洁干燥的反应容器(烧瓶C)中,将ER-076349(1份重量,1当量)溶解于无水甲苯(20份体积)中,减压浓缩至干。将该物质再次溶解于无水甲苯(20份体积)中,浓缩至干。将该物质溶于DCM(5份体积)中,将溶液置于氩气氛下。一次加入三甲基吡啶(0.66份重量,4.0当量)。一次加入吡啶的DCM溶液(烧瓶B中)(5摩尔%)。将烧瓶C中的所得混合物冷却至内温为-20至-25℃。保持内温低于-16℃下滴加Ts2O的DCM溶液(1.02当量)。-20至-25℃下搅拌反应液80分钟后经20分钟升温至0℃,进一步搅拌20分钟。用水(2份体积)猝灭反应。移除水浴,使反应液升温至室温(15-20℃)并进行搅拌(20分钟)。用IPA(100份体积)将反应液冲洗至更大的容器中,在反应液中加入氢氧化铵水溶液(100份体积)。室温下搅拌反应液15-36小时,监控就地生成的甲苯磺酸酯(ER-082892)和环氧化物(ER-809681)的消失情况。减压下,浓缩反应液至干或接近干。所得物质用DCM(25-40份体积)稀释,用pH10的缓冲液(碳酸氢钠/碳酸钠(水溶液),10份体积)洗涤。水相用25份体积的DCM反萃取,将合并的有机层浓缩至干。所得游离胺经硅胶色谱(以乙腈/水缓冲液为流动相)纯化。对合并的级分进行减压浓缩以脱除乙腈。所得水层用DCM(40份体积)和30份体积的缓冲储备液(pH10,碳酸氢钠/碳酸钠)稀释。充分混合各层并进行分离。水相用25份体积的DCM反萃取,将合并的有机层浓缩至干。所得游离胺经精致过滤成3∶1DCM/戊烷溶液,浓缩至干(0.80份重量)得到B-1939。In a clean and dry reaction vessel (flask C), ER-076349 (1 wt, 1 eq) was dissolved in anhydrous toluene (20 vol) and concentrated to dryness under reduced pressure. This material was redissolved in anhydrous toluene (20 vol) and concentrated to dryness. This material was dissolved in DCM (5 v) and the solution was placed under argon atmosphere. Collidine (0.66 wt, 4.0 eq) was added in one portion. A solution of pyridine in DCM (in flask B) (5 mol %) was added in one portion. The resulting mixture in flask C was cooled to an internal temperature of -20 to -25°C. A solution of Ts2O in DCM (1.02 equiv) was added dropwise keeping the internal temperature below -16°C. The reaction solution was stirred at -20 to -25°C for 80 minutes, then heated to 0°C over 20 minutes, and stirred for a further 20 minutes. The reaction was quenched with water (2 vol.). The water bath was removed and the reaction was allowed to warm to room temperature (15-20 °C) with stirring (20 min). The reaction was rinsed into a larger vessel with IPA (100 vol), and aqueous ammonium hydroxide (100 vol) was added to the reaction. The reaction was stirred at room temperature for 15-36 hours, monitoring the disappearance of the in situ formed tosylate (ER-082892) and epoxide (ER-809681). Under reduced pressure, the reaction solution was concentrated to dryness or nearly dryness. The resulting material was diluted with DCM (25-40 vol) and washed with pH 10 buffer (NaHCO3/NaCO3(aq), 10 vol). The aqueous phase was back extracted with 25 volumes of DCM and the combined organic layers were concentrated to dryness. The resulting free amine was purified by silica gel chromatography (acetonitrile/water buffer as mobile phase). The combined fractions were concentrated under reduced pressure to remove acetonitrile. The resulting aqueous layer was diluted with DCM (40 v) and 30 v stock buffer (pH 10, sodium bicarbonate/sodium carbonate). The layers were mixed well and separated. The aqueous phase was back extracted with 25 volumes of DCM and the combined organic layers were concentrated to dryness. The resulting free amine was polished filtered into a 3:1 DCM/pentane solution and concentrated to dryness (0.80 wt) to afford B-1939.
虽然,我们对本发明的大量实施方式进行了描述,显然可对我们的基本实施例进行变换以提供利用本发明化合物及方法的其它实施方式。因此,应理解的是,本发明的范围由所附的权利要求所定义,而不是由实施例方式表述的具体实施方式加以限定。While we have described a number of embodiments of the invention, it will be apparent that our basic examples can be altered to provide other embodiments utilizing the compounds and methods of the invention. It is therefore to be understood that the scope of the present invention is defined by the appended claims rather than by the specific embodiments set forth by way of example.
Claims (12)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410850876.5A CN104876896A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogues of halichondrin B |
| CN201811176801.8A CN109180615A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogs of halichondrin B |
| CN201810736482.5A CN108997267A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogues of halichondrin B |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57664204P | 2004-06-03 | 2004-06-03 | |
| US60/576,642 | 2004-06-03 | ||
| US60/626,769 | 2004-11-10 | ||
| US60/663,300 | 2005-03-18 |
Related Child Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811176801.8A Division CN109180615A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogs of halichondrin B |
| CN201810736482.5A Division CN108997267A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogues of halichondrin B |
| CN201010236637.2A Division CN101899026B (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogues of halichondrin B |
| CN201410850876.5A Division CN104876896A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogues of halichondrin B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1993342A true CN1993342A (en) | 2007-07-04 |
Family
ID=38214909
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200580026228 Pending CN1993342A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of halichondrin b |
| CN201810736482.5A Pending CN108997267A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogues of halichondrin B |
| CN201811176801.8A Pending CN109180615A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogs of halichondrin B |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810736482.5A Pending CN108997267A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogues of halichondrin B |
| CN201811176801.8A Pending CN109180615A (en) | 2004-06-03 | 2005-06-03 | Intermediates for the preparation of analogs of halichondrin B |
Country Status (2)
| Country | Link |
|---|---|
| CN (3) | CN1993342A (en) |
| CA (1) | CA2822994C (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102803254A (en) * | 2010-01-26 | 2012-11-28 | 卫材R&D管理有限公司 | Furo[3,2-B]pyran Derivatives Used in the Synthesis of Halichondrin B Analogues |
| CN104080793A (en) * | 2011-12-29 | 2014-10-01 | 阿方拉研究股份有限公司 | 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation |
| CN101883763B (en) * | 2007-10-03 | 2016-04-20 | 卫材R&D管理有限公司 | Intermediates and methods for the synthesis of halichondrin B analogs |
| CN105683198A (en) * | 2013-11-04 | 2016-06-15 | 卫材R&D管理有限公司 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b |
| CN105713031A (en) * | 2014-12-05 | 2016-06-29 | 正大天晴药业集团股份有限公司 | Intermediate for preparing eribulin and preparation method thereof |
| CN105916861A (en) * | 2013-12-06 | 2016-08-31 | 卫材R&D管理有限公司 | Methods that can be used for the synthesis of halichondrin B analogs |
| CN108658956A (en) * | 2017-03-28 | 2018-10-16 | 上海时莱生物技术有限公司 | Eribulin intermediate and preparation method thereof |
| WO2018210297A1 (en) * | 2017-05-17 | 2018-11-22 | 上海时莱生物技术有限公司 | Intermediate of eribulin and preparation method therefor |
| CN109694379A (en) * | 2017-10-24 | 2019-04-30 | 江苏恒瑞医药股份有限公司 | It is used to prepare the intermediate and preparation method thereof of eribulin |
| WO2019166019A1 (en) * | 2018-03-02 | 2019-09-06 | 北京天一绿甫医药科技有限公司 | Pyran fused ring compound, preparation method therefor and use thereof |
| CN113354659A (en) * | 2021-06-08 | 2021-09-07 | 江苏慧聚药业有限公司 | Synthesis of eribulin mesylate |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111689982B (en) * | 2019-03-15 | 2023-04-07 | 博瑞生物医药(苏州)股份有限公司 | Eribulin intermediate and preparation method thereof |
| CN110684036B (en) * | 2019-11-22 | 2022-04-12 | 江苏慧聚药业股份有限公司 | Method for preparing eribulin mesylate |
| CN113121555B (en) * | 2020-01-16 | 2024-03-08 | 南通诺泰生物医药技术有限公司 | Method for preparing eribulin intermediate through microchannel reactor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436238A (en) * | 1992-03-12 | 1995-07-25 | President And Fellows Of Harvard College | Halichondrins and related compounds |
| US5338865A (en) * | 1992-03-12 | 1994-08-16 | President And Fellows Of Harvard College | Synthesis of halichondrin B and norhalichondrin B |
| JP4454151B2 (en) * | 1998-06-17 | 2010-04-21 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Macrocyclic analogs and their use and methods of preparation |
-
2005
- 2005-06-03 CN CN 200580026228 patent/CN1993342A/en active Pending
- 2005-06-03 CN CN201810736482.5A patent/CN108997267A/en active Pending
- 2005-06-03 CA CA2822994A patent/CA2822994C/en not_active Expired - Lifetime
- 2005-06-03 CN CN201811176801.8A patent/CN109180615A/en active Pending
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101883763B (en) * | 2007-10-03 | 2016-04-20 | 卫材R&D管理有限公司 | Intermediates and methods for the synthesis of halichondrin B analogs |
| CN102803254B (en) * | 2010-01-26 | 2016-09-14 | 卫材R&D管理有限公司 | furo [3,2-B ] pyran derivatives for halichondrin B analog synthesis |
| CN102803254A (en) * | 2010-01-26 | 2012-11-28 | 卫材R&D管理有限公司 | Furo[3,2-B]pyran Derivatives Used in the Synthesis of Halichondrin B Analogues |
| CN104080793A (en) * | 2011-12-29 | 2014-10-01 | 阿方拉研究股份有限公司 | 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation |
| CN104080793B (en) * | 2011-12-29 | 2017-09-19 | 阿方拉研究股份有限公司 | 2 (base of (2S, 3S, 4R, 5R) 5 (hydroxyl of (S) 3 amino 2 the third 1 base) 4 methoxyl group 3 (benzenesulfonylmethyl) tetrahydrofuran 2) acetaldehyde derivatives and their preparation method |
| CN109942560A (en) * | 2013-11-04 | 2019-06-28 | 卫材R&D管理有限公司 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B |
| CN105683198A (en) * | 2013-11-04 | 2016-06-15 | 卫材R&D管理有限公司 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b |
| US11643418B2 (en) | 2013-11-04 | 2023-05-09 | Eisai R&D Management Co., Ltd. | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B |
| CN109942560B (en) * | 2013-11-04 | 2022-06-17 | 卫材R&D管理有限公司 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B |
| CN105683198B (en) * | 2013-11-04 | 2019-03-12 | 卫材R&D管理有限公司 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B |
| CN105916861A (en) * | 2013-12-06 | 2016-08-31 | 卫材R&D管理有限公司 | Methods that can be used for the synthesis of halichondrin B analogs |
| CN105916861B (en) * | 2013-12-06 | 2018-12-14 | 卫材R&D管理有限公司 | Methods useful for the synthesis of halichondrin B analogs |
| CN105713031B (en) * | 2014-12-05 | 2021-05-07 | 正大天晴药业集团股份有限公司 | Intermediate for preparing eribulin and preparation method thereof |
| CN105713031A (en) * | 2014-12-05 | 2016-06-29 | 正大天晴药业集团股份有限公司 | Intermediate for preparing eribulin and preparation method thereof |
| CN108658956B (en) * | 2017-03-28 | 2021-02-02 | 上海时莱生物技术有限公司 | Eribulin intermediate and preparation method thereof |
| CN108658956A (en) * | 2017-03-28 | 2018-10-16 | 上海时莱生物技术有限公司 | Eribulin intermediate and preparation method thereof |
| WO2018210297A1 (en) * | 2017-05-17 | 2018-11-22 | 上海时莱生物技术有限公司 | Intermediate of eribulin and preparation method therefor |
| US11186570B2 (en) | 2017-05-17 | 2021-11-30 | Selection Bioscience Llc | Intermediate of eribulin and preparation method therefor |
| CN109694379A (en) * | 2017-10-24 | 2019-04-30 | 江苏恒瑞医药股份有限公司 | It is used to prepare the intermediate and preparation method thereof of eribulin |
| CN109694379B (en) * | 2017-10-24 | 2020-09-11 | 江苏恒瑞医药股份有限公司 | Intermediate for preparing eribulin and preparation method thereof |
| WO2019166019A1 (en) * | 2018-03-02 | 2019-09-06 | 北京天一绿甫医药科技有限公司 | Pyran fused ring compound, preparation method therefor and use thereof |
| CN110218213A (en) * | 2018-03-02 | 2019-09-10 | 北京天一绿甫医药科技有限公司 | The thick cyclics of pyrans, preparation method and use |
| US11396515B2 (en) | 2018-03-02 | 2022-07-26 | Beijing Tienyi Lufu Pharmatech Co. Ltd. | Pyran fused ring compound, preparation method therefor and use thereof |
| CN113354659A (en) * | 2021-06-08 | 2021-09-07 | 江苏慧聚药业有限公司 | Synthesis of eribulin mesylate |
| CN113354659B (en) * | 2021-06-08 | 2022-04-08 | 江苏慧聚药业股份有限公司 | Synthesis of eribulin mesylate |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2822994C (en) | 2016-09-27 |
| CN108997267A (en) | 2018-12-14 |
| CA2822994A1 (en) | 2005-12-15 |
| CN109180615A (en) | 2019-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1122668C (en) | Epothilone derivatives and their use as antitumor agents | |
| CN1046261C (en) | Synthesis of Paclitaxel and Its Derivatives | |
| CN1134444C (en) | Epothilone analogs and pharmaceutical compositions thereof | |
| CN1205196C (en) | Process for selective derivatization of taxanes | |
| CN1341115A (en) | 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use | |
| CN1192031C (en) | Epothilones derivatives, their synthesis and uses | |
| CN1153771C (en) | Benzofuran [3, 4-f ] quinoline derivative, pharmaceutical composition containing same and application thereof | |
| CN1188477A (en) | pentacyclic compound | |
| CN1759115A (en) | Epothilone (EPOTHILONE), an intermediate for synthesizing Epothilone, its analogue and its use | |
| CN1993342A (en) | Intermediates for the preparation of halichondrin b | |
| CN1492865A (en) | Beta-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same | |
| CN1349534A (en) | 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations | |
| CN1300289A (en) | Novel harringane derivatives and their preparation methods | |
| CN1340053A (en) | Epothilon derivatives, method for the production and the use as pharmaceuticals | |
| CN1037773C (en) | Tricyclic Compounds Containing Heteroatoms | |
| CN1230166A (en) | Illudin Antineoplastic Agents | |
| CN1278825A (en) | Sarcodictyin and eleutherobin useful for stabilising microtubules | |
| CN1138040A (en) | New cyclohexane compounds, process for their preparation and pharmaceutical compositions containing them | |
| CN100338066C (en) | Hexacyclic compounds | |
| CN1968942A (en) | Novel tetracyclic tetrahydrofuran derivatives | |
| CN1796363A (en) | Compounds of class of styracin and cinepazid ester phenylpropionic acid, prepration method and application | |
| CN1753898A (en) | Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof | |
| CN1086188C (en) | Novel phenanethridinium derivatives | |
| CN1177842C (en) | New agarwood furan derivatives, their pharmaceutical compositions and their use in preparing medicines | |
| CN1127757A (en) | Novel tetrahydropyran compounds, their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WEI CAI & D MANAGEMENT CO., LTD. Free format text: FORMER OWNER: EISAI CO., LTD. Effective date: 20080314 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20080314 Address after: Tokyo, Japan, Japan Applicant after: Eisai R. & D. Man Co., Ltd. Address before: Tokyo, Japan Applicant before: Eisai co., Ltd. |
|
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20070704 |